MVB Financial (MVBF) 10-Q 1 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Oct. 29, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-38314
Entity Registrant Name	MVB Financial Corp
Entity Incorporation, State or Country Code	WV
Entity Tax Identification Number	20-0034461
Entity Address, Address Line One	301 Virginia Avenue
Entity Address, City or Town	Fairmont
Entity Address, State or Province	WV
Entity Address, Postal Zip Code	26554
City Area Code	304
Local Phone Number	363-4800
Title of 12(b) Security	Common stock, $1.00 par value
Trading Symbol	MVBF
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		12,039,548
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Central Index Key	0001277902

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Cash and cash equivalents:
Cash and due from banks	$ 9,784	$ 19,110
Interest-bearing balances with banks	380,297	244,783
Total cash and cash equivalents	390,081	263,893
Certificates of deposit with banks	9,582	11,803
Investment securities available-for-sale	439,023	410,624
Equity securities	29,809	27,585
Loans held-for-sale	0	1,062
Loans receivable	1,764,186	1,453,744
Allowance for loan losses	(25,187)	(25,844)
Loans receivable, net	1,738,999	1,427,900
Premises and equipment, net	25,043	26,203
Bank-owned life insurance	42,011	41,262
Equity method investments	38,935	46,494
Accrued interest receivable and other assets	71,353	72,300
Goodwill	3,988	2,350
TOTAL ASSETS	2,788,824	2,331,476
Deposits:
Noninterest-bearing	999,328	715,791
Interest-bearing	1,399,612	1,266,598
Total deposits	2,398,940	1,982,389
Accrued interest payable and other liabilities	39,079	55,931
Repurchase agreements	11,139	10,266
Subordinated debt	72,966	43,407
Total liabilities	2,522,124	2,091,993
STOCKHOLDERS’ EQUITY
Preferred stock - par value $1,000; 20,000 shares authorized; no shares issued and outstanding as of September 30, 2021 and 733 shares issued and outstanding as December 31, 2020	0	7,334
Common stock - par value $1; 20,000,000 shares authorized; 12,820,220 and 11,972,204 shares issued and outstanding, respectively, as of September 30, 2021 and 12,374,322 and 11,526,306 shares issued and outstanding, respectively, as of December 31, 2020	12,820	12,374
Additional paid-in capital	140,235	129,119
Retained earnings	130,066	105,171
Accumulated other comprehensive income (loss)	(815)	2,226
Treasury stock - 848,016 shares as of September 30, 2021 and December 31, 2020, at cost	(16,741)	(16,741)
Total equity attributable to parent	265,565	239,483
Noncontrolling interest	1,135	0
Total stockholders' equity	266,700	239,483
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 2,788,824	$ 2,331,476

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1,000	$ 1,000
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	733
Preferred stock, shares outstanding (in shares)	0	733
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	12,820,220	12,374,322
Common stock, shares outstanding (in shares)	11,972,204	11,526,306
Treasury stock, shares (in shares)	848,016	848,016

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
INTEREST INCOME
Interest and fees on loans	$ 18,530	$ 16,976	$ 54,175	$ 56,064
Interest on deposits with banks	112	106	332	297
Interest on investment securities	575	411	1,831	1,554
Interest on tax-exempt loans and securities	1,267	1,134	4,042	3,185
Total interest income	20,484	18,627	60,380	61,100
INTEREST EXPENSE
Interest on deposits	898	1,894	3,182	8,840
Interest on short-term borrowings	9	703	105	1,543
Interest on subordinated debt	481	20	1,437	78
Total interest expense	1,388	2,617	4,724	10,461
NET INTEREST INCOME	19,096	16,010	55,656	50,639
Provision for loan losses	380	8,631	(542)	16,365
Net interest income (loss) after provision for loan losses	18,716	7,379	56,198	34,274
NONINTEREST INCOME
Payment card and service charge income	1,685	638	5,104	1,716
Mortgage fee income	0	7,264	0	33,427
Insurance and investment services income	236	224	707	620
Gain on sale of available-for-sale securities, net	529	35	3,380	865
Gain on sale of equity securities, net	0	18	5	48
Gain on sale of loans, net	908	172	3,125	302
Gain (loss) on derivatives, net	0	(7,508)	0	2,365
Holding gain on equity securities, net	536	94	1,750	111
Compliance and consulting income	3,013	1,085	6,162	3,035
Equity method investment income	3,573	13,620	14,570	13,620
Gains on acquisition and divestiture activity	10,783	0	10,783	14,302
Other operating income	688	3,756	2,467	5,350
Total noninterest income	21,951	19,398	48,053	75,761
NONINTEREST EXPENSES
Salaries and employee benefits	16,528	10,519	42,100	49,360
Occupancy expense	1,024	1,101	3,297	3,508
Equipment depreciation and maintenance	1,250	845	3,497	2,636
Data processing and communications	1,080	1,372	3,409	4,268
Mortgage processing	0	3	0	1,744
Marketing, contributions and sponsorships	207	227	418	891
Professional fees	2,665	1,606	6,857	5,931
Insurance, tax and assessment expense	532	577	1,570	1,607
Travel, entertainment, dues and subscriptions	1,437	624	3,525	2,683
Other operating expenses	1,106	1,391	3,677	3,626
Total noninterest expense	25,829	18,265	68,350	76,254
Income before income taxes	14,838	8,512	35,901	33,781
Income tax expense	3,164	2,021	7,006	8,208
Net income before noncontrolling interest	11,674	6,491	28,895	25,573
Net loss attributable to noncontrolling interest	154	0	265	0
Net income attributable to parent	11,828	6,491	29,160	25,573
Preferred dividends	0	116	35	345
Net income available to common shareholders	$ 11,828	$ 6,375	$ 29,125	$ 25,228
Earnings per common shareholder - basic (in dollars per share)	$ 1	$ 0.53	$ 2.49	$ 2.11
Earnings per common shareholder - diluted (in dollars per share)	$ 0.92	$ 0.53	$ 2.32	$ 2.07
Weighted average shares outstanding - basic (in shares)	11,880,348	11,948,989	11,684,570	11,948,857
Weighted average shares outstanding - diluted (in shares)	12,824,309	12,116,418	12,565,809	12,185,137

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 11,674	$ 6,491	$ 28,895	$ 25,573
Other comprehensive (loss) income:
Unrealized holding gain (loss) on securities available-for-sale	239	1,226	(2,723)	3,191
Income tax effect	(56)	(331)	638	(862)
Reclassification adjustment for gain recognized in income	(529)	(35)	(3,380)	(865)
Income tax effect	124	9	793	234
Change in defined benefit pension plan	(914)	(102)	1,112	(1,809)
Income tax effect	214	28	(261)	489
Reclassification adjustment for amortization of net actuarial loss recognized in income	127	105	381	315
Income tax effect	(30)	(28)	(89)	(85)
Reclassification adjustment for carrying value adjustment - investment hedge recognized in income	14	95	637	(738)
Income tax effect	(3)	(26)	(149)	199
Total other comprehensive (loss) income	(814)	941	(3,041)	69
Comprehensive loss attributable to noncontrolling interest	154	0	265	0
Comprehensive income	$ 11,014	$ 7,432	$ 26,119	$ 25,642

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Preferred stock	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive income (loss)	Treasury stock	Total stockholders' equity attributable to parent	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2019		733	11,995,366				51,077
Beginning balance at Dec. 31, 2019	$ 211,936	$ 7,334	$ 11,995	$ 122,516	$ 72,496	$ (1,321)	$ (1,084)	$ 211,936	$ 0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	1,048				1,048			1,048
Other comprehensive loss	(917)					(917)		(917)
Dividends on common stock	(1,076)				(1,076)			(1,076)
Dividends on preferred stock	(114)				(114)			(114)
Stock-based compensation	498			498				498
Common stock options exercised (in shares)			2,500
Common stock options exercised	38		$ 3	35				38
Common stock repurchased (in shares)							16,300
Common stock repurchased	(260)						$ (260)	(260)
Ending balance (in shares) at Mar. 31, 2020		733	11,997,866				(67,377)
Ending balance at Mar. 31, 2020	211,153	$ 7,334	$ 11,998	123,049	72,354	(2,238)	$ (1,344)	211,153	0
Beginning balance (in shares) at Dec. 31, 2019		733	11,995,366				51,077
Beginning balance at Dec. 31, 2019	211,936	$ 7,334	$ 11,995	122,516	72,496	(1,321)	$ (1,084)	211,936	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	25,573
Other comprehensive loss	69
Fair value of noncontrolling interests at acquisition date	0
Common stock issued related to acquisition	240
Ending balance (in shares) at Sep. 30, 2020		733	12,068,627				(179,626)
Ending balance at Sep. 30, 2020	234,116	$ 7,334	$ 12,069	124,474	94,496	(1,252)	$ (3,005)	234,116	0
Beginning balance (in shares) at Mar. 31, 2020		733	11,997,866				(67,377)
Beginning balance at Mar. 31, 2020	211,153	$ 7,334	$ 11,998	123,049	72,354	(2,238)	$ (1,344)	211,153	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	18,034				18,034			18,034
Other comprehensive loss	45					45		45
Dividends on common stock	(1,076)				(1,076)			(1,076)
Dividends on preferred stock	(115)				(115)			(115)
Stock-based compensation	627			627				627
Restricted stock units issued (in shares)			48,483				525
Restricted stock units issued	(7)		$ 49	(49)			$ (7)	(7)
Common stock issued related to acquisition (in shares)			19,278
Common stock issued related to acquisition	240		$ 19	221				240
Common stock repurchased (in shares)							29,300
Common stock repurchased	(401)						$ (401)	(401)
Ending balance (in shares) at Jun. 30, 2020		733	12,065,627				(97,202)
Ending balance at Jun. 30, 2020	228,500	$ 7,334	$ 12,066	123,848	89,197	(2,193)	$ (1,752)	228,500	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	6,491				6,491			6,491
Other comprehensive loss	941					941		941
Dividends on common stock	(1,076)				(1,076)			(1,076)
Dividends on preferred stock	(116)				(116)			(116)
Stock-based compensation	592			592				592
Common stock options exercised (in shares)			3,000
Common stock options exercised	37		$ 3	34				37
Common stock repurchased (in shares)							82,424
Common stock repurchased	(1,253)						$ (1,253)	(1,253)
Ending balance (in shares) at Sep. 30, 2020		733	12,068,627				(179,626)
Ending balance at Sep. 30, 2020	234,116	$ 7,334	$ 12,069	124,474	94,496	(1,252)	$ (3,005)	234,116	0
Beginning balance (in shares) at Dec. 31, 2020		733	12,374,322				(848,016)
Beginning balance at Dec. 31, 2020	239,483	$ 7,334	$ 12,374	129,119	105,171	2,226	$ (16,741)	239,483	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	8,058				8,085			8,085	(27)
Other comprehensive loss	(4,118)					(4,118)		(4,118)
Dividends on common stock	(1,153)				(1,153)			(1,153)
Dividends on preferred stock	(35)				(35)			(35)
Stock-based compensation	592			592				592
Redemption of preferred stock (in shares)		(733)
Redemption of preferred stock	(7,334)	$ (7,334)						(7,334)
Common stock options exercised (in shares)			52,584
Common stock options exercised	690		$ 53	637				690
Restricted stock units issued (in shares)			11,155
Restricted stock units issued	0		$ 11	(11)
Fair value of noncontrolling interests at acquisition date	500								500
Ending balance (in shares) at Mar. 31, 2021		0	12,438,061				(848,016)
Ending balance at Mar. 31, 2021	236,683	$ 0	$ 12,438	130,337	112,068	(1,892)	$ (16,741)	236,210	473
Beginning balance (in shares) at Dec. 31, 2020		733	12,374,322				(848,016)
Beginning balance at Dec. 31, 2020	239,483	$ 7,334	$ 12,374	129,119	105,171	2,226	$ (16,741)	239,483	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	28,895
Other comprehensive loss	(3,041)
Fair value of noncontrolling interests at acquisition date	1,400
Common stock issued related to acquisition	708
Ending balance (in shares) at Sep. 30, 2021		0	12,820,220				(848,016)
Ending balance at Sep. 30, 2021	266,700	$ 0	$ 12,820	140,235	130,066	(815)	$ (16,741)	265,565	1,135
Beginning balance (in shares) at Mar. 31, 2021		0	12,438,061				(848,016)
Beginning balance at Mar. 31, 2021	236,683	$ 0	$ 12,438	130,337	112,068	(1,892)	$ (16,741)	236,210	473
Increase (Decrease) in Stockholders' Equity
Net income (loss)	9,163				9,247			9,247	(84)
Other comprehensive loss	1,891					1,891		1,891
Dividends on common stock	(1,405)				(1,405)			(1,405)
Stock-based compensation	692			692				692
Common stock options exercised (in shares)			108,511
Common stock options exercised	1,607		$ 108	1,499				1,607
Restricted stock units issued (in shares)			57,906
Restricted stock units issued	0		$ 58	(58)				0
Minimum tax withholding on restricted stock units issued	(231)			(231)				(231)
Fair value of noncontrolling interests at acquisition date	400								400
Common stock issued related to acquisition (in shares)			17,597
Common stock issued related to acquisition	600		$ 18	582				600
Ending balance (in shares) at Jun. 30, 2021		0	12,622,075				(848,016)
Ending balance at Jun. 30, 2021	249,400	$ 0	$ 12,622	132,821	119,910	(1)	$ (16,741)	248,611	789
Increase (Decrease) in Stockholders' Equity
Net income (loss)	11,674				11,828			11,828	(154)
Other comprehensive loss	(814)					(814)		(814)
Dividends on common stock	(1,672)				(1,672)			(1,672)
Stock-based compensation	1,055			1,055				1,055
Common stock options exercised (in shares)			64,399
Common stock options exercised	1,108		$ 64	1,044				1,108
Restricted stock units issued (in shares)			1,410
Restricted stock units issued	0		$ 1	(1)				0
Minimum tax withholding on restricted stock units issued	(25)			(25)				(25)
Common stock issued related to stock-based compensation (in shares)			24,408
Common stock issued related to stock-based compensation	1,000		$ 25	975				1,000
Common stock issued related to equity method investment (in shares)			107,928
Common stock issued related to equity method investment	4,474		$ 108	4,366				4,474
MVB Technology membership units issued	500								500
Ending balance (in shares) at Sep. 30, 2021		0	12,820,220				(848,016)
Ending balance at Sep. 30, 2021	$ 266,700	$ 0	$ 12,820	$ 140,235	$ 130,066	$ (815)	$ (16,741)	$ 265,565	$ 1,135

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Statement of Stockholders' Equity [Abstract]
Cash dividends paid (in dollars per share)	$ 0.14	$ 0.12	$ 0.10	$ 0.09	$ 0.09	$ 0.09

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
OPERATING ACTIVITIES
Net income before noncontrolling interest	$ 28,895	$ 25,573
Adjustments to reconcile net income to net cash from operating activities:
Net amortization and accretion of investments	3,011	1,112
Net amortization of deferred loan costs	2,062	779
Provision for loan losses	(542)	16,365
Depreciation and amortization	2,800	761
Stock-based compensation	2,339	1,717
Loans originated for sale	(23,950)	(1,334,910)
Proceeds of loans sold	17,871	1,475,854
Holding gain on equity securities	(1,750)	(111)
Mortgage fee income	0	(33,427)
Gain on sale of available-for-sale securities	(3,411)	(899)
Loss on sale of available-for-sale securities	31	34
Gain on sale of equity securities	(5)	(48)
Gain on sale of loans	(3,125)	(302)
Gains on acquisition and divestiture activity	(10,783)	(14,302)
Gain on sale of other real estate owned	(116)	0
Income on bank-owned life insurance	(749)	(663)
Deferred income taxes	(1,186)	3,958
Equity method investment income	(14,570)	(13,620)
Return on equity method investment	29,795	(3,338)
Other assets	(503)	(36,669)
Other liabilities	(14,327)	3,444
Net cash from operating activities	11,787	91,308
INVESTING ACTIVITIES
Purchases of available-for-sale investment securities	(176,468)	(132,896)
Maturities/paydowns of available-for-sale investment securities	38,846	42,770
Sales of available-for-sale investment securities	103,365	48,579
Purchases of premises and equipment	(3,589)	(4,211)
Disposals of premises and equipment	0	1,687
Loans, net	(356,623)	(43,869)
Purchases of restricted bank stock	(1,410)	(24,013)
Redemptions of restricted bank stock	2,821	33,578
Proceeds from sale of certificates of deposit with banks	2,221	1,241
Purchases of certificates of deposit with banks	0	(993)
Proceeds from sale of other real estate owned	2,761	7,700
Purchase of equity securities	(3,472)	(6,260)
Sales of equity securities	61	669
Net cash transferred for banking center sale	(95,697)	0
Cash paid for acquisitions, net of cash acquired	(772)	(78,699)
Net cash from investing activities	(487,956)	(154,717)
FINANCING ACTIVITIES
Deposits, net	579,875	491,259
Repurchase agreements, net	873	(127)
FHLB and other borrowings, net	0	(154,483)
Issuance of subordinated debt	30,000	0
Payment of subordinated debt issuance costs	441	0
Preferred stock redemption	(7,334)	0
Common stock repurchased	0	(1,921)
Common stock options exercised	3,405	75
Withholding cash issued in lieu of restricted stock	(256)	0
Cash dividends paid on common stock	(4,230)	(3,228)
Cash dividends paid on preferred stock	(35)	(345)
Issuance of subsidiary membership units	500	0
Net cash from financing activities	602,357	331,230
Increase in cash and cash equivalents	126,188	267,821
Cash and cash equivalents, beginning of period	263,893	28,002
Cash and cash equivalents, end of period	390,081	295,823
Cash payments for:
Interest on deposits, repurchase agreements and borrowings	4,488	13,275
Income taxes	9,600	7,613
Business combination non-cash disclosures:
Assets acquired in business combination (net of cash received)	739	87,722
Liabilities assumed in business combination	605	148,731
Supplemental disclosure of cash flow information:
Fair value of noncontrolling interests at acquisition date	1,400	0
Loans transferred to other real estate owned	357	800
Employee stock-based compensation tax withholding obligations	4,155	35
Restricted stock units vested	70	49
Common stock issued related to investments and acquisitions	$ 708	$ 240

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Nature of Operations and Basis of Presentation	Note 1 – Nature of Operations and Basis of Presentation Business and Organization MVB Financial Corp. is a financial holding company organized as a West Virginia corporation that operates principally through its wholly-owned subsidiary, MVB Bank, Inc.. The Bank’s subsidiaries include MVB Insurance, LLC, a title insurance company (“MVB Insurance”), MVB Community Development Corporation (“MVB CDC”), ProCo Global, Inc. (“Chartwell”, which began doing business under the registered trade name Chartwell Compliance), Paladin Fraud, LLC (“Paladin Fraud”) and MVB Edge Ventures, LLC (“Edge Ventures”). We also own equity method investments in Intercoastal Mortgage Company, LLC (“ICM”) and Interchecks Technologies, Inc. ("Interchecks"). The Bank owns controlling interests in Trabian Technology, Inc. (“Trabian”) and Edge Ventures owns controlling interests in MVB Technology, LLC ("MVB Technology") and Flexia Payments, LLC (“Flexia”). In 2021, Edge Ventures was created as a management company providing oversight, alignment and structure for MVB’s Fintech companies and allocates resources to help incubate venture businesses and technologies acquired and developed by MVB. Subsidiaries of Edge Ventures include MVB Technology, Flexia and Victor Technologies, Inc. (“Victor”). We conduct a wide range of business activities, primarily commercial and retail (“CoRe”) banking. We also continue to be involved in new innovative strategies to provide independent banking to corporate clients throughout the United States by leveraging recent investments in Fintech-related companies. We consider Fintech companies as those entities that use technology to electronically move funds. Principles of Consolidation and Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of MVB and our subsidiaries, including the Bank and the Bank’s subsidiaries. In our opinion, the accompanying consolidated financial statements contain all normal recurring adjustments necessary for a fair presentation of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with instructions for Form 10-Q and Article 10 of Regulation S-X of the SEC. All material intercompany accounts and transactions have been eliminated in consolidation. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted. The consolidated balance sheet as of December 31, 2020 has been derived from audited financial statements included in the 2020 Form 10-K. The information presented in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and notes thereto included in the 2020 Form 10-K. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. In 2021, the Bank entered into agreements to acquire majority interests in both Flexia and in Trabian and to divest a minority interest in MVB Technology. Although we own, through our subsidiaries, an 80.0% interest in each of Flexia and Trabian and a 93.4% interest in MVB Technology, we are required to consolidate 100% of Flexia, Trabian and MVB Technology within the consolidated financial statements. The remaining 20.0% of Flexia and Trabian and 6.6% of MVB Technology are accounted for separately as noncontrolling interests within the consolidated financial statements. Noncontrolling interest represents the portion of ownership and profit or loss that is attributable to the minority owners of these entities. Unconsolidated investments where we have the ability to exercise significant influence over the operating and financial policies of the respective investee are accounted for using the equity method of accounting; those that are not consolidated or accounted for using the equity method of accounting are accounted for under cost or fair value accounting. For these investments accounted for under the equity method, we record our investment in non-consolidated affiliates and the portion of income or loss in equity in earnings of non-consolidated affiliates. We periodically evaluate these investments for impairment. As of September 30, 2021, we hold two equity method investments. Preparation of our consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates are based upon the best available information and actual results could differ from those estimates. Estimates that are particularly significant to the consolidated financial statements relate to the determination of the allowance for loan losses (“ALL”), purchased credit impaired (“PCI”) loans, derivative instruments, goodwill and deferred tax assets and liabilities. In certain instances, amounts reported in prior periods’ consolidated financial statements have been reclassified to conform to the current presentation. We have evaluated subsequent events for potential recognition and/or disclosure through the date these consolidated financial statements were issued. COVID-19 Pandemic Throughout 2020 and into 2021, economies throughout the world have been severely disrupted as a result of the outbreak of COVID-19. The outbreak and any preventative or protective actions that we or our clients may take related to this virus may result in a period of disruption, including our financial reporting capabilities, our operations generally and could potentially impact our clients, providers and third parties. While significant progress has been made to combat the outbreak of COVID-19, the extent to which the COVID-19 pandemic continues to impact our future operating results will depend on future developments, including if there is a resurgence in the virus, which are highly uncertain and cannot be predicted. Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance in November 2018, ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , in April 2019, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments , in May 2019, ASU 2019-05, Financial Instruments – Credit Losses, Topic 326 and in November 2019, ASU 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates and ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , all of which clarifies codification and corrects unintended application of the guidance. The new guidance replaces the incurred loss impairment methodology in current U.S. GAAP with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. PCI loans will receive an allowance account at the acquisition date that represents a component of the purchase price allocation. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses, with such allowance limited to the amount by which fair value is below amortized cost. The guidance was initially effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. On November 15, 2019, the FASB issued ASU 2019-10, Financial Investments – Credit Issues (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates , which finalizes a delay in the effective date of the standard for smaller reporting companies (“SRCs”). Effective in the first quarter of 2022, we will lose our SRC designation. However, because we met the criteria to be an SRC as of the issuance date of this guidance, we are eligible for the delay in effective date and plan to adopt this standard for fiscal years ending after December 15, 2022. We expect to recognize a one-time cumulative effect adjustment to the ALL as of the beginning of the first reporting period in which the new standard is effective, but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements. In that regard, we have formed a cross-functional implementation team. The team is working to develop an implementation plan which will include assessment and documentation of processes, internal controls and data sources; model development and documentation; and system configuration, among other things. We are also in the process of implementing a third-party vendor solution to assist us in the application of this standard. The adoption of this standard could result in an increase in the ALL as a result of changing from an “incurred loss” model, which encompasses allowances for current known and inherent losses within the portfolio, to an “expected loss” model, which encompasses allowances for losses expected to be incurred over the life of the portfolio. While we are currently unable to reasonably estimate the impact of adopting ASU 2016-13, we expect that the impact of adoption will be significantly influenced by the composition, characteristics and quality of our loan portfolio, as well as the prevailing economic conditions and forecasts as of the adoption date. In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirement for Defined Benefit Plans , which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The updates in this ASU are part of the disclosure framework project ASU 2018-14 and modify the disclosure requirements under Accounting Standards Codification (“ASC”) 715-20 for employers that sponsor defined benefit pension or other postretirement plans. Those modifications include the removal and addition of disclosure requirements as well as clarifying specific disclosure requirements. The ASU removed the following disclosures: 1) the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year; 2) the amount and timing of plan assets expected to be returned to the employer; 3) the disclosures related to the June 2001 amendments to the Japanese Welfare Pension Insurance Law; 4) related party disclosures about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan; 5) for nonpublic entities, the reconciliation of the opening balances to the closing balances of plan assets measured on a recurring basis in Level 3 of the fair value hierarchy; however, nonpublic entities will be required to disclose separately the amounts of transfers into and out of Level 3 of the fair value hierarchy and purchases of Level 3 plan assets and 6) for public entities, the effects of a one-percentage-point change in assumed health care cost trend rates on the (i) aggregate of the service and interest cost components of net periodic benefit costs and (ii) benefit obligation for postretirement health care benefits. The ASU added the following disclosures: 1) the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates and 2) an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. The ASU then clarified the following disclosures: 1) the projected benefit obligation (“PBO”) and fair value of plan assets for plans with PBOs more than plan assets; and 2) the accumulated benefit obligation (“ABO”) and fair value of plan assets for plans with ABOs more than plan assets. ASU 2018-14 is effective for public business entities for fiscal years ending after December 15, 2020. As ASU 2018-04 is specific to disclosure requirements, adoption did not have a material impact on our interim consolidated financial statements. Our year-end disclosures will be revised to comply with the new requirements. In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 . ASU 2020-01 clarifies the interaction between accounting standards related to equity securities, equity method investments and certain derivatives, including accounting for the transition into and out of the equity method and measuring certain purchased options and forward contracts to acquire investments. The amendments were effective for us beginning January 1, 2021 and adoption did not have a material effect on our consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments provide optional expedients and exceptions for certain contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of rate reform. The guidance is effective from the date of issuance until December 31, 2022. The guidance permits entities to not apply modification accounting or remeasure lease payments in lease contracts if the changes to the contract are related to the discontinuation of the reference rate. If certain criteria are met, the amendments also allow exceptions to the de-designation criteria of the hedging relationship and the assessment of hedge effectiveness during the transition period. In January 2021, ASU 2021-01 was issued by the FASB and clarified that certain exceptions in reference rate reform apply to derivatives that are affected by the discounting transition. We will continue to assess the impact as the reference rate transition occurs.

Investment Securities

Investment Securities	9 Months Ended
	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Note 2 – Investment Securities The following tables present amortized cost and fair values of investment securities available-for-sale as of the periods indicated: September 30, 2021 (Dollars in thousands) Amortized Cost Unrealized Gain Unrealized Loss Fair Value United States government agency securities $ 42,226 $ 342 $ (597) $ 41,971 United States sponsored mortgage-backed securities 85,754 401 (884) 85,271 United States treasury securities 82,738 — (316) 82,422 Municipal securities 202,717 5,182 (476) 207,423 Other debt securities 7,500 — — 7,500 Total debt securities 420,935 5,925 (2,273) 424,587 Other securities 14,282 177 (23) 14,436 Total investment securities available-for-sale $ 435,217 $ 6,102 $ (2,296) $ 439,023 December 31, 2020 (Dollars in thousands) Amortized Cost Unrealized Gain Unrealized Loss Fair Value United States government agency securities $ 53,207 $ 872 $ (210) $ 53,869 United States sponsored mortgage-backed securities 94,968 972 (171) 95,769 United States treasury securities 3,000 123 — 3,123 Municipal securities 223,642 8,327 (82) 231,887 Other debt securities 7,500 — — 7,500 Total debt securities 382,317 10,294 (463) 392,148 Other securities 18,401 146 (71) 18,476 Total investment securities available-for-sale $ 400,718 $ 10,440 $ (534) $ 410,624 The following table presents amortized cost and fair values of available-for-sale debt securities by contractual maturity as of the period indicated: September 30, 2021 (Dollars in thousands) Amortized Cost Fair Value Within one year $ 5 $ 5 After one year, but within five years 86,798 86,542 After five years, but within ten years 34,205 35,079 After ten years 299,927 302,961 Total $ 420,935 $ 424,587 The table above reflects contractual maturities. Actual results will differ as the loans underlying the mortgage-backed securities may be repaid sooner than scheduled. Investment securities with a carrying value of $280.0 million and $229.4 million at September 30, 2021 and December 31, 2020, respectively, were pledged to secure public funds, repurchase agreements and potential borrowings at the Federal Reserve Discount Window. Our investment portfolio includes securities that are in an unrealized loss position as of September 30, 2021, the details of which are included in the following table. Although these securities would result in a pretax loss of $2.3 million if sold at September 30, 2021, we currently have no intention of selling the applicable securities at such fair values, and maintain that we have the ability to hold these securities until all principal has been recovered. It is more likely than not that we will not, for liquidity purposes, sell any securities at a loss. Declines in the fair values of these securities can be traced to general market conditions, which reflect the prospect for the economy as a whole. When determining other-than-temporary impairment on securities, we consider such factors as adverse conditions specifically related to a certain security or to specific conditions in an industry or geographic area, the time frame securities have been in an unrealized loss position, our ability to hold the security for a period of time sufficient to allow for anticipated recovery in value, whether or not the security has been downgraded by a rating agency and whether or not the financial condition of the security issuer has severely deteriorated. As of September 30, 2021, we consider all securities with unrealized loss positions to be temporarily impaired. As a result, we do not believe we will sustain any material realized losses as a result of the current decline in fair value. The following tables present investments in an unrealized loss position as of the periods indicated: September 30, 2021 (Dollars in thousands) Less than 12 months 12 months or more Description and number of positions Fair Value Unrealized Loss Fair Value Unrealized Loss United States government agency securities (20) $ 4,334 $ (138) $ 18,113 $ (459) United States sponsored mortgage-backed securities (27) 57,861 (803) 4,431 (81) United States treasury securities (18) 82,423 (316) — — Municipal securities (56) 40,069 (430) 2,898 (46) Other securities (1) — — 1,477 (23) $ 184,687 $ (1,687) $ 26,919 $ (609) December 31, 2020 (Dollars in thousands) Less than 12 months 12 months or more Description and number of positions Fair Value Unrealized Loss Fair Value Unrealized Loss United States government agency securities (27) $ 19,021 $ (68) $ 12,574 $ (142) United States sponsored mortgage-backed securities (9) 15,331 (155) 3,349 (16) Municipal securities (14) 11,856 (82) — — Other securities (5) 3,947 (71) — — $ 50,155 $ (376) $ 15,923 $ (158) The following table summarizes investment sales, related gains and losses and unrealized holding gains for the periods shown: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Sales of available-for-sale securities $ 28,049 $ 7,379 $ 103,365 $ 48,579 Gains, gross 547 69 3,411 899 Losses, gross 18 34 31 34 Sales of equity securities $ — $ 669 $ 61 $ 669 Gain, gross — 18 5 48 Losses, gross — — — — Unrealized holding gains on equity securities 536 94 1,750 111 Qualified Affordable Housing Projects We have invested in limited partnerships that sponsor affordable housing projects utilizing low income house tax credits pursuant to Section 42 of the Internal Revenue Code. In exchange for these investments, we receive our pro-rata share of income, expense, gains and losses, including tax credits, that are received by the projects using the proportional amortization method. As of both September 30, 2021 and December 31, 2020, we have recognized investments totaling $4.0 million between the five affordable housing investment limited partnerships and have recognized cumulative amortization of $1.5 million and $1.2 million from these funds as of September 30, 2021 and December 31, 2020, respectively.

Loans and Allowance for Loan Lo

Loans and Allowance for Loan Losses	9 Months Ended
	Sep. 30, 2021
Receivables [Abstract]
Loans and Allowance for Loan Losses	Note 3 – Loans and Allowance for Loan Losses Prior to the ICM transaction, we routinely generated one-to-four family mortgages for sale into the secondary market. During the three months ended September 30, 2020, we did not receive any sales proceeds and during the nine months ended September 30, 2020, we received sales proceeds of $1.23 billion, resulting in mortgage fee income of $33.4 million. Subsequent to the ICM transaction and during the three and nine months ended September 30, 2021, we did not receive any sales proceeds or recognize any mortgage fee income related to the sale of one-to-four family mortgages. The following table presents the components of loans as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Commercial and non-residential real estate $ 1,430,290 $ 1,141,114 Residential real estate 269,967 240,264 Home equity 23,777 30,828 Consumer 22,144 3,156 Total 1,746,178 1,415,362 Purchased credit impaired loans: Commercial and non-residential real estate 15,079 21,008 Residential real estate 4,430 16,943 Consumer 601 1,488 Total purchased credit impaired loans 20,110 39,439 Total Loans $ 1,766,288 $ 1,454,801 Deferred loan origination costs and (fees), net (2,102) (1,057) Loans receivable $ 1,764,186 $ 1,453,744 We currently manage our loan portfolios and the respective exposure to credit losses (credit risk) by the following specific portfolio segments, which are levels at which we develop and document our systematic methodology to determine the allowance for credit losses attributable to each respective portfolio segment. These segments are as follows: Commercial business loans – Commercial loans are made to provide funds for equipment and general corporate needs, as well as to finance owner-occupied real estate, and to finance future cash flows of Federal government lease contracts. Repayment of these loans primarily uses the funds obtained from the operation of the borrower’s business. Commercial loans also include lines of credit that are utilized to finance a borrower’s short-term credit needs and/or to finance a percentage of eligible receivables and inventory. This segment includes both internally originated and purchased participation loans. Credit risk arises from the successful operation of the business, which may be affected by competition, rising interest rates, regulatory changes and adverse conditions in the local and regional economy. Commercial real estate loans – Commercial real estate loans consist of non-owner occupied properties, such as investment properties for retail, office and multifamily with a history of occupancy and cash flow. This segment includes both internally originated and purchased participation loans. These loans carry the risk of adverse changes in the local economy and a tenant’s deteriorating credit strength, lease expirations in soft markets and sustained vacancies, which can adversely impact cash flow. Commercial acquisition, development and construction loans – Commercial acquisition, development and construction loans are intended to finance the construction of commercial and residential properties, including the construction of single-family dwellings, and also includes loans for the acquisition and development of land. Construction loans represent a higher degree of risk than permanent real estate loans and may be affected by a variety of factors such as the borrower’s ability to control costs and adhere to time schedules and the risk that constructed units may not be absorbed by the market within the anticipated time frame or at the anticipated price. The loan commitment on these loans often includes an interest reserve that allows the lender to periodically advance loan funds to pay interest charges on the outstanding balance of the loan. Commercial Small Business Administration (“SBA”) loans – Loans originated through the various SBA programs have become an area of lending focus for the Bank. As of June 30, 2021, these loans have not yet been designated as a unique portfolio segment due to the relative insignificance from a loan volume perspective. These loans are currently included within the loan types noted above, based on the purpose of each loan originated. However, it is anticipated that this portfolio will continue to expand through a dedicated SBA lending focus, which we continue to monitor. When appropriate, the portfolio segments will be adjusted to segregate the SBA loan portfolio segment from the other commercial loan portfolio segments. Commercial SBA Paycheck Protection Program (“PPP”) loans –This segment includes the loan originated through the recently created SBA PPP loans. Credit risk is heightened as this SBA program mandates that these loans require no collateral and no guarantors of the loans. However, the loans are backed by a full guaranty of the SBA, so long as the loans were originated in accordance with the program guidelines. Additionally, these loans are eligible for full forgiveness by the SBA so long as the borrowers comply with the program guidelines as it pertains to their eligibility to borrow these funds, as well as their use of the funds. Residential mortgage loans – This residential real estate subsegment contains permanent and construction mortgage loans principally to consumers secured by residential real estate. Residential real estate loans are evaluated for the adequacy of repayment sources at the time of approval, based upon measures including credit scores, debt-to-income ratios and collateral values. Credit risk arises from the borrower’s, and where applicable, the builder’s, continuing financial stability, which can be adversely impacted by job loss, divorce, illness or personal bankruptcy, among other factors. Also impacting credit risk would be a shortfall in the value of the residential real estate in relation to the outstanding loan balance in the event of a default or subsequent liquidation of the real estate collateral. Home equity lines of credit – This segment includes subsegment for senior lien and subordinate lien lines of credit. Credit risk is similar to residential real estate loans described above as it is subject to the borrower’s continuing financial stability and the value of the collateral securing the loan. Consumer loans – This segment of loans includes primarily installment loans and personal lines of credit. Consumer loans include installment loans used by clients to purchase automobiles, boats and recreational vehicles. Credit risk is similar to residential real estate loans described above as it is subject to the borrower’s continuing financial stability and the value of the collateral securing the loan. This segment also includes loans purchased from a third-party originator which it originates to finance the purchase of personal automotive vehicles. Credit risk is unique in comparison to the Consumer segment as this segment includes only those loans provided to consumers that cannot typically obtain financing through traditional lenders. As such, these loans are subject to a higher risk of default than the typical consumer loan. The following table presents impaired loans by class, excluding PCI loans, segregated by those for which a specific allowance was required and those for which a specific allowance was not necessary as of the periods indicated: Impaired Loans with Specific Allowance Impaired Loans with No Specific Allowance Total Impaired Loans (Dollars in thousands) Recorded Investment Related Allowance Recorded Investment Recorded Investment Unpaid Principal Balance September 30, 2021 Commercial Commercial business $ 5,931 $ 3,792 $ 3,646 $ 9,577 $ 11,283 Commercial real estate 676 243 495 1,171 1,341 Acquisition and development — — 1,401 1,401 2,816 Total commercial 6,607 4,035 5,542 12,149 15,440 Residential — — 6,971 6,971 7,222 Home equity 69 69 26 95 95 Consumer — — 3 3 3 Total impaired loans $ 6,676 $ 4,104 $ 12,542 $ 19,218 $ 22,760 December 31, 2020 Commercial Commercial business $ 3,431 $ 1,032 $ 5,653 $ 9,084 $ 10,440 Commercial real estate 772 264 944 1,716 1,864 Acquisition and development — — 2,534 2,534 3,939 Total commercial 4,203 1,296 9,131 13,334 16,243 Residential — — 1,960 1,960 2,232 Home equity — — 95 95 95 Consumer — — 5 5 5 Total impaired loans $ 4,203 $ 1,296 $ 11,191 $ 15,394 $ 18,575 The following table presents the average recorded investment in impaired loans, excluding PCI loans, and related interest income recognized for the periods indicated: Three Months Ended September 30, 2021 2020 (Dollars in thousands) Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Commercial Commercial business $ 7,223 $ — $ — $ 7,785 $ — $ — Commercial real estate 1,943 11 11 3,264 26 26 Acquisition and development 340 — — 375 10 54 Total commercial 9,506 11 11 11,424 36 80 Residential 7,029 3 3 3,085 5 5 Home equity 69 — — 69 — — Consumer 3 — — 5 — — Total $ 16,607 $ 14 $ 14 $ 14,583 $ 41 $ 85 Nine Months Ended September 30, 2021 2020 (Dollars in thousands) Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Commercial Commercial business $ 6,701 $ — $ — $ 5,225 $ — $ — Commercial real estate 2,125 33 33 3,124 77 79 Acquisition and development 348 — — 1,487 67 73 Total commercial 9,174 33 33 9,836 144 152 Residential 5,418 11 10 2,683 14 14 Home equity 69 — — 94 — — Consumer 3 — — 8 — — Total $ 14,664 $ 44 $ 43 $ 12,621 $ 158 $ 166 As of September 30, 2021, the Bank’s other real estate owned balance totaled $3.4 million, of which $2.7 million was related to the acquisition of The First State Bank (“First State”) in 2020. The Bank held $2.6 million, or 76.5%, of other real estate owned as a result of the foreclosure of 20 unrelated commercial loans. The remaining $0.8 million, or 23.5%, consists of 11 foreclosed residential real estate properties. There are five additional consumer mortgage loans collateralized by residential real estate properties in the process of foreclosure, with a total recorded investment of $0.4 million as of September 30, 2021. These include four legacy Bank loans totaling $0.2 million and one loan acquired from First State totaling $0.2 million. These loans are included in the table above and have no specific allowance allocated to them. Bank management uses a nine-point internal risk rating system to monitor the credit quality of the overall loan portfolio. The first six categories are considered not criticized and are aggregated as “Pass” rated. The criticized rating categories utilized by management generally follow bank regulatory definitions. Loans categorized as “Pass” rated have adequate sources of repayment, with little identifiable risk of collection and general conformity to the Bank's policy requirements, product guidelines and underwriting standards. Any exceptions that are identified during the underwriting and approval process have been adequately mitigated by other factors. Loans categorized as “Special Mention” rated have potential weaknesses that deserve management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the asset or in the institution’s credit position at some future date. Special mention assets are not adversely classified and do not expose the institution to sufficient risk to warrant adverse classification. Loans categorized as “Substandard” rated are inadequately protected by the current sound worth and paying capacity of the borrower or of the collateral pledged, if any. Loans so classified must have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt and are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans categorized as “Doubtful” rated have all the weakness inherent in those classified substandard with the added characteristic that the weakness makes collections or liquidation in full, on the basis of currently known facts, conditions and values, highly questionable and improbable. However, these loans are not yet rated as loss because certain events may occur which would salvage the debt. The Special Mention category includes assets that are currently protected but are potentially weak, resulting in undue and unwarranted credit risk, but not to the point of justifying a Substandard classification. Loans in the Substandard category have well-defined weaknesses that jeopardize the liquidation of the debt and have a distinct possibility that some loss will be sustained if the weaknesses are not corrected. Any portion of a loan that has been or is expected to be charged off is placed in the Loss category. To help ensure that risk ratings are accurate and reflect the present and future capacity of borrowers to repay a loan as agreed, the Bank has a structured loan rating process with several layers of internal and external oversight. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as past due status, bankruptcy, repossession or death, occurs to raise awareness of a possible credit event. The Bank’s Chief Credit Officer is responsible for the timely and accurate risk rating of the loans in the portfolio at origination and on an ongoing basis. The Credit Department ensures that a review of all commercial relationships of $1.0 million or greater is performed annually. Review of the appropriate risk grade is included in both the internal and external loan review process and on an ongoing basis. The Bank has an experienced Credit Department that continually reviews and assesses loans within the portfolio. The Bank engages an external consultant to conduct independent loan reviews on at least an annual basis. Generally, the external consultant reviews larger commercial relationships or criticized relationships. The Credit Department compiles detailed reviews, including plans for resolution, on loans classified as Substandard on a quarterly basis. Loans in the Special Mention and Substandard categories that are collectively evaluated for impairment are given separate consideration in the determination of the allowance. The following table represents the classes of the loan portfolio, excluding PCI loans, summarized by the aggregate Pass and the criticized categories of Special Mention, Substandard and Doubtful within the internal risk rating system as of the periods indicated: (Dollars in thousands) Pass Special Mention Substandard Doubtful Total September 30, 2021 Commercial Commercial business $ 589,196 $ 13,623 $ 12,910 $ 3,605 $ 619,334 Commercial real estate 508,729 22,004 33,687 156 564,576 Acquisition and development 86,205 7,624 4,149 1,064 99,042 SBA PPP 147,338 — — — 147,338 Total commercial 1,331,468 43,251 50,746 4,825 1,430,290 Residential 259,864 917 8,693 493 269,967 Home equity 23,304 378 — 95 23,777 Consumer 22,123 18 3 — 22,144 Total Loans $ 1,636,759 $ 44,564 $ 59,442 $ 5,413 $ 1,746,178 December 31, 2020 Commercial Commercial business $ 496,222 $ 9,529 $ 17,045 $ 1,095 $ 523,891 Commercial real estate 356,544 32,044 34,001 533 423,122 Acquisition and development 80,771 25,001 4,184 2,170 112,126 SBA PPP 81,975 — — — 81,975 Total commercial 1,015,512 66,574 55,230 3,798 1,141,114 Residential 236,250 948 2,896 170 240,264 Home equity 30,277 381 144 26 30,828 Consumer 3,124 32 — — 3,156 Total Loans $ 1,285,163 $ 67,935 $ 58,270 $ 3,994 $ 1,415,362 Management further monitors the performance and credit quality of the loan portfolio by analyzing the age of the portfolio as determined by the length of time a recorded payment is past due. A loan that has deteriorated and requires additional collection efforts by the Bank could warrant non-accrual status. A complete review is presented to the Chief Credit Officer and/or the Special Asset Review Committee (“SARC”), as required with respect to any loan which is in a collection process and to make a determination as to whether the loan should be placed on non-accrual status. The placement of loans on non-accrual status is subject to applicable regulatory restrictions and guidelines. Generally, loans should be placed in non-accrual status when the loan reaches 90 days past due, when it becomes likely the borrower cannot or will not make scheduled principal or interest payments, when full repayment of principal and interest is not expected or when the loan displays potential loss characteristics. Normally, all accrued interest is charged off when a loan is placed in non-accrual status unless we believe it is likely the accrued interest will be collected. Any payments subsequently received are applied to the principal. All principal and interest due must be paid up-to-date and the Bank is reasonably sure of future satisfactory payment performance to remove a loan from non-accrual status. Usually, this requires the receipt of six The following table presents the classes of the loan portfolio, excluding PCI loans, summarized by aging categories of performing loans and non-accrual loans as of the periods indicated: (Dollars in thousands) Current 30-59 Days Past Due 60-89 Days Past Due 90+ Days Past Due Total Past Due Total Loans Non-Accrual 90+ Days Still Accruing September 30, 2021 Commercial Commercial business $ 608,407 $ 6,315 $ 1,052 $ 3,560 $ 10,927 $ 619,334 $ 9,102 $ — Commercial real estate 564,420 — — 156 156 564,576 495 — Acquisition and development 97,966 — — 1,076 1,076 99,042 1,157 — SBA PPP 147,338 — — — — 147,338 — — Total commercial 1,418,131 6,315 1,052 4,792 12,159 1,430,290 10,754 — Residential 268,281 726 415 545 1,686 269,967 6,601 — Home equity 23,550 117 15 95 227 23,777 95 — Consumer 22,138 3 3 — 6 22,144 3 — Total Loans $ 1,732,100 $ 7,161 $ 1,485 $ 5,432 $ 14,078 $ 1,746,178 $ 17,453 $ — December 31, 2020 Commercial Commercial business $ 521,799 $ 1,040 $ 33 $ 1,019 $ 2,092 $ 523,891 $ 8,601 $ — Commercial real estate 422,343 34 212 533 779 423,122 944 — Acquisition and development 109,686 — — 2,440 2,440 112,126 2,534 — SBA PPP 81,975 — — — — 81,975 — — Total commercial 1,135,803 1,074 245 3,992 5,311 1,141,114 12,079 — Residential 235,420 2,058 1,969 817 4,844 240,264 1,534 — Home equity 30,369 289 75 95 459 30,828 95 — Consumer 3,156 — — — — 3,156 5 — Total Loans $ 1,404,748 $ 3,421 $ 2,289 $ 4,904 $ 10,614 $ 1,415,362 $ 13,713 $ — An ALL is maintained to absorb losses from the loan portfolio. The ALL is based on management’s continuing evaluation of the risk characteristics and credit quality of the loan portfolio, assessment of current economic conditions, diversification and size of the portfolio, adequacy of collateral, past and anticipated loss experience and the amount of non-performing loans. The Bank’s methodology for determining the ALL is based on the requirements of ASC Section 310-10-35 for loans individually evaluated for impairment and ASC Subtopic 450-20 for loans collectively evaluated for impairment, as well as the Interagency Policy Statements on the Allowance for Loan and Lease Losses and other bank regulatory guidance. The total of the two components represents the Bank’s ALL. The Bank’s methodology allows for the analysis of certain impaired loans in homogeneous pools, rather than on an individual basis, when those loans are below specific thresholds based on the outstanding principal balance. More specifically, residential mortgage loans, home equity lines of credit and consumer loans, when considered impaired, are evaluated collectively for impairment by applying allocation rates derived from the Bank’s historical losses specific to impaired loans. Total collectively evaluated impaired loans, excluding the PCI loans acquired from First State, were $1.4 million and $2.0 million, while the related reserves were $0.1 million and $0.1 million as of September 30, 2021 and December 31, 2020. Such collectively evaluated impaired loans are included in total loans individually evaluated for impairment and in total impaired loans. Loans that are collectively evaluated for impairment are analyzed with general allowances being made as appropriate. For general allowances, historical loss trends are used in the estimation of losses in the current portfolio. These historical loss amounts are modified by qualified factors. The segments described above, which are based on the federal call code assigned to each loan, provide the starting point for the ALL analysis. Management tracks the historical net charge-off activity at the call code level. A historical charge-off factor is calculated utilizing a defined number of consecutive historical quarters. All pools currently utilize a rolling 12 quarters. “Pass” rated credits are segregated from “Criticized” credits for the application of qualitative factors. Loans in the criticized pools, which possess certain qualities or characteristics that may lead to collection and loss issues, are closely monitored by management and subject to additional qualitative factors. Management has identified a number of additional qualitative factors which it uses to supplement the historical charge-off factor because these factors are likely to cause estimated credit losses associated with the existing loan pools to differ from historical loss experience. The additional factors that are evaluated quarterly and updated using information obtained from internal, regulatory and governmental sources are: lending policies and procedures, nature and volume of the portfolio, experience and ability of lending management and staff, volume and severity of problem credits, quality of the loan review system, changes in the value of underlying collateral, effect of concentrations of credit from a loan type, industry and/or geographic standpoint, changes in economic and business conditions, consumer sentiment and other external factors. The combination of historical charge-off and qualitative factors are then weighted for each risk grade. These weightings are determined internally based upon the likelihood of loss as a loan risk grading deteriorates. Bank management analyzed the portfolios of letters of credit, non-revolving lines of credit and revolving lines of credit and based its calculation to estimate the liability for off-balance sheet credit exposures on the expectation of future advances of each loan category. Letters of credit were determined to be highly unlikely to advance since they are generally in place only to ensure various forms of performance of the borrowers. In the Bank’s history, there have been no letters of credit drawn upon. In addition, many of the letters of credit are cash secured and do not warrant an allocation. Non-revolving lines of credit were determined to be highly likely to advance as these are typically construction lines. Meanwhile, the likelihood of revolving lines of credit advancing varies with each individual borrower. Therefore, the future usage of each line was estimated based on the average line utilization of the revolving line of credit portfolio as a whole. Once the estimated future advances were calculated, an allocation rate, which was derived from the Bank’s historical losses and qualitative environmental factors, was applied in a similar manner as those used for the allowance for loan loss calculation. The resulting estimated loss allocations were totaled to determine the liability for unfunded commitments related to these loans, which management considers necessary to anticipate potential losses on those commitments that have a reasonable probability of funding. As of September 30, 2021 and December 31, 2020, the liability for unfunded commitments related to loans held for investment, excluding loans acquired from First State, was $0.5 million. Bank management reviews the loan portfolio on a quarterly basis using a defined, consistently applied process in order to make appropriate and timely adjustments to the ALL. When information confirms all or part of specific loans to be uncollectible, these amounts are promptly charged off against the ALL. The following table presents the primary segments of the ALL, excluding PCI loans, segregated into the amount required for loans individually evaluated for impairment and the amount required for loans collectively evaluated for impairment as of the periods indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at June 30, 2021 $ 22,659 $ 1,363 $ 284 $ 576 $ 24,882 Charge-offs (96) (2) — — (98) Recoveries 10 — 13 — 23 Provision (release) (529) (42) (37) 609 1 ALL balance at September 30, 2021 $ 22,044 $ 1,319 $ 260 $ 1,185 $ 24,808 (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at December 31, 2020 $ 24,033 $ 1,378 $ 298 $ 51 $ 25,760 Charge-offs (361) (2) — — (363) Recoveries 224 — 21 3 248 Provision (release) (1,852) (57) (59) 1,131 (837) ALL balance at September 30, 2021 $ 22,044 $ 1,319 $ 260 $ 1,185 $ 24,808 Individually evaluated for impairment $ 4,035 $ — $ 69 $ — $ 4,104 Collectively evaluated for impairment $ 18,009 $ 1,319 $ 191 $ 1,185 $ 20,704 The following table presents the primary segments of our loan portfolio, excluding PCI loans, as of the period indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total September 30, 2021 Individually evaluated for impairment $ 12,148 $ 6,971 $ 95 $ 3 $ 19,217 Collectively evaluated for impairment 1,418,142 262,996 23,682 22,141 1,726,961 Total Loans $ 1,430,290 $ 269,967 $ 23,777 $ 22,144 $ 1,746,178 The following table presents the primary segments of the ALL, excluding PCI loans, segregated into the amount required for loans individually evaluated for impairment and the amount required for loans collectively evaluated for impairment as of the periods indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at June 30, 2020 $ 15,401 $ 1,846 $ 264 $ 58 $ 17,569 Charge-offs (100) — — — (100) Recoveries 3 — 2 — 5 Provision (release) 8,840 (218) 82 (8) 8,696 ALL balance at Allowance contributed with mortgage combination transaction — (354) — — (354) ALL balance at September 30, 2020 $ 24,144 $ 1,274 $ 348 $ 50 $ 25,816 (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at December 31, 2019 $ 10,098 $ 1,272 $ 327 $ 78 $ 11,775 Charge-offs (1,856) — (23) — (1,879) Recoveries 9 — 6 2 17 Provision (release) 15,893 356 38 (30) 16,257 Allowance contributed with mortgage combination transaction — (354) — — (354) ALL balance at September 30, 2020 $ 24,144 $ 1,274 $ 348 $ 50 $ 25,816 Individually evaluated for impairment $ 1,984 $ — $ — $ — $ 1,984 Collectively evaluated for impairment $ 22,160 $ 1,274 $ 348 $ 50 $ 23,832 The following table presents the primary segments of our loan portfolio, excluding PCI loans, as of the period indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total September 30, 2020 Individually evaluated for impairment $ 14,350 $ 3,051 $ 95 $ 6 $ 17,502 Collectively evaluated for impairment 1,102,976 231,707 34,689 3,980 1,373,352 Total Loans $ 1,117,326 $ 234,758 $ 34,784 $ 3,986 $ 1,390,854 The ALL is based on estimates and actual losses will vary from current estimates. Management believes that the granularity of the homogeneous pools and the related historical loss ratios and other qualitative factors, as well as the consistency in the application of assumptions, result in an ALL that is representative of the risk found in the components of the portfolio at any given date. Troubled Debt Restructurings At September 30, 2021 and December 31, 2020, the Bank had specific reserve allocations for troubled debt restructurings (“TDRs”) of $0.5 million and $0.6 million, respectively. Loans considered to be troubled debt restructured loans totaled $7.7 million and $10.2 million as of September 30, 2021 and December 31, 2020, respectively. Of these totals, $1.4 million and $1.6 million, respectively, represent accruing troubled debt restructured loans and represent 8% and 10%, respectively, of total impaired loans. Meanwhile, as of September 30, 2021, $2.6 million represent four loans to two borrowers that have defaulted under the restructured terms. The largest of these loans, totaling $2.1 million, is a commercial loan, and the other three of these loans, totaling $0.5 million, are commercial acquisition and development loans that were considered TDRs due to extended interest-only periods and/or unsatisfactory repayment structures once transitioned to principal and interest payments. These borrowers have experienced continued financial difficulty and are considered non-performing loans as of September 30, 2021 and December 31, 2020. During the nine months ended September 30, 2021, no additional loans were classified as TDRs and no restructured loan defaulted under their modified terms that were not already classified as non-performing for having previously defaulted under their modified terms. During the three months ended September 30, 2020, no additional loans were classified as TDRs and no restructured loans defaulted under their modified terms that were already classified as non-performing for having previously defaulted under their modified terms. For the nine months ended September 30, 2020, the following table presents the new TDRs as of the period indicated: Nine Months Ended September 30, 2020 (Dollars in thousands) Number of Contracts Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Commercial Commercial business 5 $ 6,237 $ 5,427 Commercial real estate 2 159 152 Total commercial 7 6,396 5,579 Residential 1 87 86 Total 8 $ 6,483 $ 5,665 The pre-modification and post-modification balances represent the balances outstanding immediately before and after modification of the loan. Purchased Credit Impaired Loans As a result of the acquisition of First State, we have PCI loans. The following table presents the carrying amount of the PCI loan portfolio as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Commercial $ 15,079 $ 21,008 Residential 4,430 16,943 Consumer 601 1,488 Outstanding balance $ 20,110 $ 39,439 Carrying amount, net of allowance $ 20,110 $ 39,355 The following table presents the accretable yield, or income expected to be collected, as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Beginning balance $ 8,313 $ — New loans purchased — 11,746 Accretion of income (3,080) (2,945) Other changes in expected cash flows 1,234 (488) Ending balance $ 6,467 $ 8,313 There were no PCI loans purchased during the three or nine months ended September 30, 2021. Income is not recognized on PCI loans if we cannot reasonably estimate cash flows expected to be collected and, as of September 30, 2021, we held no such loans. The following tables summarize the primary segments of the ALL, segregated into the amount required for loans individually evaluated for impairment and the amount required for loans collectively evaluated for impairment for the PCI loan portfolio as of the periods indicated: (Dollars in thousands) Commercial Residential Total ALL balance at June 30, 2021 $ — $ — $ — Provision 14 365 379 ALL balance at September 30, 2021 $ 14 $ 365 $ 379 (Dollars in thousands) Commercial Residential Total ALL balance at December 31, 2020 $ — $ 84 $ 84 Provision 14 281 295 ALL balance at September 30, 2021 $ 14 $ 365 $ 379 Collectively evaluated for impairment $ 14 $ 365 $ 379 (Dollars in thousands) Commercial Residential Total ALL balance at June 30, 2020 $ 121 $ 52 $ 173 Charge-offs — (11) (11) Provision (121) 56 (65) ALL balance at September 30, 2020 $ — $ 97 $ 97 (Dollars in thousands) Commercial Residential Total ALL balance at December 31, 2019 $ — $ — $ — Charge-offs — (11) (11) Provision — 108 108 ALL balance at September 30, 2020 $ — $ 97 $ 97 Collectively evaluated for impairment $ — $ 97 $ 97 As of September 30, 2021, the loans in our PCI portfolio were all collectively evaluated for impairment and are segmented into three categories: commercial loans totaling $15.1 million, residential loans totaling $4.4 million, and consumer loans totaling $0.6 million, for a portfolio total of $20.1 million. The following table presents the classes of the PCI loan portfolio summarized by

Premises and Equipment

Premises and Equipment	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Premises and Equipment	Note 4 – Premises and Equipment The following table presents the components of premises and equipment as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Land $ 3,465 $ 3,936 Buildings and improvements 13,393 14,350 Furniture, fixtures and equipment 16,615 17,451 Software 3,978 1,527 Construction in progress 113 49 Leasehold improvements 2,865 3,079 40,429 40,392 Accumulated depreciation (15,386) (14,189) Premises and equipment, net $ 25,043 $ 26,203 We lease certain premises and equipment under operating and finance leases. At September 30, 2021, we had lease liabilities totaling $17.1 million, of which $17.0 million was related to operating leases and $0.1 million was related to finance leases, and right-of-use assets totaling $18.2 million, of which $17.8 million was related to operating leases and $0.4 million was related to finance leases. Lease liabilities and right-of-use assets are reflected in other liabilities and other assets, respectively. At September 30, 2021, the weighted-average remaining lease term for operating leases was 12.2 years and the weighted-average discount rate used in the measurement of operating lease liabilities was 2.8%. At September 30, 2021, the weighted-average remaining lease term for finance leases was 1.9 years and the weighted-average discount rate used in the measurement of finance lease liabilities was 2.1%. At December 31, 2020, we had lease liabilities totaling $18.4 million, of which $18.3 million was related to operating leases and $0.2 million was related to finance leases, and right-of-use assets totaling $17.7 million, of which $17.5 million was related to operating leases and $0.2 million was related to finance leases. Lease liabilities and right-of-use assets are reflected in other liabilities and other assets, respectively. At December 31, 2020, the weighted-average remaining lease term for operating leases was 12.9 years and the weighted-average discount rate used in the measurement of operating lease liabilities was 2.9%. At December 31, 2020, the weighted-average remaining lease term for finance leases was 2.3 years and the weighted-average discount rate used in the measurement of finance lease liabilities was 2.4%. The following table presents lease costs for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Operating lease cost $ 504 $ 473 $ 1,458 1,594 Short-term lease cost 2 — 4 26 Variable lease cost 9 10 29 30 Amortization of right-of-use assets, finance leases 16 13 44 49 Interest on lease liabilities, finance leases — 1 2 3 Total lease cost $ 531 $ 497 $ 1,537 $ 1,702 The following table presents future minimum payments for finance leases and operating leases with initial or remaining terms of one year or more as of September 30, 2021: (Dollars in thousands) Operating Leases Finance Leases 2021 $ 468 $ 15 2022 1,946 42 2023 1,897 5 2024 1,827 5 2025 1,826 4 2026 and thereafter 12,901 — Total future minimum lease payments $ 20,865 $ 71 Less: Amounts representing interest (3,878) (1) Present value of net future minimum lease payments $ 16,987 $ 70
Premises and Equipment	Note 4 – Premises and Equipment The following table presents the components of premises and equipment as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Land $ 3,465 $ 3,936 Buildings and improvements 13,393 14,350 Furniture, fixtures and equipment 16,615 17,451 Software 3,978 1,527 Construction in progress 113 49 Leasehold improvements 2,865 3,079 40,429 40,392 Accumulated depreciation (15,386) (14,189) Premises and equipment, net $ 25,043 $ 26,203 We lease certain premises and equipment under operating and finance leases. At September 30, 2021, we had lease liabilities totaling $17.1 million, of which $17.0 million was related to operating leases and $0.1 million was related to finance leases, and right-of-use assets totaling $18.2 million, of which $17.8 million was related to operating leases and $0.4 million was related to finance leases. Lease liabilities and right-of-use assets are reflected in other liabilities and other assets, respectively. At September 30, 2021, the weighted-average remaining lease term for operating leases was 12.2 years and the weighted-average discount rate used in the measurement of operating lease liabilities was 2.8%. At September 30, 2021, the weighted-average remaining lease term for finance leases was 1.9 years and the weighted-average discount rate used in the measurement of finance lease liabilities was 2.1%. At December 31, 2020, we had lease liabilities totaling $18.4 million, of which $18.3 million was related to operating leases and $0.2 million was related to finance leases, and right-of-use assets totaling $17.7 million, of which $17.5 million was related to operating leases and $0.2 million was related to finance leases. Lease liabilities and right-of-use assets are reflected in other liabilities and other assets, respectively. At December 31, 2020, the weighted-average remaining lease term for operating leases was 12.9 years and the weighted-average discount rate used in the measurement of operating lease liabilities was 2.9%. At December 31, 2020, the weighted-average remaining lease term for finance leases was 2.3 years and the weighted-average discount rate used in the measurement of finance lease liabilities was 2.4%. The following table presents lease costs for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Operating lease cost $ 504 $ 473 $ 1,458 1,594 Short-term lease cost 2 — 4 26 Variable lease cost 9 10 29 30 Amortization of right-of-use assets, finance leases 16 13 44 49 Interest on lease liabilities, finance leases — 1 2 3 Total lease cost $ 531 $ 497 $ 1,537 $ 1,702 The following table presents future minimum payments for finance leases and operating leases with initial or remaining terms of one year or more as of September 30, 2021: (Dollars in thousands) Operating Leases Finance Leases 2021 $ 468 $ 15 2022 1,946 42 2023 1,897 5 2024 1,827 5 2025 1,826 4 2026 and thereafter 12,901 — Total future minimum lease payments $ 20,865 $ 71 Less: Amounts representing interest (3,878) (1) Present value of net future minimum lease payments $ 16,987 $ 70

Equity Method Investments

Equity Method Investments	9 Months Ended
	Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	Note 5 – Equity Method Investments ICM In the third quarter of 2020, we acquired a portion of ICM, a direct mortgage lender, and account for our ownership as an equity method investment, initially recorded at fair value and subsequently adjusted for our share of ICM's earnings. In accordance with Rule 8-03(b)(3) of Regulation S-X, we must assess whether our equity method investment is significant. In evaluating the significance of this investment, we performed the income, asset and investment tests described in S-X 3-05 and S-X 1-02(w). Rule 8-03(b)(3) of Regulation S-X requires summarized financial information in a quarterly report if any of the three tests exceeds 20%. Under the income test, our proportionate share of our equity method investee's aggregated net income exceeded the applicable threshold of 20%, and accordingly, we are requir ed to provide summarized income statement information for this investee for all periods presented. Our share of net income from our equity method investment totaled $3.6 million and $14.6 million for the three and nine months ended September 30, 2021 . The following table presents summarized income statement information for our equity method investment for the period indicated. Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Total revenues $ 35,229 $ 62,915 $ 126,106 $ 62,915 Net income 9,962 28,979 36,747 28,979 Gain on sale of loans $ 30,720 $ 39,518 $ 122,621 $ 39,518 Volume of loans sold $ 1,098,475 $ 1,215,512 $ 4,368,875 $ 1,215,512 As of September 30, 2021 and December 31, 2020 , the mortgage pipeline was $1.15 billion an d $1.54 billion, respectively. Interchecks In September 2021, we increased our equity investment in Interchecks by $4.5 million, for a total investment to $7.7 million as of September 30, 2021 . The additional investment increased our ownership percentage to 16.9% and allows us to have significant influence over the operations and decision making at Interchecks; therefore, the investment has now been accounted for as an equity method investment as of September 30, 2021 . The equity method investment in Interchecks is not considered a significant investment based on the criteria of Rule 8-03(b)(3) of Regulation S-X. We have multiple business relationships with Interchecks beyond our investment. Interchecks is a banking client of ours and utilizes the Victor platform, which provides revenue to us. Additionally, Interchecks provides management services to MVB Technology, which provides revenue to Interchecks. Such revenues have not been material.

Deposits

Deposits	9 Months Ended
	Sep. 30, 2021
Deposits [Abstract]
Deposits	Note 6 – Deposits The following table presents the components of deposits as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Noninterest-bearing demand $ 999,328 $ 715,791 Interest-bearing demand 767,268 496,502 Savings and money markets 530,538 545,501 Time deposits, including CDs and IRAs 101,806 224,595 Total deposits $ 2,398,940 $ 1,982,389 Time deposits that meet or exceed the FDIC insurance limit $ 9,563 $ 16,955 The following table presents the maturities of time deposits for the twelve month periods ended September 30: (Dollars in thousands) 2022 $ 64,757 2023 21,466 2024 10,794 2025 3,726 2026 1,063 Total $ 101,806 As of September 30, 2021, overdrawn deposit accounts totaling $54 thousand were reclassified as loan balances.

Borrowed Funds

Borrowed Funds	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Borrowed Funds	Note 7 – Borrowed Funds The Bank is a member of the Federal Home Loan Bank ("FHLB") of Pittsburgh, Pennsylvania. As of September 30, 2021, the Bank's maximum borrowing capacity with the FHLB was $454.4 million and the remaining borrowing capacity was $443.0 million, with the difference being deposit letters of credit. Short-term borrowings As of September 30, 2021 and December 31, 2020, the Bank had no borrowings under Fed Funds purchased outstanding. The following table presents information related to short-term borrowings as of and for the periods indicated: (Dollars in thousands) Nine Months Ended September 30, 2021 Year Ended December 31, 2020 Balance at end of period $ — $ — Average balance during the period 33,914 68,407 Maximum month-end balance 130,047 154,248 Weighted-average rate during the period 0.36 % 0.58 % Weighted-average rate at end of period — % — % Long-term borrowings As of September 30, 2021 and December 31, 2020, the Bank had no long-term borrowings with the FHLB or the Federal Reserve Bank. Repurchase agreements Along with traditional deposits, the Bank has access to securities sold under agreements to repurchase (“repurchase agreements”) with clients representing funds deposited by clients, on an overnight basis, that are collateralized by investment securities owned by us. All repurchase agreements are subject to terms and conditions of repurchase/security agreements between us and the client and are accounted for as secured borrowings. Our repurchase agreements reflected in liabilities consist of client accounts and securities which are pledged on an individual security basis. We monitor the fair value of the underlying securities on a monthly basis. Repurchase agreements are reflected in the amount of cash received in connection with the transaction. The primary risk with our repurchase agreements is the market risk associated with the investments securing the transactions, as we may be required to provide additional collateral based on fair value changes of the underlying investments. Securities pledged as collateral under repurchase agreements are maintained with our safekeeping agents. As of September 30, 2021 and December 31, 2020, all of our repurchase agreements were overnight agreements. These borrowings were collateralized with investment securities with a carrying value of $11.5 million and $10.7 million at September 30, 2021 and December 31, 2020, respectively, and were comprised of United States government agency securities and United States sponsored mortgage-backed securities. Declines in the value of the collateral would require us to increase the amounts of securities pledged. The following table presents information related to repurchase agreements as of and for the periods shown: (Dollars in thousands) Nine Months Ended September 30, 2021 Year Ended December 31, 2020 Balance at end of period $ 11,139 $ 10,266 Average balance during the period 10,677 9,856 Maximum month-end balance 11,361 10,505 Weighted-average rate during the period 0.14 % 0.23 % Weighted-average rate at end of period 0.12 % 0.14 % Subordinated debt The following table presents information related to subordinated debt as of and for the periods shown: (Dollars in thousands) Nine Months Ended September 30, 2021 Year Ended December 31, 2020 Balance at end of period $ 72,966 $ 43,407 Average balance during the period 43,786 7,568 Maximum month-end balance 72,966 43,524 Weighted-average rate during the period 0.17 % 3.45 % Weighted-average rate at end of period 4.03 % 4.02 % In September 2021, MVB completed the private placement of $30 million fixed-to-floating rate subordinated notes to certain qualified institutional investors. These notes are unsecured and have a ten-year term, maturing October 1, 2031, and will bear interest at a fixed rate of 3.25%, payable semi-annually in arrears, for the first five years of the term. Thereafter, the interest rate will reset quarterly to an interest rate per annum equal to a benchmark rate, which is expected to be Three-Month Term SOFR, plus 254 basis points, payable quarterly in arrears. These notes have been structured to qualify as Tier 2 capital for regulatory capital purposes. In November 2020, MVB completed the private placement of $40 million fixed-to-floating rate subordinated notes to certain qualified institutional investors. These notes are unsecured and have a ten-year term, maturing December 1, 2030, and will bear interest at a fixed rate of 4.25%, payable semi-annually in arrears, for the first five years of the term. Thereafter, the interest rate will reset quarterly to an interest rate per annum equal to a benchmark rate, which is expected to be Three-Month Term SOFR, plus 401 basis points, payable quarterly in arrears. These notes have been structured to qualify as Tier 2 capital for regulatory capital purposes. The weighted-average rate during the period of nine months ended September 30, 2021 exceeds the coupon rate of the 4.25% subordinated debt due to the impact of the amortization of the issuance costs to interest expense. In March 2007, we completed the private placement of $4 million Floating Rate, Trust Preferred Securities through our subsidiary, MVB Financial Statutory Trust I (the “Trust”). We established the Trust for the sole purpose of issuing the Trust Preferred Securities pursuant to an Amended and Restated Declaration of Trust. The proceeds from the sale of the Trust Preferred Securities will be loaned to us under subordinated Debentures (the “Debentures”) issued to the Trust pursuant to an Indenture. The Debentures are the only asset of the Trust. The Trust Preferred Securities have been issued to a pooling vehicle that will use the distributions on the Trust Preferred Securities to securitize note obligations. The securities issued by the Trust are includable for regulatory purposes as a component of our Tier 1 capital. The Trust Preferred Securities and the Debentures mature in 2037 and have been redeemable by us since 2012. Interest payments are due in March, June, September and December and are adjusted at the interest due dates at a rate of 1.62% over the three-month LIBOR Rate. Our obligations with respect to the issuance of the trust preferred securities constitute a full and unconditional guarantee by us of the Trust’s obligations with respect to the trust preferred securities to the extent set forth in the related guarantees.

Pension and Supplemental Execut

Pension and Supplemental Executive Retirement Plans	9 Months Ended
	Sep. 30, 2021
Retirement Benefits [Abstract]
Pension and Supplemental Executive Retirement Plans	Note 8 – Pension and Supplemental Executive Retirement Plans Supplemental executive retirement plan In June 2017, we, along with MVB Mortgage, approved a Supplemental Executive Retirement Plan (“SERP”), pursuant to which the Chief Executive Officer of MVB Mortgage is entitled to receive certain supplemental nonqualified retirement benefits. The SERP took effect on December 31, 2017. As the executive completed three years of continuous employment with MVB Mortgage prior to retirement date (which shall be no earlier than the date he attains age 55) he will, upon retirement, be entitled to receive $1.8 million payable in 180 equal consecutive monthly installments of $10 thousand. The liability is calculated by discounting the anticipated future cash flows at 4.0%. The liability accrued for this obligation was $1.3 million as of September 30, 2021 and $1.2 million as of December 31, 2020. Service costs were not material for any periods covered by this report. Pension plan We participate in a trusteed pension plan known as the Allegheny Group Retirement Plan covering virtually all full-time employees. Benefits are based on years of service and the employee’s compensation. Accruals under the plan were frozen as of May 31, 2014. Freezing the plan resulted in a remeasurement of the pension obligations and plan assets as of the freeze date. The pension obligation was remeasured using the discount rate based on the Citigroup Above Median Pension Discount Curve in effect on May 31, 2014 of 4.5%. The following table presents information pertaining to the activity in our defined benefit plan, using the latest available actuarial valuations with a measurement date of September 30, 2021 and 2020 for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Service cost $ — $ — $ — $ — Interest cost 78 91 234 273 Expected return on plan assets (118) (109) (354) (327) Amortization of net actuarial loss 127 105 381 315 Amortization of prior service cost — — — — Net periodic benefit cost $ 87 $ 87 $ 261 $ 261 Contributions paid $ — $ 119 $ 3,835 $ 587

Stock Offerings

Stock Offerings	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Stock Offerings	Note 9 – Stock Offerings In December 2020, we issued a notice of redemption to redeem all of our outstanding shares of Convertible Noncumulative Perpetual Preferred Stock, Series B, par value $1.00 per share, with a liquidation preference of $1,000 per share (the “Series B Preferred Stock”) and all of our outstanding shares of Convertible Noncumulative Perpetual Preferred Stock, Series C, par value $1.00 per share, with a liquidation preference of $1,000 per share (the “Series C Preferred Stock, together with the Series B Preferred Stock, referred to herein as the “Preferred Stock”), at a redemption price per share equal to $10,000, plus declared and unpaid dividends of $46.03 per share of Series B Preferred Stock, and $49.86 per share of Series C Preferred Stock, for the period from and including December 31, 2020, to but excluding January 28, 2021, the date of redemption (the “Preferred Stock Redemption”). The Preferred Stock Redemption is in accordance with the terms of our Articles of Incorporation, as amended. All outstanding shares of our preferred stock were redeemed in January 2021. In April 2021, the Bank entered into a Stock Purchase Agreement with Trabian, a leading software development firm servicing financial institutions. Pursuant to the agreement, a portion of the Bank's purchase consideration for Trabian included 17,597 unregistered shares of MVB common stock. For more information regarding the Trabian acquisition, see Note 15 – Acquisitions and Divestitures . In August 2021, the Bank entered into a Stock Purchase Agreement with Interchecks, a leading payment disbursement platform. Pursuant to the agreement, a portion of the Bank's purchase consideration for Interchecks included 107,928 unregistered shares of MVB common stock. For more information regarding the Interchecks investment, see Note 5 – Equity Method Investments.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Note 10 – Fair Value of Financial InstrumentsThe following table presents the carrying values and estimated fair values of our financial instruments as of the periods indicated: (Dollars in thousands) Carrying Value Estimated Fair Value Quoted Prices in Active Markets for Identical Assets (Level I) Significant Other Observable Inputs (Level II) Significant Unobservable Inputs (Level III) September 30, 2021 Financial Assets: Cash and cash equivalents $ 390,081 $ 390,081 $ 390,081 $ — $ — Certificates of deposit with banks 9,582 9,657 — 9,657 — Securities available-for-sale 439,023 439,023 — 397,609 41,414 Equity securities 29,809 29,809 729 — 29,080 Loans receivable, net 1,738,999 1,748,759 — — 1,748,759 Servicing Assets 2,667 2,667 — — 2,667 Interest rate swap 8,444 8,444 — 8,444 — Fair value hedge 1,699 1,699 — 1,699 — Accrued interest receivable 8,513 8,513 — 2,621 5,892 Bank-owned life insurance 42,011 42,011 — 42,011 — Financial Liabilities: Deposits $ 2,398,940 $ 2,375,650 $ — $ 2,375,650 $ — Repurchase agreements 11,139 11,139 — 11,139 — FHLB and other borrowings — — — — — Interest rate swap 8,444 8,444 — 8,444 — Fair value hedge 1,129 1,129 — 1,129 — Accrued interest payable 802 802 — 802 — Subordinated debt 72,966 73,825 — 73,825 — December 31, 2020 Financial assets: Cash and cash equivalents $ 263,893 $ 263,893 $ 263,893 $ — $ — Certificates of deposits with banks 11,803 11,986 — 11,986 — Securities available-for-sale 410,624 410,624 — 366,945 43,679 Equity securities 27,585 27,585 472 — 27,113 Loans held-for-sale 1,062 1,062 — 1,062 — Loans receivable, net 1,427,900 1,434,275 — — 1,434,275 Mortgage servicing rights 2,942 2,942 — — 2,942 Interest rate swap 13,822 13,822 — 13,822 — Fair value hedge 2,215 2,215 — 2,215 Accrued interest receivable 7,793 7,793 — 2,770 5,023 Bank-owned life insurance 41,262 41,262 — 41,262 — Financial liabilities: Deposits $ 1,982,389 $ 1,964,860 $ — $ 1,964,860 $ — Repurchase agreements 10,266 10,266 — 10,266 — Interest rate swap 13,822 13,822 — 13,822 — Fair value hedge 2,141 2,141 — 2,141 — Accrued interest payable 572 572 — 572 — Subordinated debt 43,407 45,536 — 45,536 —

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 11 – Fair Value Measurements Fair value estimates are made at a specific point in time, based on relevant market information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time of our entire holdings of a particular financial instrument. Because no market exists for a significant portion of our financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment, and therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Fair value estimates are based on existing on-and-off balance sheet financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. The methods of determining the fair value of assets and liabilities presented in this footnote are consistent with our methodologies disclosed in Note 1 - Summary of Significant Accounting Policies of the Notes to the Consolidated Financial Statements included in Item 8, Financial Statements and Supplementary Data , of the 2020 Form 10-K. Assets Measured on a Recurring Basis As required by accounting standards, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. We classified investments in government securities as Level II instruments and valued them using the market approach. The following measurements are made on a recurring basis. Available-for-sale investment securities – Available-for-sale investment securities are recorded at fair value on a recurring basis. Fair value measurement is based upon quoted prices, if available. If quoted prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions. Level I securities include those traded on an active exchange, such as the New York Stock Exchange, United States Treasury securities that are traded by dealers or brokers in active over-the-counter markets and money market funds. Level II securities include mortgage-backed securities issued by government-sponsored entities and private label entities, municipal bonds and corporate debt securities. There have been no changes in valuation techniques for the three and nine months ended September 30, 2021. Valuation techniques are consistent with techniques used in prior periods. Certain local municipal securities related to tax increment financing (“TIF”) are independently valued and classified as Level III instruments. We classified investments in government securities as Level II instruments and valued them using the market approach. Equity securities – Certain equity securities are recorded at fair value on both a recurring and nonrecurring basis. Fair value measurement is based upon quoted prices, if available. If quoted prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security's credit rating, prepayment assumptions and other factors such as credit loss assumptions. The valuation methodologies utilized may include significant unobservable inputs. There have been no changes in valuation techniques for the three and nine months ended September 30, 2021. Valuation techniques are consistent with techniques used in prior periods. Loans held-for-sale – The fair value of mortgage loans held-for-sale is determined, when possible, using quoted secondary-market prices or investor commitments. If no such quoted price exists, the fair value of a loan is determined using quoted prices for a similar asset or assets, adjusted for the specific attributes of that loan, which would be used by other market participants. Interest rate swap – Interest rate swaps are recorded at fair value based on third-party vendors who compile prices from various sources and may determine the fair value of identical or similar instruments by using pricing models that consider observable market data. Fair value hedge – Treated like an interest rate swap, fair value hedges are recorded at fair value based on third-party vendors who compile prices from various sources and may determine fair value of identical or similar instruments by using pricing models that consider observable market data. The following tables present assets and liabilities reported on the consolidated statements of financial condition at their fair value on a recurring basis as of the periods indicated by level within the fair value hierarchy: September 30, 2021 (Dollars in thousands) Level I Level II Level III Total Assets: United States government agency securities $ — $ 41,971 $ — $ 41,971 United States sponsored mortgage-backed securities — 85,271 — 85,271 United States treasury securities 82,422 — — 82,422 Municipal securities — 166,009 41,414 207,423 Other securities — 14,436 — 14,436 Equity securities 729 — — 729 Interest rate swap — 8,444 — 8,444 Fair value hedge — 1,699 — 1,699 Liabilities: Interest rate swap — 8,444 — 8,444 Fair value hedge — 1,129 — 1,129 December 31, 2020 (Dollars in thousands) Level I Level II Level III Total Assets: United States government agency securities $ — $ 56,992 $ — $ 56,992 United States sponsored mortgage-backed securities — 95,769 — 95,769 Municipal securities — 188,208 43,679 231,887 Other securities — 18,476 — 18,476 Equity securities 472 — — 472 Loans held-for-sale — 1,062 — 1,062 Interest rate swap — 13,822 — 13,822 Fair value hedge — 2,215 — 2,215 Liabilities: Interest rate swap — 13,822 — 13,822 Fair value hedge — 2,141 — 2,141 The following table represents recurring Level III assets as of the periods indicated: (Dollars in thousands) Interest Rate Lock Commitments Municipal Securities Total Balance at June 30, 2021 $ — $ 39,770 $ 39,770 Realized and unrealized gains included in earnings — 5 5 Purchase of securities — 1,757 1,757 Maturities/calls — (74) (74) Unrealized gain included in other comprehensive income (loss) — 3,300 3,300 Unrealized loss included in other comprehensive income (loss) — (3,344) (3,344) Balance at September 30, 2021 $ — $ 41,414 $ 41,414 Balance at December 31, 2020 $ — $ 43,679 $ 43,679 Realized and unrealized gains included in earnings — 25 25 Purchase of securities — 3,575 3,575 Maturities/calls — (5,248) (5,248) Unrealized gain included in other comprehensive income (loss) — 7,720 7,720 Unrealized loss included in other comprehensive income (loss) — (8,337) (8,337) Balance at September 30, 2021 $ — $ 41,414 $ 41,414 Balance at June 30, 2020 $ 7,338 $ 40,457 $ 47,795 Realized and unrealized losses included in earnings (7,338) — (7,338) Purchase of securities — 368 368 Maturities/calls — (61) (61) Unrealized gain included in other comprehensive income (loss) — 1,810 1,810 Unrealized loss included in other comprehensive income (loss) — (466) (466) Balance at September 30, 2020 $ — $ 42,108 $ 42,108 Balance at December 31, 2019 $ 1,660 $ 37,259 $ 38,919 Realized and unrealized gains included in earnings (1,660) 3 (1,657) Purchase of securities — 21,147 21,147 Maturities/calls — (15,574) (15,574) Unrealized gain included in other comprehensive income (loss) — 5,872 5,872 Unrealized loss included in other comprehensive income (loss) — (6,599) (6,599) Balance at September 30, 2020 $ — $ 42,108 $ 42,108 Assets Measured on a Nonrecurring Basis We may be required, from time to time, to measure certain financial assets, financial liabilities, non-financial assets and non-financial liabilities at fair value on a nonrecurring basis in accordance with U.S. GAAP. These include assets that are measured at the lower of cost or market value that were recognized at fair value below cost at the end of the period. Certain non-financial assets measured at fair value on a nonrecurring basis include foreclosed assets (upon initial recognition or subsequent impairment), non-financial assets and non-financial liabilities measured at fair value in the second step of a goodwill impairment test and intangible assets and other non-financial long-lived assets measured at fair value for impairment assessment. Non-financial assets measured at fair value on a nonrecurring basis during 2021 and 2020 include certain foreclosed assets which, upon initial recognition, were remeasured and reported at fair value through a charge-off to the allowance for possible loan losses and certain foreclosed assets which, subsequent to their initial recognition, were remeasured at fair value through a write-down included in other noninterest expense. Impaired loans – Loans for which it is probable that payment of interest and principal will not be made in accordance with the contractual terms of the loan agreement are considered impaired. Once a loan is identified as individually impaired, management measures impairment using one of several methods, including collateral value, liquidation value and discounted cash flows. Those impaired loans not requiring an allowance represent loans for which the fair value of the expected repayments or collateral exceed the recorded investments in such loans. Collateral values are estimated using Level II inputs based on observable market data or Level III inputs based on customized discounting criteria. For a majority of impaired real estate-related loans, we obtain a current external appraisal. Other valuation techniques are used as well, including internal valuations, comparable property analysis and contractual sales information. Other real estate owned – Other real estate owned, which is obtained through the Bank’s foreclosure process, is valued utilizing the appraised collateral value. Collateral values are estimated using Level II inputs based on observable market data or Level III inputs based on customized discounting criteria. At the time the foreclosure is completed, we obtain a current external appraisal. Other debt securities – Certain debt securities are recorded at fair value on a nonrecurring basis. These other debt securities, which include preferred member interest in an equity method investment, are securities without a readily determinable fair value and are measured at cost minus impairment, if any, plus or minus any changes resulting from observable price changes in orderly transactions, as defined, for identical or similar investments of the same issuer. Equity securities – Certain equity securities are recorded at fair value on a nonrecurring basis. Equity securities without a readily determinable fair value are measured at cost minus impairment, if any, plus or minus any changes resulting from observable price changes in orderly transactions, as defined, for identical or similar investments of the same issuer. The following table presents the fair value of these assets as of the periods indicated: September 30, 2021 (Dollars in thousands) Level I Level II Level III Total Impaired loans $ — $ — $ 15,114 $ 15,114 Other real estate owned — — 3,442 3,442 December 31, 2020 (Dollars in thousands) Level I Level II Level III Total Impaired loans $ — $ — $ 14,098 $ 14,098 Other real estate owned — — 5,730 5,730 There were no changes to the fair value of other debt securities or equity securities measured on a nonrecurring basis as of September 30, 2021. The following tables present quantitative information about the Level III significant unobservable inputs for assets and liabilities measured at fair value as of the periods indicated: Quantitative Information about Level III Fair Value Measurements (Dollars in thousands) Fair Value Valuation Technique Unobservable Input Range September 30, 2021 Nonrecurring measurements: Impaired loans $ 15,114 Appraisal of collateral 1 Appraisal adjustments 2 20% - 62% Liquidation expense 2 5% - 10% Other real estate owned $ 3,442 Appraisal of collateral 1 Appraisal adjustments 2 20% - 30% Liquidation expense 2 5% - 10% Recurring measurements: Municipal securities 5 $ 41,414 Appraisal of bond 3 Bond appraisal adjustment 4 5% - 15% December 31, 2020 Nonrecurring measurements: Impaired loans $ 14,098 Appraisal of collateral 1 Appraisal adjustments 2 20% - 62% Liquidation expense 2 5% - 10% Other real estate owned $ 5,730 Appraisal of collateral 1 Appraisal adjustments 2 20% - 30% Liquidation expense 2 5% - 10% Recurring measurements: Municipal securities 5 $ 43,679 Appraisal of bond 3 Bond appraisal adjustment 4 5% - 15% 1 Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level III inputs that are not identifiable. 2 Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. 3 Fair value is determined through independent analysis of liquidity, rating, yield and duration. 4 Appraisals may be adjusted for qualitative factors such as local economic conditions. 5 Municipal securities classified as Level III instruments are comprised of TIF bonds related to certain local municipal securities.

Earnings per Share

Earnings per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Earnings per Share	Note 12 – Earnings per Share We determine basic earnings per share (“EPS”) by dividing net income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted EPS is determined by dividing net income available to common shareholders by the weighted-average number of shares outstanding, increased by both the number of shares that would be issued assuming the exercise of instruments under our incentive stock plan. The following table presents our calculation of EPS for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands except shares and per share data) 2021 2020 2021 2020 Numerator for basic earnings per share: Net income $ 11,828 $ 6,491 $ 29,160 $ 25,573 Less: Dividends on preferred stock — 116 35 345 Net income available to common shareholders - basic $ 11,828 $ 6,375 $ 29,125 $ 25,228 Numerator for diluted earnings per share: Net income available to common shareholders - diluted $ 11,828 $ 6,375 $ 29,125 $ 25,228 Denominator: Total weighted-average shares outstanding 11,880,348 11,948,989 11,684,570 11,948,857 Effect of dilutive stock options and restricted stock units 943,961 167,429 881,239 236,280 Total diluted weighted-average shares outstanding 12,824,309 12,116,418 12,565,809 12,185,137 Earnings per share - basic $ 1.00 $ 0.53 $ 2.49 $ 2.11 Earnings per share - diluted $ 0.92 $ 0.53 $ 2.32 $ 2.07 Stock options not included in the computation of diluted EPS because the effect would be antidilutive 179,694 849,589 185,944 815,089

Comprehensive Income

Comprehensive Income	9 Months Ended
	Sep. 30, 2021
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Comprehensive Income	Note 13 – Comprehensive Income The following tables present the reclassified components of accumulated other comprehensive income (“AOCI”) as of and for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Details about AOCI components Amount reclassified from AOCI Amount reclassified from AOCI Amount reclassified from AOCI Amount reclassified from AOCI Affected income statement line item Available-for-sale securities Unrealized holding gains $ 529 $ 35 $ 3,380 $ 865 Gain on sale of available-for-sale securities (124) (9) (793) (234) Income tax effect 405 26 2,587 631 Net of tax Defined benefit pension plan items Amortization of net actuarial loss (127) (105) (381) (315) Salaries and employee benefits 30 28 89 85 Income tax effect (97) (77) (292) (230) Net of tax Investment hedge Carrying value adjustment (14) (95) (637) 738 Interest on investment securities 3 26 149 (199) Income tax effect (11) (69) (488) 539 Net of tax Total reclassifications $ 297 $ (120) $ 1,807 $ 940 (Dollars in thousands) Unrealized gains (losses) on available for-sale securities Defined benefit pension plan items Investment hedge Total Balance at June 30, 2021 $ 3,136 $ (3,301) $ 164 $ (1) Other comprehensive income (loss) before reclassification 183 (700) — (517) Amounts reclassified from AOCI (405) 97 11 (297) Net current period OCI (222) (603) 11 (814) Balance at September 30, 2021 $ 2,914 $ (3,904) $ 175 $ (815) Balance at December 31, 2020 7,586 (5,047) (313) 2,226 Other comprehensive income (loss) before reclassification (2,085) 851 — (1,234) Amounts reclassified from AOCI (2,587) 292 488 (1,807) Net current period OCI (4,672) 1,143 488 (3,041) Balance at September 30, 2021 $ 2,914 $ (3,904) $ 175 $ (815) Balance at June 30, 2020 $ 3,771 $ (5,388) $ (576) $ (2,193) Other comprehensive income (loss) before reclassification 895 (74) — 821 Amounts reclassified from AOCI (26) 77 69 120 Net current period OCI 869 3 69 941 Balance at September 30, 2020 $ 4,640 $ (5,385) $ (507) $ (1,252) Balance at December 31, 2019 2,942 (4,295) 32 (1,321) Other comprehensive income (loss) before reclassification 2,329 (1,320) — 1,009 Amounts reclassified from AOCI (631) 230 (539) (940) Net current period OCI 1,698 (1,090) (539) 69 Balance at September 30, 2020 $ 4,640 $ (5,385) $ (507) $ (1,252)

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Segment Reporting	Note 14 – Segment Reporting We have identified three reportable segments: CoRe banking; mortgage banking; and financial holding company. Revenue from CoRe banking activities consists primarily of interest earned on loans and investment securities and service charges on deposit accounts. Our Fintech division, MVB Edge Ventures, MVB CDC, Chartwell, Trabian and Paladin Fraud are included in the CoRe banking segment. Revenue from the mortgage banking activities is comprised of interest earned on loans and fees received as a result of the mortgage loan origination process. Prior to July 1, 2020, the mortgage banking services were conducted by a subsidiary of the Bank, Potomac Mortgage Group ("PMG"). In July 2020, we announced the completion of PMG’s combination with Intercoastal Mortgage Company to form ICM. We have recognized our ownership of ICM as an equity method investment. Income related to this equity method investment is included in the Mortgage Banking segment. Revenue from financial holding company activities is mainly comprised of intercompany service income and dividends. The following tables present information about the reportable segments and reconciliation to the consolidated financial statements for the periods indicated: Three Months Ended September 30, 2021 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 20,383 $ 105 $ 1 $ (5) $ 20,484 Interest expense 912 — 481 (5) 1,388 Net interest income 19,471 105 (480) — 19,096 Provision for loan losses 379 1 — — 380 Net interest income (loss) after provision for loan losses 19,092 104 (480) — 18,716 Total noninterest income 20,211 3,546 2,002 (3,808) 21,951 Noninterest Expenses: Salaries and employee benefits 13,097 47 3,384 — 16,528 Other expense 11,654 (198) 1,653 (3,808) 9,301 Total noninterest expenses 24,751 (151) 5,037 (3,808) 25,829 Income (loss) before income taxes 14,552 3,801 (3,515) — 14,838 Income tax expense (benefit) 2,973 922 (731) — 3,164 Net income (loss) before noncontrolling interest 11,579 2,879 (2,784) — 11,674 Net loss attributable to noncontrolling interest 154 — — — 154 Net income (loss) attributable to parent $ 11,733 $ 2,879 $ (2,784) $ — $ 11,828 Preferred stock dividends — — — — — Net income (loss) available to common shareholders $ 11,733 $ 2,879 $ (2,784) $ — $ 11,828 Capital expenditures for the three months ended September 30, 2021 $ 1,975 $ — $ — $ — $ 1,975 Total assets as of September 30, 2021 2,827,019 53,261 342,677 (434,133) 2,788,824 Total assets as of December 31, 2020 2,343,556 58,140 284,943 (355,163) 2,331,476 Goodwill as of September 30, 2021 3,988 — — — 3,988 Goodwill as of December 31, 2020 2,350 — — — 2,350 Three Months Ended September 30, 2020 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 18,737 $ 78 $ — $ (188) $ 18,627 Interest expense 2,553 232 20 (188) 2,617 Net interest income 16,184 (154) (20) — 16,010 Provision for loan losses 8,631 — — — 8,631 Net interest income (loss) after provision for loan losses 7,553 (154) (20) — 7,379 Total noninterest income 3,106 16,793 1,481 (1,982) 19,398 Noninterest Expense: Salaries and employee benefits 7,526 82 2,911 — 10,519 Other expense 8,389 68 1,271 (1,982) 7,746 Total noninterest expenses 15,915 150 4,182 (1,982) 18,265 Income (loss) before income taxes (5,256) 16,489 (2,721) — 8,512 Income tax expense (benefit) (1,556) 4,245 (668) — 2,021 Net income (loss) $ (3,700) $ 12,244 $ (2,053) $ — $ 6,491 Preferred stock dividends — — 116 — 116 Net income (loss) available to common shareholders $ (3,700) $ 12,244 $ (2,169) $ — $ 6,375 Capital expenditures for the three months ended September 30, 2020 $ 1,652 $ — $ — $ — $ 1,652 Nine Months Ended September 30, 2021 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 60,078 $ 307 $ 2 $ (7) $ 60,380 Interest expense 3,294 — 1,437 (7) 4,724 Net interest income 56,784 307 (1,435) — 55,656 Release of allowance for loan losses (541) (1) — — (542) Net interest income (loss) after release of allowance for loan losses 57,325 308 (1,435) — 56,198 Total noninterest income 36,634 14,499 5,892 (8,972) 48,053 Noninterest Expenses: Salaries and employee benefits 32,323 47 9,730 — 42,100 Other expense 31,261 (112) 4,073 (8,972) 26,250 Total noninterest expenses 63,584 (65) 13,803 (8,972) 68,350 Income (loss) before income taxes 30,375 14,872 (9,346) — 35,901 Income tax expense (benefit) 5,290 3,606 (1,890) — 7,006 Net income (loss) before noncontrolling interest 25,085 11,266 (7,456) — 28,895 Net loss attributable to noncontrolling interest 265 — — — 265 Net income (loss) attributable to parent $ 25,350 $ 11,266 $ (7,456) $ — $ 29,160 Preferred stock dividends — — 35 — 35 Net income (loss) available to common shareholders $ 25,350 $ 11,266 $ (7,491) $ — $ 29,125 Capital expenditures for the nine months ended September 30, 2021 $ 4,127 $ — $ — $ — $ 4,127 Nine Months Ended September 30, 2020 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 56,693 $ 6,034 $ 2 $ (1,629) $ 61,100 Interest expense 9,418 3,136 78 (2,171) 10,461 Net interest income 47,275 2,898 (76) 542 50,639 Provision for loan losses 16,361 4 — — 16,365 Net interest income (loss) after provision for loan losses 30,914 2,894 (76) 542 34,274 Total noninterest income 24,394 53,140 4,664 (6,437) 75,761 Noninterest Expenses: Salaries and employee benefits 19,562 21,550 8,248 — 49,360 Other expense 24,172 4,780 3,837 (5,895) 26,894 Total noninterest expenses 43,734 26,330 12,085 (5,895) 76,254 Income (loss) before income taxes 11,574 29,704 (7,497) — 33,781 Income tax expense (benefit) 2,336 7,696 (1,824) — 8,208 Net income (loss) $ 9,238 $ 22,008 $ (5,673) $ — $ 25,573 Preferred stock dividends — — 345 — 345 Net income (loss) available to common shareholders $ 9,238 $ 22,008 $ (6,018) $ — $ 25,228 Capital Expenditures for the nine-month period ended September 30, 2020 $ 4,092 $ 99 $ 20 $ — $ 4,211

Acquisitions and Divestitures

Acquisitions and Divestitures	9 Months Ended
	Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Acquisitions and Divestitures	Note 15 – Acquisitions and Divestitures Flexia Payments, LLC In February 2021, the Bank entered into an agreement to acquire an 80% interest in Flexia. The Bank invested approximately $2.5 million for the 80% interest. At the time of acquisition, Flexia had no assets or liabilities. Soon after the Bank's investment, Flexia purchased a license for technology that allows users to access a reloadable account that combines a debit card account and casino gaming accounts into one card and to utilize them for non-cash transactions at participating casinos, for approximately $1 million for exclusive use in the United States and Canada. On the acquisition date, $0.5 million was recorded on the consolidated balance sheet for the 20% noncontrolling interest. Trabian Technology, Inc. In April 2021, the Bank entered into a Stock Purchase Agreement with Trabian, a leading software development firm servicing financial institutions. Pursuant to the agreement, the Bank invested approximately $1.6 million, including unregistered shares of MVB common stock, for the 80% interest. At the time of acquisition, Trabian had assets totaling $0.8 million and liabilities totaling $0.7 million. As a result of the transaction, the Bank recorded goodwill of $1.6 million and intangible assets related to Trabian's customer relationships and trade name totaling $0.6 million. On the acquisition date, $0.4 million was recorded on the consolidated balance sheet for the 20% noncontrolling interest. Sale of Southern Market, WV Banking Centers

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Principles of Consolidation	The accompanying unaudited consolidated financial statements include the accounts of MVB and our subsidiaries, including the Bank and the Bank’s subsidiaries.
Basis of Presentation	nerally accepted in the United States of America (“U.S. GAAP”) and with instructions for Form 10-Q and Article 10 of Regulation S-X of the SEC. All material intercompany accounts and transactions have been eliminated in consolidation. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted. The consolidated balance sheet as of December 31, 2020 has been derived from audited financial statements included in the 2020 Form 10-K. The information presented in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and notes thereto included in the 2020 Form 10-K. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. In 2021, the Bank entered into agreements to acquire majority interests in both Flexia and in Trabian and to divest a minority interest in MVB Technology. Although we own, through our subsidiaries, an 80.0% interest in each of Flexia and Trabian and a 93.4% interest in MVB Technology, we are required to consolidate 100% of Flexia, Trabian and MVB Technology within the consolidated financial statements. The remaining 20.0% of Flexia and Trabian and 6.6% of MVB Technology are accounted for separately as noncontrolling interests within the consolidated financial statements. Noncontrolling interest represents the portion of ownership and profit or loss that is attributable to the minority owners of these entities. Unconsolidated investments where we have the ability to exercise significant influence over the operating and financial policies of the respective investee are accounted for using the equity method of accounting; those that are not consolidated or accounted for using the equity method of accounting are accounted for under cost or fair value accounting. For these investments accounted for under the equity method, we record our investment in non-consolidated affiliates and the portion of income or loss in equity in earnings of non-consolidated affiliates. We periodically evaluate these investments for impairment. As of September 30, 2021, we hold two equity method investments. Preparation of our consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates are based upon the best available information and actual results could differ from those estimates. Estimates that are particularly significant to the consolidated financial statements relate to the determination of the allowance for loan losses (“ALL”), purchased credit impaired (“PCI”) loans, derivative instruments, goodwill and deferred tax assets and liabilities.
Reclassification	In certain instances, amounts reported in prior periods’ consolidated financial statements have been reclassified to conform to the current presentation.
Subsequent Events	We have evaluated subsequent events for potential recognition and/or disclosure through the date these consolidated financial statements were issued.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance in November 2018, ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , in April 2019, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments , in May 2019, ASU 2019-05, Financial Instruments – Credit Losses, Topic 326 and in November 2019, ASU 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates and ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , all of which clarifies codification and corrects unintended application of the guidance. The new guidance replaces the incurred loss impairment methodology in current U.S. GAAP with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. PCI loans will receive an allowance account at the acquisition date that represents a component of the purchase price allocation. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses, with such allowance limited to the amount by which fair value is below amortized cost. The guidance was initially effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. On November 15, 2019, the FASB issued ASU 2019-10, Financial Investments – Credit Issues (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates , which finalizes a delay in the effective date of the standard for smaller reporting companies (“SRCs”). Effective in the first quarter of 2022, we will lose our SRC designation. However, because we met the criteria to be an SRC as of the issuance date of this guidance, we are eligible for the delay in effective date and plan to adopt this standard for fiscal years ending after December 15, 2022. We expect to recognize a one-time cumulative effect adjustment to the ALL as of the beginning of the first reporting period in which the new standard is effective, but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements. In that regard, we have formed a cross-functional implementation team. The team is working to develop an implementation plan which will include assessment and documentation of processes, internal controls and data sources; model development and documentation; and system configuration, among other things. We are also in the process of implementing a third-party vendor solution to assist us in the application of this standard. The adoption of this standard could result in an increase in the ALL as a result of changing from an “incurred loss” model, which encompasses allowances for current known and inherent losses within the portfolio, to an “expected loss” model, which encompasses allowances for losses expected to be incurred over the life of the portfolio. While we are currently unable to reasonably estimate the impact of adopting ASU 2016-13, we expect that the impact of adoption will be significantly influenced by the composition, characteristics and quality of our loan portfolio, as well as the prevailing economic conditions and forecasts as of the adoption date. In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirement for Defined Benefit Plans , which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The updates in this ASU are part of the disclosure framework project ASU 2018-14 and modify the disclosure requirements under Accounting Standards Codification (“ASC”) 715-20 for employers that sponsor defined benefit pension or other postretirement plans. Those modifications include the removal and addition of disclosure requirements as well as clarifying specific disclosure requirements. The ASU removed the following disclosures: 1) the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year; 2) the amount and timing of plan assets expected to be returned to the employer; 3) the disclosures related to the June 2001 amendments to the Japanese Welfare Pension Insurance Law; 4) related party disclosures about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan; 5) for nonpublic entities, the reconciliation of the opening balances to the closing balances of plan assets measured on a recurring basis in Level 3 of the fair value hierarchy; however, nonpublic entities will be required to disclose separately the amounts of transfers into and out of Level 3 of the fair value hierarchy and purchases of Level 3 plan assets and 6) for public entities, the effects of a one-percentage-point change in assumed health care cost trend rates on the (i) aggregate of the service and interest cost components of net periodic benefit costs and (ii) benefit obligation for postretirement health care benefits. The ASU added the following disclosures: 1) the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates and 2) an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. The ASU then clarified the following disclosures: 1) the projected benefit obligation (“PBO”) and fair value of plan assets for plans with PBOs more than plan assets; and 2) the accumulated benefit obligation (“ABO”) and fair value of plan assets for plans with ABOs more than plan assets. ASU 2018-14 is effective for public business entities for fiscal years ending after December 15, 2020. As ASU 2018-04 is specific to disclosure requirements, adoption did not have a material impact on our interim consolidated financial statements. Our year-end disclosures will be revised to comply with the new requirements. In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 . ASU 2020-01 clarifies the interaction between accounting standards related to equity securities, equity method investments and certain derivatives, including accounting for the transition into and out of the equity method and measuring certain purchased options and forward contracts to acquire investments. The amendments were effective for us beginning January 1, 2021 and adoption did not have a material effect on our consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments provide optional expedients and exceptions for certain contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of rate reform. The guidance is effective from the date of issuance until December 31, 2022. The guidance permits entities to not apply modification accounting or remeasure lease payments in lease contracts if the changes to the contract are related to the discontinuation of the reference rate. If certain criteria are met, the amendments also allow exceptions to the de-designation criteria of the hedging relationship and the assessment of hedge effectiveness during the transition period. In January 2021, ASU 2021-01 was issued by the FASB and clarified that certain exceptions in reference rate reform apply to derivatives that are affected by the discounting transition. We will continue to assess the impact as the reference rate transition occurs.

Investment Securities (Tables)

Investment Securities (Tables)	9 Months Ended
	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Amortized Cost and Fair Values of Investment Securities Available-for-sale	The following tables present amortized cost and fair values of investment securities available-for-sale as of the periods indicated: September 30, 2021 (Dollars in thousands) Amortized Cost Unrealized Gain Unrealized Loss Fair Value United States government agency securities $ 42,226 $ 342 $ (597) $ 41,971 United States sponsored mortgage-backed securities 85,754 401 (884) 85,271 United States treasury securities 82,738 — (316) 82,422 Municipal securities 202,717 5,182 (476) 207,423 Other debt securities 7,500 — — 7,500 Total debt securities 420,935 5,925 (2,273) 424,587 Other securities 14,282 177 (23) 14,436 Total investment securities available-for-sale $ 435,217 $ 6,102 $ (2,296) $ 439,023 December 31, 2020 (Dollars in thousands) Amortized Cost Unrealized Gain Unrealized Loss Fair Value United States government agency securities $ 53,207 $ 872 $ (210) $ 53,869 United States sponsored mortgage-backed securities 94,968 972 (171) 95,769 United States treasury securities 3,000 123 — 3,123 Municipal securities 223,642 8,327 (82) 231,887 Other debt securities 7,500 — — 7,500 Total debt securities 382,317 10,294 (463) 392,148 Other securities 18,401 146 (71) 18,476 Total investment securities available-for-sale $ 400,718 $ 10,440 $ (534) $ 410,624 The following table presents amortized cost and fair values of available-for-sale debt securities by contractual maturity as of the period indicated: September 30, 2021 (Dollars in thousands) Amortized Cost Fair Value Within one year $ 5 $ 5 After one year, but within five years 86,798 86,542 After five years, but within ten years 34,205 35,079 After ten years 299,927 302,961 Total $ 420,935 $ 424,587
Investments in an Unrealized Loss Position	The following tables present investments in an unrealized loss position as of the periods indicated: September 30, 2021 (Dollars in thousands) Less than 12 months 12 months or more Description and number of positions Fair Value Unrealized Loss Fair Value Unrealized Loss United States government agency securities (20) $ 4,334 $ (138) $ 18,113 $ (459) United States sponsored mortgage-backed securities (27) 57,861 (803) 4,431 (81) United States treasury securities (18) 82,423 (316) — — Municipal securities (56) 40,069 (430) 2,898 (46) Other securities (1) — — 1,477 (23) $ 184,687 $ (1,687) $ 26,919 $ (609) December 31, 2020 (Dollars in thousands) Less than 12 months 12 months or more Description and number of positions Fair Value Unrealized Loss Fair Value Unrealized Loss United States government agency securities (27) $ 19,021 $ (68) $ 12,574 $ (142) United States sponsored mortgage-backed securities (9) 15,331 (155) 3,349 (16) Municipal securities (14) 11,856 (82) — — Other securities (5) 3,947 (71) — — $ 50,155 $ (376) $ 15,923 $ (158)
Realized Gain (Loss) on Investments	The following table summarizes investment sales, related gains and losses and unrealized holding gains for the periods shown: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Sales of available-for-sale securities $ 28,049 $ 7,379 $ 103,365 $ 48,579 Gains, gross 547 69 3,411 899 Losses, gross 18 34 31 34 Sales of equity securities $ — $ 669 $ 61 $ 669 Gain, gross — 18 5 48 Losses, gross — — — — Unrealized holding gains on equity securities 536 94 1,750 111

Loans and Allowance for Loan _2

Loans and Allowance for Loan Losses (Tables)	9 Months Ended
	Sep. 30, 2021
Receivables [Abstract]
Components of Loans in the Consolidated Balance Sheet	The following table presents the components of loans as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Commercial and non-residential real estate $ 1,430,290 $ 1,141,114 Residential real estate 269,967 240,264 Home equity 23,777 30,828 Consumer 22,144 3,156 Total 1,746,178 1,415,362 Purchased credit impaired loans: Commercial and non-residential real estate 15,079 21,008 Residential real estate 4,430 16,943 Consumer 601 1,488 Total purchased credit impaired loans 20,110 39,439 Total Loans $ 1,766,288 $ 1,454,801 Deferred loan origination costs and (fees), net (2,102) (1,057) Loans receivable $ 1,764,186 $ 1,453,744
Impaired Loans by Class	The following table presents impaired loans by class, excluding PCI loans, segregated by those for which a specific allowance was required and those for which a specific allowance was not necessary as of the periods indicated: Impaired Loans with Specific Allowance Impaired Loans with No Specific Allowance Total Impaired Loans (Dollars in thousands) Recorded Investment Related Allowance Recorded Investment Recorded Investment Unpaid Principal Balance September 30, 2021 Commercial Commercial business $ 5,931 $ 3,792 $ 3,646 $ 9,577 $ 11,283 Commercial real estate 676 243 495 1,171 1,341 Acquisition and development — — 1,401 1,401 2,816 Total commercial 6,607 4,035 5,542 12,149 15,440 Residential — — 6,971 6,971 7,222 Home equity 69 69 26 95 95 Consumer — — 3 3 3 Total impaired loans $ 6,676 $ 4,104 $ 12,542 $ 19,218 $ 22,760 December 31, 2020 Commercial Commercial business $ 3,431 $ 1,032 $ 5,653 $ 9,084 $ 10,440 Commercial real estate 772 264 944 1,716 1,864 Acquisition and development — — 2,534 2,534 3,939 Total commercial 4,203 1,296 9,131 13,334 16,243 Residential — — 1,960 1,960 2,232 Home equity — — 95 95 95 Consumer — — 5 5 5 Total impaired loans $ 4,203 $ 1,296 $ 11,191 $ 15,394 $ 18,575 (Dollars in thousands) September 30, 2021 December 31, 2020 Commercial $ 15,079 $ 21,008 Residential 4,430 16,943 Consumer 601 1,488 Outstanding balance $ 20,110 $ 39,439 Carrying amount, net of allowance $ 20,110 $ 39,355
Average Recorded Investment in Impaired Loans and Related Interest Income Recognized	The following table presents the average recorded investment in impaired loans, excluding PCI loans, and related interest income recognized for the periods indicated: Three Months Ended September 30, 2021 2020 (Dollars in thousands) Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Commercial Commercial business $ 7,223 $ — $ — $ 7,785 $ — $ — Commercial real estate 1,943 11 11 3,264 26 26 Acquisition and development 340 — — 375 10 54 Total commercial 9,506 11 11 11,424 36 80 Residential 7,029 3 3 3,085 5 5 Home equity 69 — — 69 — — Consumer 3 — — 5 — — Total $ 16,607 $ 14 $ 14 $ 14,583 $ 41 $ 85 Nine Months Ended September 30, 2021 2020 (Dollars in thousands) Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Average Investment in Impaired Loans Interest Income Recognized on Accrual Basis Interest Income Recognized on Cash Basis Commercial Commercial business $ 6,701 $ — $ — $ 5,225 $ — $ — Commercial real estate 2,125 33 33 3,124 77 79 Acquisition and development 348 — — 1,487 67 73 Total commercial 9,174 33 33 9,836 144 152 Residential 5,418 11 10 2,683 14 14 Home equity 69 — — 94 — — Consumer 3 — — 8 — — Total $ 14,664 $ 44 $ 43 $ 12,621 $ 158 $ 166
Classes of the Loan Portfolio Summarized by the Aggregate Pass and the Criticized Categories	The following table represents the classes of the loan portfolio, excluding PCI loans, summarized by the aggregate Pass and the criticized categories of Special Mention, Substandard and Doubtful within the internal risk rating system as of the periods indicated: (Dollars in thousands) Pass Special Mention Substandard Doubtful Total September 30, 2021 Commercial Commercial business $ 589,196 $ 13,623 $ 12,910 $ 3,605 $ 619,334 Commercial real estate 508,729 22,004 33,687 156 564,576 Acquisition and development 86,205 7,624 4,149 1,064 99,042 SBA PPP 147,338 — — — 147,338 Total commercial 1,331,468 43,251 50,746 4,825 1,430,290 Residential 259,864 917 8,693 493 269,967 Home equity 23,304 378 — 95 23,777 Consumer 22,123 18 3 — 22,144 Total Loans $ 1,636,759 $ 44,564 $ 59,442 $ 5,413 $ 1,746,178 December 31, 2020 Commercial Commercial business $ 496,222 $ 9,529 $ 17,045 $ 1,095 $ 523,891 Commercial real estate 356,544 32,044 34,001 533 423,122 Acquisition and development 80,771 25,001 4,184 2,170 112,126 SBA PPP 81,975 — — — 81,975 Total commercial 1,015,512 66,574 55,230 3,798 1,141,114 Residential 236,250 948 2,896 170 240,264 Home equity 30,277 381 144 26 30,828 Consumer 3,124 32 — — 3,156 Total Loans $ 1,285,163 $ 67,935 $ 58,270 $ 3,994 $ 1,415,362 The following table presents the classes of the PCI loan portfolio summarized by the aggregate Pass and the criticized categories of Special Mention, Substandard and Doubtful within the internal risk rating system as of the periods indicated: (Dollars in thousands) Pass Special Mention Substandard Doubtful Total September 30, 2021 Commercial Commercial business $ 2,360 $ 158 $ 211 $ 209 $ 2,938 Commercial real estate 7,784 1,549 2,189 73 11,595 Acquisition and development 259 78 163 46 546 Total commercial 10,403 1,785 2,563 328 15,079 Residential 3,586 — 844 — 4,430 Consumer 36 — 563 2 601 Total Loans $ 14,025 $ 1,785 $ 3,970 $ 330 $ 20,110 December 31, 2020 Commercial Commercial business $ 12,263 $ 136 $ 345 $ 4,860 $ 17,604 Commercial real estate 982 3 263 21 1,269 Acquisition and development 1,900 — — 235 2,135 Total commercial 15,145 139 608 5,116 21,008 Residential 15,157 — 1,665 121 16,943 Consumer 1,256 — — 232 1,488 Total Loans $ 31,558 $ 139 $ 2,273 $ 5,469 $ 39,439
Classes of the Loan Portfolio Summarized by Aging Categories	The following table presents the classes of the loan portfolio, excluding PCI loans, summarized by aging categories of performing loans and non-accrual loans as of the periods indicated: (Dollars in thousands) Current 30-59 Days Past Due 60-89 Days Past Due 90+ Days Past Due Total Past Due Total Loans Non-Accrual 90+ Days Still Accruing September 30, 2021 Commercial Commercial business $ 608,407 $ 6,315 $ 1,052 $ 3,560 $ 10,927 $ 619,334 $ 9,102 $ — Commercial real estate 564,420 — — 156 156 564,576 495 — Acquisition and development 97,966 — — 1,076 1,076 99,042 1,157 — SBA PPP 147,338 — — — — 147,338 — — Total commercial 1,418,131 6,315 1,052 4,792 12,159 1,430,290 10,754 — Residential 268,281 726 415 545 1,686 269,967 6,601 — Home equity 23,550 117 15 95 227 23,777 95 — Consumer 22,138 3 3 — 6 22,144 3 — Total Loans $ 1,732,100 $ 7,161 $ 1,485 $ 5,432 $ 14,078 $ 1,746,178 $ 17,453 $ — December 31, 2020 Commercial Commercial business $ 521,799 $ 1,040 $ 33 $ 1,019 $ 2,092 $ 523,891 $ 8,601 $ — Commercial real estate 422,343 34 212 533 779 423,122 944 — Acquisition and development 109,686 — — 2,440 2,440 112,126 2,534 — SBA PPP 81,975 — — — — 81,975 — — Total commercial 1,135,803 1,074 245 3,992 5,311 1,141,114 12,079 — Residential 235,420 2,058 1,969 817 4,844 240,264 1,534 — Home equity 30,369 289 75 95 459 30,828 95 — Consumer 3,156 — — — — 3,156 5 — Total Loans $ 1,404,748 $ 3,421 $ 2,289 $ 4,904 $ 10,614 $ 1,415,362 $ 13,713 $ — The following table presents the classes of the PCI loan portfolio summarized by aging categories of performing loans and non-accrual loans as of the periods indicated: (Dollars in thousands) Current 30-59 Days Past Due 60-89 Days Past Due 90+ Days Past Due Total Past Due Total Loans September 30, 2021 Commercial Commercial business $ 2,519 $ — $ — $ 419 $ 419 $ 2,938 Commercial real estate 7,967 640 — 2,988 3,628 11,595 Acquisition and development 146 177 — 223 400 546 Total commercial 10,632 817 — 3,630 4,447 15,079 Residential 3,522 — 64 844 908 4,430 Consumer 36 — — 565 565 601 Total Loans $ 14,190 $ 817 $ 64 $ 5,039 $ 5,920 $ 20,110 December 31, 2020 Commercial Commercial business $ 16,264 $ 71 $ 65 $ 1,204 $ 1,340 $ 17,604 Commercial real estate 1,157 — — 112 112 1,269 Acquisition and development 2,135 — — — — 2,135 Total commercial 19,556 71 65 1,316 1,452 21,008 Residential 13,714 710 145 2,374 3,229 16,943 Consumer 1,245 3 1 239 243 1,488 Total Loans $ 34,515 $ 784 $ 211 $ 3,929 $ 4,924 $ 39,439
Allowance Activity	The following table presents the primary segments of the ALL, excluding PCI loans, segregated into the amount required for loans individually evaluated for impairment and the amount required for loans collectively evaluated for impairment as of the periods indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at June 30, 2021 $ 22,659 $ 1,363 $ 284 $ 576 $ 24,882 Charge-offs (96) (2) — — (98) Recoveries 10 — 13 — 23 Provision (release) (529) (42) (37) 609 1 ALL balance at September 30, 2021 $ 22,044 $ 1,319 $ 260 $ 1,185 $ 24,808 (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at December 31, 2020 $ 24,033 $ 1,378 $ 298 $ 51 $ 25,760 Charge-offs (361) (2) — — (363) Recoveries 224 — 21 3 248 Provision (release) (1,852) (57) (59) 1,131 (837) ALL balance at September 30, 2021 $ 22,044 $ 1,319 $ 260 $ 1,185 $ 24,808 Individually evaluated for impairment $ 4,035 $ — $ 69 $ — $ 4,104 Collectively evaluated for impairment $ 18,009 $ 1,319 $ 191 $ 1,185 $ 20,704 The following table presents the primary segments of our loan portfolio, excluding PCI loans, as of the period indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total September 30, 2021 Individually evaluated for impairment $ 12,148 $ 6,971 $ 95 $ 3 $ 19,217 Collectively evaluated for impairment 1,418,142 262,996 23,682 22,141 1,726,961 Total Loans $ 1,430,290 $ 269,967 $ 23,777 $ 22,144 $ 1,746,178 The following table presents the primary segments of the ALL, excluding PCI loans, segregated into the amount required for loans individually evaluated for impairment and the amount required for loans collectively evaluated for impairment as of the periods indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at June 30, 2020 $ 15,401 $ 1,846 $ 264 $ 58 $ 17,569 Charge-offs (100) — — — (100) Recoveries 3 — 2 — 5 Provision (release) 8,840 (218) 82 (8) 8,696 ALL balance at Allowance contributed with mortgage combination transaction — (354) — — (354) ALL balance at September 30, 2020 $ 24,144 $ 1,274 $ 348 $ 50 $ 25,816 (Dollars in thousands) Commercial Residential Home Equity Consumer Total ALL balance at December 31, 2019 $ 10,098 $ 1,272 $ 327 $ 78 $ 11,775 Charge-offs (1,856) — (23) — (1,879) Recoveries 9 — 6 2 17 Provision (release) 15,893 356 38 (30) 16,257 Allowance contributed with mortgage combination transaction — (354) — — (354) ALL balance at September 30, 2020 $ 24,144 $ 1,274 $ 348 $ 50 $ 25,816 Individually evaluated for impairment $ 1,984 $ — $ — $ — $ 1,984 Collectively evaluated for impairment $ 22,160 $ 1,274 $ 348 $ 50 $ 23,832 The following table presents the primary segments of our loan portfolio, excluding PCI loans, as of the period indicated: (Dollars in thousands) Commercial Residential Home Equity Consumer Total September 30, 2020 Individually evaluated for impairment $ 14,350 $ 3,051 $ 95 $ 6 $ 17,502 Collectively evaluated for impairment 1,102,976 231,707 34,689 3,980 1,373,352 Total Loans $ 1,117,326 $ 234,758 $ 34,784 $ 3,986 $ 1,390,854 The following tables summarize the primary segments of the ALL, segregated into the amount required for loans individually evaluated for impairment and the amount required for loans collectively evaluated for impairment for the PCI loan portfolio as of the periods indicated: (Dollars in thousands) Commercial Residential Total ALL balance at June 30, 2021 $ — $ — $ — Provision 14 365 379 ALL balance at September 30, 2021 $ 14 $ 365 $ 379 (Dollars in thousands) Commercial Residential Total ALL balance at December 31, 2020 $ — $ 84 $ 84 Provision 14 281 295 ALL balance at September 30, 2021 $ 14 $ 365 $ 379 Collectively evaluated for impairment $ 14 $ 365 $ 379 (Dollars in thousands) Commercial Residential Total ALL balance at June 30, 2020 $ 121 $ 52 $ 173 Charge-offs — (11) (11) Provision (121) 56 (65) ALL balance at September 30, 2020 $ — $ 97 $ 97 (Dollars in thousands) Commercial Residential Total ALL balance at December 31, 2019 $ — $ — $ — Charge-offs — (11) (11) Provision — 108 108 ALL balance at September 30, 2020 $ — $ 97 $ 97 Collectively evaluated for impairment $ — $ 97 $ 97
Troubled Debt Restructurings on Financing Receivables	For the nine months ended September 30, 2020, the following table presents the new TDRs as of the period indicated: Nine Months Ended September 30, 2020 (Dollars in thousands) Number of Contracts Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Commercial Commercial business 5 $ 6,237 $ 5,427 Commercial real estate 2 159 152 Total commercial 7 6,396 5,579 Residential 1 87 86 Total 8 $ 6,483 $ 5,665 The pre-modification and post-modification balances represent the balances outstanding immediately before and after modification of the loan.
Schedule of Accretable Yield	The following table presents the accretable yield, or income expected to be collected, as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Beginning balance $ 8,313 $ — New loans purchased — 11,746 Accretion of income (3,080) (2,945) Other changes in expected cash flows 1,234 (488) Ending balance $ 6,467 $ 8,313

Premises and Equipment (Tables)

Premises and Equipment (Tables)	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
Schedule of Premises and Equipment	The following table presents the components of premises and equipment as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Land $ 3,465 $ 3,936 Buildings and improvements 13,393 14,350 Furniture, fixtures and equipment 16,615 17,451 Software 3,978 1,527 Construction in progress 113 49 Leasehold improvements 2,865 3,079 40,429 40,392 Accumulated depreciation (15,386) (14,189) Premises and equipment, net $ 25,043 $ 26,203
Summary of Lease Cost	The following table presents lease costs for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Operating lease cost $ 504 $ 473 $ 1,458 1,594 Short-term lease cost 2 — 4 26 Variable lease cost 9 10 29 30 Amortization of right-of-use assets, finance leases 16 13 44 49 Interest on lease liabilities, finance leases — 1 2 3 Total lease cost $ 531 $ 497 $ 1,537 $ 1,702
Summary of Finance Lease Liability	The following table presents future minimum payments for finance leases and operating leases with initial or remaining terms of one year or more as of September 30, 2021: (Dollars in thousands) Operating Leases Finance Leases 2021 $ 468 $ 15 2022 1,946 42 2023 1,897 5 2024 1,827 5 2025 1,826 4 2026 and thereafter 12,901 — Total future minimum lease payments $ 20,865 $ 71 Less: Amounts representing interest (3,878) (1) Present value of net future minimum lease payments $ 16,987 $ 70
Summary of Operating Lease Liability	The following table presents future minimum payments for finance leases and operating leases with initial or remaining terms of one year or more as of September 30, 2021: (Dollars in thousands) Operating Leases Finance Leases 2021 $ 468 $ 15 2022 1,946 42 2023 1,897 5 2024 1,827 5 2025 1,826 4 2026 and thereafter 12,901 — Total future minimum lease payments $ 20,865 $ 71 Less: Amounts representing interest (3,878) (1) Present value of net future minimum lease payments $ 16,987 $ 70

Equity Method Investments (Tabl

Equity Method Investments (Tables)	9 Months Ended
	Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	The following table presents summarized income statement information for our equity method investment for the period indicated. Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Total revenues $ 35,229 $ 62,915 $ 126,106 $ 62,915 Net income 9,962 28,979 36,747 28,979 Gain on sale of loans $ 30,720 $ 39,518 $ 122,621 $ 39,518 Volume of loans sold $ 1,098,475 $ 1,215,512 $ 4,368,875 $ 1,215,512

Deposits (Tables)

Deposits (Tables)	9 Months Ended
	Sep. 30, 2021
Deposits [Abstract]
Schedule of Deposits	The following table presents the components of deposits as of the periods indicated: (Dollars in thousands) September 30, 2021 December 31, 2020 Noninterest-bearing demand $ 999,328 $ 715,791 Interest-bearing demand 767,268 496,502 Savings and money markets 530,538 545,501 Time deposits, including CDs and IRAs 101,806 224,595 Total deposits $ 2,398,940 $ 1,982,389 Time deposits that meet or exceed the FDIC insurance limit $ 9,563 $ 16,955
Maturities of Time Deposits	The following table presents the maturities of time deposits for the twelve month periods ended September 30: (Dollars in thousands) 2022 $ 64,757 2023 21,466 2024 10,794 2025 3,726 2026 1,063 Total $ 101,806

Borrowed Funds (Tables)

Borrowed Funds (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Information Related to Short-term Borrowings	The following table presents information related to short-term borrowings as of and for the periods indicated: (Dollars in thousands) Nine Months Ended September 30, 2021 Year Ended December 31, 2020 Balance at end of period $ — $ — Average balance during the period 33,914 68,407 Maximum month-end balance 130,047 154,248 Weighted-average rate during the period 0.36 % 0.58 % Weighted-average rate at end of period — % — %
Information Related To Repurchase Agreements	The following table presents information related to repurchase agreements as of and for the periods shown: (Dollars in thousands) Nine Months Ended September 30, 2021 Year Ended December 31, 2020 Balance at end of period $ 11,139 $ 10,266 Average balance during the period 10,677 9,856 Maximum month-end balance 11,361 10,505 Weighted-average rate during the period 0.14 % 0.23 % Weighted-average rate at end of period 0.12 % 0.14 %
Information Related to Subordinated Debt	The following table presents information related to subordinated debt as of and for the periods shown: (Dollars in thousands) Nine Months Ended September 30, 2021 Year Ended December 31, 2020 Balance at end of period $ 72,966 $ 43,407 Average balance during the period 43,786 7,568 Maximum month-end balance 72,966 43,524 Weighted-average rate during the period 0.17 % 3.45 % Weighted-average rate at end of period 4.03 % 4.02 %

Pension and Supplemental Exec_2

Pension and Supplemental Executive Retirement Plans (Tables)	9 Months Ended
	Sep. 30, 2021
Retirement Benefits [Abstract]
Activity in the Defined Benefit Plan	The following table presents information pertaining to the activity in our defined benefit plan, using the latest available actuarial valuations with a measurement date of September 30, 2021 and 2020 for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Service cost $ — $ — $ — $ — Interest cost 78 91 234 273 Expected return on plan assets (118) (109) (354) (327) Amortization of net actuarial loss 127 105 381 315 Amortization of prior service cost — — — — Net periodic benefit cost $ 87 $ 87 $ 261 $ 261 Contributions paid $ — $ 119 $ 3,835 $ 587

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Carrying Values and Estimated Fair Values of Financial Instruments	The following table presents the carrying values and estimated fair values of our financial instruments as of the periods indicated: (Dollars in thousands) Carrying Value Estimated Fair Value Quoted Prices in Active Markets for Identical Assets (Level I) Significant Other Observable Inputs (Level II) Significant Unobservable Inputs (Level III) September 30, 2021 Financial Assets: Cash and cash equivalents $ 390,081 $ 390,081 $ 390,081 $ — $ — Certificates of deposit with banks 9,582 9,657 — 9,657 — Securities available-for-sale 439,023 439,023 — 397,609 41,414 Equity securities 29,809 29,809 729 — 29,080 Loans receivable, net 1,738,999 1,748,759 — — 1,748,759 Servicing Assets 2,667 2,667 — — 2,667 Interest rate swap 8,444 8,444 — 8,444 — Fair value hedge 1,699 1,699 — 1,699 — Accrued interest receivable 8,513 8,513 — 2,621 5,892 Bank-owned life insurance 42,011 42,011 — 42,011 — Financial Liabilities: Deposits $ 2,398,940 $ 2,375,650 $ — $ 2,375,650 $ — Repurchase agreements 11,139 11,139 — 11,139 — FHLB and other borrowings — — — — — Interest rate swap 8,444 8,444 — 8,444 — Fair value hedge 1,129 1,129 — 1,129 — Accrued interest payable 802 802 — 802 — Subordinated debt 72,966 73,825 — 73,825 — December 31, 2020 Financial assets: Cash and cash equivalents $ 263,893 $ 263,893 $ 263,893 $ — $ — Certificates of deposits with banks 11,803 11,986 — 11,986 — Securities available-for-sale 410,624 410,624 — 366,945 43,679 Equity securities 27,585 27,585 472 — 27,113 Loans held-for-sale 1,062 1,062 — 1,062 — Loans receivable, net 1,427,900 1,434,275 — — 1,434,275 Mortgage servicing rights 2,942 2,942 — — 2,942 Interest rate swap 13,822 13,822 — 13,822 — Fair value hedge 2,215 2,215 — 2,215 Accrued interest receivable 7,793 7,793 — 2,770 5,023 Bank-owned life insurance 41,262 41,262 — 41,262 — Financial liabilities: Deposits $ 1,982,389 $ 1,964,860 $ — $ 1,964,860 $ — Repurchase agreements 10,266 10,266 — 10,266 — Interest rate swap 13,822 13,822 — 13,822 — Fair value hedge 2,141 2,141 — 2,141 — Accrued interest payable 572 572 — 572 — Subordinated debt 43,407 45,536 — 45,536 —

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair value of assets and liabilities
Schedule of Recurring Level III Assets	The following table represents recurring Level III assets as of the periods indicated: (Dollars in thousands) Interest Rate Lock Commitments Municipal Securities Total Balance at June 30, 2021 $ — $ 39,770 $ 39,770 Realized and unrealized gains included in earnings — 5 5 Purchase of securities — 1,757 1,757 Maturities/calls — (74) (74) Unrealized gain included in other comprehensive income (loss) — 3,300 3,300 Unrealized loss included in other comprehensive income (loss) — (3,344) (3,344) Balance at September 30, 2021 $ — $ 41,414 $ 41,414 Balance at December 31, 2020 $ — $ 43,679 $ 43,679 Realized and unrealized gains included in earnings — 25 25 Purchase of securities — 3,575 3,575 Maturities/calls — (5,248) (5,248) Unrealized gain included in other comprehensive income (loss) — 7,720 7,720 Unrealized loss included in other comprehensive income (loss) — (8,337) (8,337) Balance at September 30, 2021 $ — $ 41,414 $ 41,414 Balance at June 30, 2020 $ 7,338 $ 40,457 $ 47,795 Realized and unrealized losses included in earnings (7,338) — (7,338) Purchase of securities — 368 368 Maturities/calls — (61) (61) Unrealized gain included in other comprehensive income (loss) — 1,810 1,810 Unrealized loss included in other comprehensive income (loss) — (466) (466) Balance at September 30, 2020 $ — $ 42,108 $ 42,108 Balance at December 31, 2019 $ 1,660 $ 37,259 $ 38,919 Realized and unrealized gains included in earnings (1,660) 3 (1,657) Purchase of securities — 21,147 21,147 Maturities/calls — (15,574) (15,574) Unrealized gain included in other comprehensive income (loss) — 5,872 5,872 Unrealized loss included in other comprehensive income (loss) — (6,599) (6,599) Balance at September 30, 2020 $ — $ 42,108 $ 42,108
Quantitative Information About the Level III Significant Unobservable Inputs for Assets and Liabilities Measured at Fair Value on Nonrecurring Basis	The following tables present quantitative information about the Level III significant unobservable inputs for assets and liabilities measured at fair value as of the periods indicated: Quantitative Information about Level III Fair Value Measurements (Dollars in thousands) Fair Value Valuation Technique Unobservable Input Range September 30, 2021 Nonrecurring measurements: Impaired loans $ 15,114 Appraisal of collateral 1 Appraisal adjustments 2 20% - 62% Liquidation expense 2 5% - 10% Other real estate owned $ 3,442 Appraisal of collateral 1 Appraisal adjustments 2 20% - 30% Liquidation expense 2 5% - 10% Recurring measurements: Municipal securities 5 $ 41,414 Appraisal of bond 3 Bond appraisal adjustment 4 5% - 15% December 31, 2020 Nonrecurring measurements: Impaired loans $ 14,098 Appraisal of collateral 1 Appraisal adjustments 2 20% - 62% Liquidation expense 2 5% - 10% Other real estate owned $ 5,730 Appraisal of collateral 1 Appraisal adjustments 2 20% - 30% Liquidation expense 2 5% - 10% Recurring measurements: Municipal securities 5 $ 43,679 Appraisal of bond 3 Bond appraisal adjustment 4 5% - 15% 1 Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level III inputs that are not identifiable. 2 Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. 3 Fair value is determined through independent analysis of liquidity, rating, yield and duration. 4 Appraisals may be adjusted for qualitative factors such as local economic conditions. 5 Municipal securities classified as Level III instruments are comprised of TIF bonds related to certain local municipal securities.
Recurring
Fair value of assets and liabilities
Financial Assets and Liabilities Measured at Fair Value	The following tables present assets and liabilities reported on the consolidated statements of financial condition at their fair value on a recurring basis as of the periods indicated by level within the fair value hierarchy: September 30, 2021 (Dollars in thousands) Level I Level II Level III Total Assets: United States government agency securities $ — $ 41,971 $ — $ 41,971 United States sponsored mortgage-backed securities — 85,271 — 85,271 United States treasury securities 82,422 — — 82,422 Municipal securities — 166,009 41,414 207,423 Other securities — 14,436 — 14,436 Equity securities 729 — — 729 Interest rate swap — 8,444 — 8,444 Fair value hedge — 1,699 — 1,699 Liabilities: Interest rate swap — 8,444 — 8,444 Fair value hedge — 1,129 — 1,129 December 31, 2020 (Dollars in thousands) Level I Level II Level III Total Assets: United States government agency securities $ — $ 56,992 $ — $ 56,992 United States sponsored mortgage-backed securities — 95,769 — 95,769 Municipal securities — 188,208 43,679 231,887 Other securities — 18,476 — 18,476 Equity securities 472 — — 472 Loans held-for-sale — 1,062 — 1,062 Interest rate swap — 13,822 — 13,822 Fair value hedge — 2,215 — 2,215 Liabilities: Interest rate swap — 13,822 — 13,822 Fair value hedge — 2,141 — 2,141
Non-recurring
Fair value of assets and liabilities
Financial Assets and Liabilities Measured at Fair Value	The following table presents the fair value of these assets as of the periods indicated: September 30, 2021 (Dollars in thousands) Level I Level II Level III Total Impaired loans $ — $ — $ 15,114 $ 15,114 Other real estate owned — — 3,442 3,442 December 31, 2020 (Dollars in thousands) Level I Level II Level III Total Impaired loans $ — $ — $ 14,098 $ 14,098 Other real estate owned — — 5,730 5,730

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Schedule of Net Income Per Common Share	The following table presents our calculation of EPS for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands except shares and per share data) 2021 2020 2021 2020 Numerator for basic earnings per share: Net income $ 11,828 $ 6,491 $ 29,160 $ 25,573 Less: Dividends on preferred stock — 116 35 345 Net income available to common shareholders - basic $ 11,828 $ 6,375 $ 29,125 $ 25,228 Numerator for diluted earnings per share: Net income available to common shareholders - diluted $ 11,828 $ 6,375 $ 29,125 $ 25,228 Denominator: Total weighted-average shares outstanding 11,880,348 11,948,989 11,684,570 11,948,857 Effect of dilutive stock options and restricted stock units 943,961 167,429 881,239 236,280 Total diluted weighted-average shares outstanding 12,824,309 12,116,418 12,565,809 12,185,137 Earnings per share - basic $ 1.00 $ 0.53 $ 2.49 $ 2.11 Earnings per share - diluted $ 0.92 $ 0.53 $ 2.32 $ 2.07 Stock options not included in the computation of diluted EPS because the effect would be antidilutive 179,694 849,589 185,944 815,089

Comprehensive Income (Tables)

Comprehensive Income (Tables)	9 Months Ended
	Sep. 30, 2021
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Reclassification out of Accumulated Other Comprehensive Income	The following tables present the reclassified components of accumulated other comprehensive income (“AOCI”) as of and for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (Dollars in thousands) 2021 2020 2021 2020 Details about AOCI components Amount reclassified from AOCI Amount reclassified from AOCI Amount reclassified from AOCI Amount reclassified from AOCI Affected income statement line item Available-for-sale securities Unrealized holding gains $ 529 $ 35 $ 3,380 $ 865 Gain on sale of available-for-sale securities (124) (9) (793) (234) Income tax effect 405 26 2,587 631 Net of tax Defined benefit pension plan items Amortization of net actuarial loss (127) (105) (381) (315) Salaries and employee benefits 30 28 89 85 Income tax effect (97) (77) (292) (230) Net of tax Investment hedge Carrying value adjustment (14) (95) (637) 738 Interest on investment securities 3 26 149 (199) Income tax effect (11) (69) (488) 539 Net of tax Total reclassifications $ 297 $ (120) $ 1,807 $ 940
Components of Accumulated Other Comprehensive Income	(Dollars in thousands) Unrealized gains (losses) on available for-sale securities Defined benefit pension plan items Investment hedge Total Balance at June 30, 2021 $ 3,136 $ (3,301) $ 164 $ (1) Other comprehensive income (loss) before reclassification 183 (700) — (517) Amounts reclassified from AOCI (405) 97 11 (297) Net current period OCI (222) (603) 11 (814) Balance at September 30, 2021 $ 2,914 $ (3,904) $ 175 $ (815) Balance at December 31, 2020 7,586 (5,047) (313) 2,226 Other comprehensive income (loss) before reclassification (2,085) 851 — (1,234) Amounts reclassified from AOCI (2,587) 292 488 (1,807) Net current period OCI (4,672) 1,143 488 (3,041) Balance at September 30, 2021 $ 2,914 $ (3,904) $ 175 $ (815) Balance at June 30, 2020 $ 3,771 $ (5,388) $ (576) $ (2,193) Other comprehensive income (loss) before reclassification 895 (74) — 821 Amounts reclassified from AOCI (26) 77 69 120 Net current period OCI 869 3 69 941 Balance at September 30, 2020 $ 4,640 $ (5,385) $ (507) $ (1,252) Balance at December 31, 2019 2,942 (4,295) 32 (1,321) Other comprehensive income (loss) before reclassification 2,329 (1,320) — 1,009 Amounts reclassified from AOCI (631) 230 (539) (940) Net current period OCI 1,698 (1,090) (539) 69 Balance at September 30, 2020 $ 4,640 $ (5,385) $ (507) $ (1,252)

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Information About the Reportable Segments and Reconciliation to the Consolidated Financial Statements	The following tables present information about the reportable segments and reconciliation to the consolidated financial statements for the periods indicated: Three Months Ended September 30, 2021 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 20,383 $ 105 $ 1 $ (5) $ 20,484 Interest expense 912 — 481 (5) 1,388 Net interest income 19,471 105 (480) — 19,096 Provision for loan losses 379 1 — — 380 Net interest income (loss) after provision for loan losses 19,092 104 (480) — 18,716 Total noninterest income 20,211 3,546 2,002 (3,808) 21,951 Noninterest Expenses: Salaries and employee benefits 13,097 47 3,384 — 16,528 Other expense 11,654 (198) 1,653 (3,808) 9,301 Total noninterest expenses 24,751 (151) 5,037 (3,808) 25,829 Income (loss) before income taxes 14,552 3,801 (3,515) — 14,838 Income tax expense (benefit) 2,973 922 (731) — 3,164 Net income (loss) before noncontrolling interest 11,579 2,879 (2,784) — 11,674 Net loss attributable to noncontrolling interest 154 — — — 154 Net income (loss) attributable to parent $ 11,733 $ 2,879 $ (2,784) $ — $ 11,828 Preferred stock dividends — — — — — Net income (loss) available to common shareholders $ 11,733 $ 2,879 $ (2,784) $ — $ 11,828 Capital expenditures for the three months ended September 30, 2021 $ 1,975 $ — $ — $ — $ 1,975 Total assets as of September 30, 2021 2,827,019 53,261 342,677 (434,133) 2,788,824 Total assets as of December 31, 2020 2,343,556 58,140 284,943 (355,163) 2,331,476 Goodwill as of September 30, 2021 3,988 — — — 3,988 Goodwill as of December 31, 2020 2,350 — — — 2,350 Three Months Ended September 30, 2020 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 18,737 $ 78 $ — $ (188) $ 18,627 Interest expense 2,553 232 20 (188) 2,617 Net interest income 16,184 (154) (20) — 16,010 Provision for loan losses 8,631 — — — 8,631 Net interest income (loss) after provision for loan losses 7,553 (154) (20) — 7,379 Total noninterest income 3,106 16,793 1,481 (1,982) 19,398 Noninterest Expense: Salaries and employee benefits 7,526 82 2,911 — 10,519 Other expense 8,389 68 1,271 (1,982) 7,746 Total noninterest expenses 15,915 150 4,182 (1,982) 18,265 Income (loss) before income taxes (5,256) 16,489 (2,721) — 8,512 Income tax expense (benefit) (1,556) 4,245 (668) — 2,021 Net income (loss) $ (3,700) $ 12,244 $ (2,053) $ — $ 6,491 Preferred stock dividends — — 116 — 116 Net income (loss) available to common shareholders $ (3,700) $ 12,244 $ (2,169) $ — $ 6,375 Capital expenditures for the three months ended September 30, 2020 $ 1,652 $ — $ — $ — $ 1,652 Nine Months Ended September 30, 2021 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 60,078 $ 307 $ 2 $ (7) $ 60,380 Interest expense 3,294 — 1,437 (7) 4,724 Net interest income 56,784 307 (1,435) — 55,656 Release of allowance for loan losses (541) (1) — — (542) Net interest income (loss) after release of allowance for loan losses 57,325 308 (1,435) — 56,198 Total noninterest income 36,634 14,499 5,892 (8,972) 48,053 Noninterest Expenses: Salaries and employee benefits 32,323 47 9,730 — 42,100 Other expense 31,261 (112) 4,073 (8,972) 26,250 Total noninterest expenses 63,584 (65) 13,803 (8,972) 68,350 Income (loss) before income taxes 30,375 14,872 (9,346) — 35,901 Income tax expense (benefit) 5,290 3,606 (1,890) — 7,006 Net income (loss) before noncontrolling interest 25,085 11,266 (7,456) — 28,895 Net loss attributable to noncontrolling interest 265 — — — 265 Net income (loss) attributable to parent $ 25,350 $ 11,266 $ (7,456) $ — $ 29,160 Preferred stock dividends — — 35 — 35 Net income (loss) available to common shareholders $ 25,350 $ 11,266 $ (7,491) $ — $ 29,125 Capital expenditures for the nine months ended September 30, 2021 $ 4,127 $ — $ — $ — $ 4,127 Nine Months Ended September 30, 2020 CoRe Banking Mortgage Banking Financial Holding Company Intercompany Eliminations Consolidated (Dollars in thousands) Interest income $ 56,693 $ 6,034 $ 2 $ (1,629) $ 61,100 Interest expense 9,418 3,136 78 (2,171) 10,461 Net interest income 47,275 2,898 (76) 542 50,639 Provision for loan losses 16,361 4 — — 16,365 Net interest income (loss) after provision for loan losses 30,914 2,894 (76) 542 34,274 Total noninterest income 24,394 53,140 4,664 (6,437) 75,761 Noninterest Expenses: Salaries and employee benefits 19,562 21,550 8,248 — 49,360 Other expense 24,172 4,780 3,837 (5,895) 26,894 Total noninterest expenses 43,734 26,330 12,085 (5,895) 76,254 Income (loss) before income taxes 11,574 29,704 (7,497) — 33,781 Income tax expense (benefit) 2,336 7,696 (1,824) — 8,208 Net income (loss) $ 9,238 $ 22,008 $ (5,673) $ — $ 25,573 Preferred stock dividends — — 345 — 345 Net income (loss) available to common shareholders $ 9,238 $ 22,008 $ (6,018) $ — $ 25,228 Capital Expenditures for the nine-month period ended September 30, 2020 $ 4,092 $ 99 $ 20 $ — $ 4,211

Nature of Operations and Basi_3

Nature of Operations and Basis of Presentation - Narrative (Details) - loan	Sep. 30, 2021	Apr. 30, 2021	Feb. 28, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of equity method investments	2
Flexia
Accounts, Notes, Loans and Financing Receivable [Line Items]
Ownership percentage	80.00%		80.00%
Trabian
Accounts, Notes, Loans and Financing Receivable [Line Items]
Ownership percentage	80.00%	80.00%
MVB Technology
Accounts, Notes, Loans and Financing Receivable [Line Items]
Ownership percentage	93.40%
Flexia
Accounts, Notes, Loans and Financing Receivable [Line Items]
Ownership percentage by noncontrolling owners	20.00%		20.00%
Trabian
Accounts, Notes, Loans and Financing Receivable [Line Items]
Ownership percentage by noncontrolling owners	20.00%	20.00%
MVB Technology
Accounts, Notes, Loans and Financing Receivable [Line Items]
Ownership percentage by noncontrolling owners	6.60%

Investment Securities - Availab

Investment Securities - Available-for-sale (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 435,217	$ 400,718
Unrealized Gain	6,102	10,440
Unrealized Loss	(2,296)	(534)
Fair Value	439,023	410,624
Total debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	420,935	382,317
Unrealized Gain	5,925	10,294
Unrealized Loss	(2,273)	(463)
Fair Value	424,587	392,148
United States government agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	42,226	53,207
Unrealized Gain	342	872
Unrealized Loss	(597)	(210)
Fair Value	41,971	53,869
United States sponsored mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	85,754	94,968
Unrealized Gain	401	972
Unrealized Loss	(884)	(171)
Fair Value	85,271	95,769
United States treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	82,738	3,000
Unrealized Gain	0	123
Unrealized Loss	(316)	0
Fair Value	82,422	3,123
Municipal securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	202,717	223,642
Unrealized Gain	5,182	8,327
Unrealized Loss	(476)	(82)
Fair Value	207,423	231,887
Other debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	7,500	7,500
Unrealized Gain	0	0
Unrealized Loss	0	0
Fair Value	7,500	7,500
Other securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	14,282	18,401
Unrealized Gain	177	146
Unrealized Loss	(23)	(71)
Fair Value	$ 14,436	$ 18,476

Investment Securities - Summary

Investment Securities - Summary of Maturities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Available for sale, Amortized Cost
Amortized Cost	$ 435,217	$ 400,718
Available for sale, Fair Value
Fair Value	439,023	410,624
Total debt securities
Available for sale, Amortized Cost
Within one year	5
After one year, but within five years	86,798
After five years, but within ten years	34,205
After ten years	299,927
Amortized Cost	420,935	382,317
Available for sale, Fair Value
Within one year	5
After one year, but within five years	86,542
After five years, but within ten years	35,079
After ten years	302,961
Fair Value	$ 424,587	$ 392,148

Investment Securities - Summa_2

Investment Securities - Summary of Unrealized Loss Positions (Details) $ in Thousands	Sep. 30, 2021USD ($)loan	Dec. 31, 2020USD ($)loan
Investments in an unrealized loss position
Carrying value of securities pledged	$ 280,000	$ 229,400
Amount of pretax loss if securities in an unrealized loss position are sold	2,300
Investments in an Unrealized Loss Position
Less than 12 months, fair value	184,687	50,155
Less than 12 months, unrealized loss	(1,687)	(376)
12 months or more, fair value	26,919	15,923
12 months or more, unrealized loss	$ (609)	$ (158)
United States government agency securities
Description and Number of Positions
Number of investments in an unrealized loss position | loan	20	27
Investments in an Unrealized Loss Position
Less than 12 months, fair value	$ 4,334	$ 19,021
Less than 12 months, unrealized loss	(138)	(68)
12 months or more, fair value	18,113	12,574
12 months or more, unrealized loss	$ (459)	$ (142)
United States sponsored mortgage-backed securities
Description and Number of Positions
Number of investments in an unrealized loss position | loan	27	9
Investments in an Unrealized Loss Position
Less than 12 months, fair value	$ 57,861	$ 15,331
Less than 12 months, unrealized loss	(803)	(155)
12 months or more, fair value	4,431	3,349
12 months or more, unrealized loss	$ (81)	$ (16)
United States treasury securities
Description and Number of Positions
Number of investments in an unrealized loss position | loan	18
Investments in an Unrealized Loss Position
Less than 12 months, fair value	$ 82,423
Less than 12 months, unrealized loss	(316)
12 months or more, fair value	0
12 months or more, unrealized loss	$ 0
Municipal securities
Description and Number of Positions
Number of investments in an unrealized loss position | loan	56	14
Investments in an Unrealized Loss Position
Less than 12 months, fair value	$ 40,069	$ 11,856
Less than 12 months, unrealized loss	(430)	(82)
12 months or more, fair value	2,898	0
12 months or more, unrealized loss	$ (46)	$ 0
Other securities
Description and Number of Positions
Number of investments in an unrealized loss position | loan	1	5
Investments in an Unrealized Loss Position
Less than 12 months, fair value	$ 0	$ 3,947
Less than 12 months, unrealized loss	0	(71)
12 months or more, fair value	1,477	0
12 months or more, unrealized loss	$ (23)	$ 0

Investment Securities - Gains (

Investment Securities - Gains (losses) on sales of investments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Sales of available-for-sale securities	$ 28,049	$ 7,379	$ 103,365	$ 48,579
Gains, gross	547	69	3,411	899
Losses, gross	18	34	31	34
Sales of equity securities	0	669	61	669
Gain, gross	0	18	5	48
Losses, gross	0	0	0	0
Unrealized holding gains on equity securities	$ 536	$ 94	$ 1,750	$ 111

Investment Securities - Qualifi

Investment Securities - Qualified Affordable Housing Projects (Details) - Affordable Housing Investment Fund $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2021USD ($)investment	Dec. 31, 2020USD ($)investment
Summary of Investment Holdings [Line Items]
Affordable housing project investments	$ 4	$ 4
Number of investments | investment	5	5
Income (loss) on affordable housing investment funds	$ 1.5	$ 1.2

Loans and Allowance for Loan _3

Loans and Allowance for Loan Losses - Loan Summary (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Components of loans
Proceeds of loans sold			$ 17,871	$ 1,475,854
Mortgage fee income	$ 0	$ 7,264	0	33,427
Total loans, excluding PCI	1,746,178	1,390,854	1,746,178	1,390,854	$ 1,415,362
Total Loans	1,766,288		1,766,288		1,454,801
Deferred loan origination costs and (fees), net	(2,102)		(2,102)		(1,057)
Loans receivable	1,764,186		1,764,186		1,453,744
Mortgage Banking
Components of loans
Proceeds of loans sold				1,230,000
Mortgage fee income				33,400
Purchased credit impaired loans
Components of loans
Total Loans	20,110		20,110		39,439
Commercial and non-residential real estate
Components of loans
Total loans, excluding PCI	1,430,290	1,117,326	1,430,290	1,117,326	1,141,114
Commercial and non-residential real estate | Purchased credit impaired loans
Components of loans
Total Loans	15,079		15,079		21,008
Residential real estate
Components of loans
Total loans, excluding PCI	269,967	234,758	269,967	234,758	240,264
Residential real estate | Purchased credit impaired loans
Components of loans
Total Loans	4,430		4,430		16,943
Home equity
Components of loans
Total loans, excluding PCI	23,777		23,777		30,828
Consumer
Components of loans
Total loans, excluding PCI	22,144	$ 3,986	22,144	$ 3,986	3,156
Consumer | Purchased credit impaired loans
Components of loans
Total Loans	$ 601		$ 601		$ 1,488

Loans and Allowance for Loan _4

Loans and Allowance for Loan Losses - Impaired Loans (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Impaired loans by class
Impaired loans with specific allowance, recorded investment	$ 6,676		$ 6,676		$ 4,203
Impaired loans with specific allowance, related allowance	4,104		4,104		1,296
Impaired loans with no specific allowance, recorded investment	12,542		12,542		11,191
Total impaired loans, recorded investment	19,218		19,218		15,394
Total impaired loans, unpaid principal balance	22,760		22,760		18,575
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	16,607	$ 14,583	14,664	$ 12,621
Interest Income Recognized on Accrual Basis	14	41	44	158
Interest Income Recognized on Cash Basis	14	85	43	166
Commercial and non-residential real estate
Impaired loans by class
Impaired loans with specific allowance, recorded investment	6,607		6,607		4,203
Impaired loans with specific allowance, related allowance	4,035		4,035		1,296
Impaired loans with no specific allowance, recorded investment	5,542		5,542		9,131
Total impaired loans, recorded investment	12,149		12,149		13,334
Total impaired loans, unpaid principal balance	15,440		15,440		16,243
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	9,506	11,424	9,174	9,836
Interest Income Recognized on Accrual Basis	11	36	33	144
Interest Income Recognized on Cash Basis	11	80	33	152
Commercial and non-residential real estate | Commercial business
Impaired loans by class
Impaired loans with specific allowance, recorded investment	5,931		5,931		3,431
Impaired loans with specific allowance, related allowance	3,792		3,792		1,032
Impaired loans with no specific allowance, recorded investment	3,646		3,646		5,653
Total impaired loans, recorded investment	9,577		9,577		9,084
Total impaired loans, unpaid principal balance	11,283		11,283		10,440
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	7,223	7,785	6,701	5,225
Interest Income Recognized on Accrual Basis	0	0	0	0
Interest Income Recognized on Cash Basis	0	0	0	0
Commercial and non-residential real estate | Commercial real estate
Impaired loans by class
Impaired loans with specific allowance, recorded investment	676		676		772
Impaired loans with specific allowance, related allowance	243		243		264
Impaired loans with no specific allowance, recorded investment	495		495		944
Total impaired loans, recorded investment	1,171		1,171		1,716
Total impaired loans, unpaid principal balance	1,341		1,341		1,864
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	1,943	3,264	2,125	3,124
Interest Income Recognized on Accrual Basis	11	26	33	77
Interest Income Recognized on Cash Basis	11	26	33	79
Commercial and non-residential real estate | Acquisition and development
Impaired loans by class
Impaired loans with specific allowance, recorded investment	0		0		0
Impaired loans with specific allowance, related allowance	0		0		0
Impaired loans with no specific allowance, recorded investment	1,401		1,401		2,534
Total impaired loans, recorded investment	1,401		1,401		2,534
Total impaired loans, unpaid principal balance	2,816		2,816		3,939
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	340	375	348	1,487
Interest Income Recognized on Accrual Basis	0	10	0	67
Interest Income Recognized on Cash Basis	0	54	0	73
Residential real estate
Impaired loans by class
Impaired loans with specific allowance, recorded investment	0		0		0
Impaired loans with specific allowance, related allowance	0		0		0
Impaired loans with no specific allowance, recorded investment	6,971		6,971		1,960
Total impaired loans, recorded investment	6,971		6,971		1,960
Total impaired loans, unpaid principal balance	7,222		7,222		2,232
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	7,029	3,085	5,418	2,683
Interest Income Recognized on Accrual Basis	3	5	11	14
Interest Income Recognized on Cash Basis	3	5	10	14
Home Equity
Impaired loans by class
Impaired loans with specific allowance, recorded investment	69		69		0
Impaired loans with specific allowance, related allowance	69		69		0
Impaired loans with no specific allowance, recorded investment	26		26		95
Total impaired loans, recorded investment	95		95		95
Total impaired loans, unpaid principal balance	95		95		95
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	69	69	69	94
Interest Income Recognized on Accrual Basis	0	0	0	0
Interest Income Recognized on Cash Basis	0	0	0	0
Consumer
Impaired loans by class
Impaired loans with specific allowance, recorded investment	0		0		0
Impaired loans with specific allowance, related allowance	0		0		0
Impaired loans with no specific allowance, recorded investment	3		3		5
Total impaired loans, recorded investment	3		3		5
Total impaired loans, unpaid principal balance	3		3		$ 5
Average recorded investment in impaired loans and related interest income recognized
Average Investment in Impaired Loans	3	5	3	8
Interest Income Recognized on Accrual Basis	0	0	0	0
Interest Income Recognized on Cash Basis	$ 0	$ 0	$ 0	$ 0

Loans and Allowance for Loan _5

Loans and Allowance for Loan Losses - Narrative (Details)	9 Months Ended
	Sep. 30, 2021USD ($)propertyloancategory	Dec. 31, 2020USD ($)	Sep. 30, 2020USD ($)
Financing Receivable, Impaired [Line Items]
Foreclosed properties held	$ 3,400,000
Investment in loans in the process of foreclosure	400,000
Investment in loans in the process of foreclosure, related allowance	$ 0
Number of points in internal risk rating system | category	9
Number of categories in internal risk rating system considered as not criticized | category	6
Commercial relationship credit review threshold amount	$ 1,000,000
Past due period before loans placed in non-accrual status	90 days
Recent loan payment history before removal from non-accrual status	6 months
Allowance for loan losses, number of evaluation components | loan	2
Impaired loans collectively evaluated	$ 1,400,000	$ 2,000,000
Impaired loans, related reserves	$ 100,000	100,000
Number of rolling quarters | loan	12
Liability for unfunded commitments	$ 500,000	$ 500,000
Collectively evaluated for impairment	1,726,961,000		$ 1,373,352,000
Purchased credit impaired loans
Financing Receivable, Impaired [Line Items]
Collectively evaluated for impairment	20,100,000
Residential real estate
Financing Receivable, Impaired [Line Items]
Foreclosed properties held	$ 2,600,000
Increase (decrease) in impaired loans (as a percentage)	76.50%
Number foreclosed properties held | property	11
Collectively evaluated for impairment	$ 262,996,000		231,707,000
Residential real estate | Purchased credit impaired loans
Financing Receivable, Impaired [Line Items]
Collectively evaluated for impairment	4,430,000
Residential real estate | Other Loan Relationships
Financing Receivable, Impaired [Line Items]
Foreclosed properties held	$ 800,000
Increase (decrease) in impaired loans (as a percentage)	23.50%
Commercial and non-residential real estate
Financing Receivable, Impaired [Line Items]
Number foreclosed properties held | property	20
Collectively evaluated for impairment	$ 1,418,142,000		1,102,976,000
Commercial and non-residential real estate | Purchased credit impaired loans
Financing Receivable, Impaired [Line Items]
Collectively evaluated for impairment	$ 15,079,000
Consumer
Financing Receivable, Impaired [Line Items]
Number of additional collateralized loans in the process of foreclosure | loan	5
Investment in loans in the process of foreclosure	$ 200,000
Collectively evaluated for impairment	22,141,000		$ 3,980,000
Consumer | Purchased credit impaired loans
Financing Receivable, Impaired [Line Items]
Collectively evaluated for impairment	601,000
The First State Bank
Financing Receivable, Impaired [Line Items]
Foreclosed properties held	2,700,000
The First State Bank | Consumer
Financing Receivable, Impaired [Line Items]
Investment in loans in the process of foreclosure	$ 200,000

Loans and Allowance for Loan _6

Loans and Allowance for Loan Losses - Internal Risk Rating Summary (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	$ 1,746,178	$ 1,415,362	$ 1,390,854
Total Loans	1,766,288	1,454,801
SBA PPP
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	119,400
Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	1,430,290	1,141,114	1,117,326
Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	619,334	523,891
Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	564,576	423,122
Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	99,042	112,126
Commercial and non-residential real estate | SBA PPP
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	147,338	81,975
Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	269,967	240,264	234,758
Home Equity
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	23,777	30,828	34,784
Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	22,144	3,156	$ 3,986
Purchased credit impaired loans
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	20,110	39,439
Purchased credit impaired loans | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	15,079	21,008
Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	2,938	17,604
Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	11,595	1,269
Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	546	2,135
Purchased credit impaired loans | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	4,430	16,943
Purchased credit impaired loans | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	601	1,488
Pass
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	1,636,759	1,285,163
Pass | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	1,331,468	1,015,512
Pass | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	589,196	496,222
Pass | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	508,729	356,544
Pass | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	86,205	80,771
Pass | Commercial and non-residential real estate | SBA PPP
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	147,338	81,975
Pass | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	259,864	236,250
Pass | Home Equity
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	23,304	30,277
Pass | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	22,123	3,124
Pass | Purchased credit impaired loans
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	14,025	31,558
Pass | Purchased credit impaired loans | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	10,403	15,145
Pass | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	2,360	12,263
Pass | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	7,784	982
Pass | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	259	1,900
Pass | Purchased credit impaired loans | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	3,586	15,157
Pass | Purchased credit impaired loans | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	36	1,256
Special Mention
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	44,564	67,935
Special Mention | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	43,251	66,574
Special Mention | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	13,623	9,529
Special Mention | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	22,004	32,044
Special Mention | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	7,624	25,001
Special Mention | Commercial and non-residential real estate | SBA PPP
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	0	0
Special Mention | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	917	948
Special Mention | Home Equity
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	378	381
Special Mention | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	18	32
Special Mention | Purchased credit impaired loans
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	1,785	139
Special Mention | Purchased credit impaired loans | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	1,785	139
Special Mention | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	158	136
Special Mention | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	1,549	3
Special Mention | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	78	0
Special Mention | Purchased credit impaired loans | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	0	0
Special Mention | Purchased credit impaired loans | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	0	0
Substandard
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	59,442	58,270
Substandard | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	50,746	55,230
Substandard | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	12,910	17,045
Substandard | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	33,687	34,001
Substandard | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	4,149	4,184
Substandard | Commercial and non-residential real estate | SBA PPP
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	0	0
Substandard | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	8,693	2,896
Substandard | Home Equity
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	0	144
Substandard | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	3	0
Substandard | Purchased credit impaired loans
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	3,970	2,273
Substandard | Purchased credit impaired loans | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	2,563	608
Substandard | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	211	345
Substandard | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	2,189	263
Substandard | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	163	0
Substandard | Purchased credit impaired loans | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	844	1,665
Substandard | Purchased credit impaired loans | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	563	0
Doubtful
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	5,413	3,994
Doubtful | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	4,825	3,798
Doubtful | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	3,605	1,095
Doubtful | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	156	533
Doubtful | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	1,064	2,170
Doubtful | Commercial and non-residential real estate | SBA PPP
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	0	0
Doubtful | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	493	170
Doubtful | Home Equity
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	95	26
Doubtful | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total loans, excluding PCI	0	0
Doubtful | Purchased credit impaired loans
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	330	5,469
Doubtful | Purchased credit impaired loans | Commercial and non-residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	328	5,116
Doubtful | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	209	4,860
Doubtful | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	73	21
Doubtful | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	46	235
Doubtful | Purchased credit impaired loans | Residential real estate
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	0	121
Doubtful | Purchased credit impaired loans | Consumer
Classes of the loan portfolio summarized by credit quality indicators:
Total Loans	$ 2	$ 232

Loans and Allowance for Loan _7

Loans and Allowance for Loan Losses - Aging (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	$ 1,746,178	$ 1,415,362	$ 1,390,854
Total Loans	1,766,288	1,454,801
Non-Accrual	17,453	13,713
90 Plus Days Still Accruing	0	0
SBA PPP
Aging categories of performing loans and nonaccrual loans
Total Loans	119,400
Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,430,290	1,141,114	1,117,326
Non-Accrual	10,754	12,079
90 Plus Days Still Accruing	0	0
Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	619,334	523,891
Non-Accrual	9,102	8,601
90 Plus Days Still Accruing	0	0
Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	564,576	423,122
Non-Accrual	495	944
90 Plus Days Still Accruing	0	0
Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	99,042	112,126
Non-Accrual	1,157	2,534
90 Plus Days Still Accruing	0	0
Commercial and non-residential real estate | SBA PPP
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	147,338	81,975
Non-Accrual	0	0
90 Plus Days Still Accruing	0	0
Residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	269,967	240,264	234,758
Non-Accrual	6,601	1,534
90 Plus Days Still Accruing	0	0
Home Equity
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	23,777	30,828	34,784
Non-Accrual	95	95
90 Plus Days Still Accruing	0	0
Consumer
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	22,144	3,156	$ 3,986
Non-Accrual	3	5
90 Plus Days Still Accruing	0	0
Purchased credit impaired loans
Aging categories of performing loans and nonaccrual loans
Total Loans	20,110	39,439
Purchased credit impaired loans | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	15,079	21,008
Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total Loans	2,938	17,604
Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	11,595	1,269
Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total Loans	546	2,135
Purchased credit impaired loans | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	4,430	16,943
Purchased credit impaired loans | Consumer
Aging categories of performing loans and nonaccrual loans
Total Loans	601	1,488
Financial Asset, Not Past Due
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,732,100	1,404,748
Financial Asset, Not Past Due | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,418,131	1,135,803
Financial Asset, Not Past Due | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	608,407	521,799
Financial Asset, Not Past Due | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	564,420	422,343
Financial Asset, Not Past Due | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	97,966	109,686
Financial Asset, Not Past Due | Commercial and non-residential real estate | SBA PPP
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	147,338	81,975
Financial Asset, Not Past Due | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	268,281	235,420
Financial Asset, Not Past Due | Home Equity
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	23,550	30,369
Financial Asset, Not Past Due | Consumer
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	22,138	3,156
Financial Asset, Not Past Due | Purchased credit impaired loans
Aging categories of performing loans and nonaccrual loans
Total Loans	14,190	34,515
Financial Asset, Not Past Due | Purchased credit impaired loans | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	10,632	19,556
Financial Asset, Not Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total Loans	2,519	16,264
Financial Asset, Not Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	7,967	1,157
Financial Asset, Not Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total Loans	146	2,135
Financial Asset, Not Past Due | Purchased credit impaired loans | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	3,522	13,714
Financial Asset, Not Past Due | Purchased credit impaired loans | Consumer
Aging categories of performing loans and nonaccrual loans
Total Loans	36	1,245
Financing Receivables, 30 to 59 Days Past Due
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	7,161	3,421
Financing Receivables, 30 to 59 Days Past Due | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	6,315	1,074
Financing Receivables, 30 to 59 Days Past Due | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	6,315	1,040
Financing Receivables, 30 to 59 Days Past Due | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	34
Financing Receivables, 30 to 59 Days Past Due | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financing Receivables, 30 to 59 Days Past Due | Commercial and non-residential real estate | SBA PPP
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financing Receivables, 30 to 59 Days Past Due | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	726	2,058
Financing Receivables, 30 to 59 Days Past Due | Home Equity
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	117	289
Financing Receivables, 30 to 59 Days Past Due | Consumer
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	3	0
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans
Aging categories of performing loans and nonaccrual loans
Total Loans	817	784
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	817	71
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total Loans	0	71
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	640	0
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total Loans	177	0
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	0	710
Financing Receivables, 30 to 59 Days Past Due | Purchased credit impaired loans | Consumer
Aging categories of performing loans and nonaccrual loans
Total Loans	0	3
Financing Receivables, 60 to 89 Days Past Due
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,485	2,289
Financing Receivables, 60 to 89 Days Past Due | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,052	245
Financing Receivables, 60 to 89 Days Past Due | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,052	33
Financing Receivables, 60 to 89 Days Past Due | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	212
Financing Receivables, 60 to 89 Days Past Due | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financing Receivables, 60 to 89 Days Past Due | Commercial and non-residential real estate | SBA PPP
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financing Receivables, 60 to 89 Days Past Due | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	415	1,969
Financing Receivables, 60 to 89 Days Past Due | Home Equity
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	15	75
Financing Receivables, 60 to 89 Days Past Due | Consumer
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	3	0
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans
Aging categories of performing loans and nonaccrual loans
Total Loans	64	211
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	0	65
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total Loans	0	65
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	0	0
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total Loans	0	0
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	64	145
Financing Receivables, 60 to 89 Days Past Due | Purchased credit impaired loans | Consumer
Aging categories of performing loans and nonaccrual loans
Total Loans	0	1
Financing Receivables, Equal to Greater than 90 Days Past Due
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	5,432	4,904
Financing Receivables, Equal to Greater than 90 Days Past Due | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	4,792	3,992
Financing Receivables, Equal to Greater than 90 Days Past Due | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	3,560	1,019
Financing Receivables, Equal to Greater than 90 Days Past Due | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	156	533
Financing Receivables, Equal to Greater than 90 Days Past Due | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,076	2,440
Financing Receivables, Equal to Greater than 90 Days Past Due | Commercial and non-residential real estate | SBA PPP
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financing Receivables, Equal to Greater than 90 Days Past Due | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	545	817
Financing Receivables, Equal to Greater than 90 Days Past Due | Home Equity
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	95	95
Financing Receivables, Equal to Greater than 90 Days Past Due | Consumer
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans
Aging categories of performing loans and nonaccrual loans
Total Loans	5,039	3,929
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	3,630	1,316
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total Loans	419	1,204
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	2,988	112
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total Loans	223	0
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	844	2,374
Financing Receivables, Equal to Greater than 90 Days Past Due | Purchased credit impaired loans | Consumer
Aging categories of performing loans and nonaccrual loans
Total Loans	565	239
Financial Asset, Past Due
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	14,078	10,614
Financial Asset, Past Due | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	12,159	5,311
Financial Asset, Past Due | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	10,927	2,092
Financial Asset, Past Due | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	156	779
Financial Asset, Past Due | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,076	2,440
Financial Asset, Past Due | Commercial and non-residential real estate | SBA PPP
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	0	0
Financial Asset, Past Due | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	1,686	4,844
Financial Asset, Past Due | Home Equity
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	227	459
Financial Asset, Past Due | Consumer
Aging categories of performing loans and nonaccrual loans
Total loans, excluding PCI	6	0
Financial Asset, Past Due | Purchased credit impaired loans
Aging categories of performing loans and nonaccrual loans
Total Loans	5,920	4,924
Financial Asset, Past Due | Purchased credit impaired loans | Commercial and non-residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	4,447	1,452
Financial Asset, Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial business
Aging categories of performing loans and nonaccrual loans
Total Loans	419	1,340
Financial Asset, Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Commercial real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	3,628	112
Financial Asset, Past Due | Purchased credit impaired loans | Commercial and non-residential real estate | Acquisition and development
Aging categories of performing loans and nonaccrual loans
Total Loans	400	0
Financial Asset, Past Due | Purchased credit impaired loans | Residential real estate
Aging categories of performing loans and nonaccrual loans
Total Loans	908	3,229
Financial Asset, Past Due | Purchased credit impaired loans | Consumer
Aging categories of performing loans and nonaccrual loans
Total Loans	$ 565	$ 243

Loans and Allowance for Loan _8

Loans and Allowance for Loan Losses - Allowance (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Changes in the allowance for loan losses
Beginning balance, excluding PCI loans acquired	$ 24,882	$ 17,569	$ 25,760	$ 11,775
Balance at beginning of period			25,844
Recoveries	23	5	248	17
Provision (release)	1	8,696	(837)	16,257
Charge-offs	(98)	(100)	(363)	(1,879)
Allowance contributed with mortgage combination transaction		(354)		(354)
Ending balance, excluding PCI loans acquired	24,808	25,816	24,808	25,816
Balance at end of period	25,187		25,187
Individually evaluated for impairment	4,104	1,984	4,104	1,984
Collectively evaluated for impairment	20,704	23,832	20,704	23,832
Purchased credit impaired loans
Changes in the allowance for loan losses
Balance at beginning of period	0	173	84	0
Provision (release)	379	(65)	295	108
Charge-offs		(11)		(11)
Balance at end of period	379	97	379	97
Collectively evaluated for impairment	379	97	379	97
Commercial and non-residential real estate
Changes in the allowance for loan losses
Beginning balance, excluding PCI loans acquired	22,659	15,401	24,033	10,098
Recoveries	10	3	224	9
Provision (release)	(529)	8,840	(1,852)	15,893
Charge-offs	(96)	(100)	(361)	(1,856)
Allowance contributed with mortgage combination transaction		0		0
Ending balance, excluding PCI loans acquired	22,044	24,144	22,044	24,144
Individually evaluated for impairment	4,035	1,984	4,035	1,984
Collectively evaluated for impairment	18,009	22,160	18,009	22,160
Commercial and non-residential real estate | Purchased credit impaired loans
Changes in the allowance for loan losses
Balance at beginning of period	0	121	0	0
Provision (release)	14	(121)	14	0
Charge-offs		0		0
Balance at end of period	14	0	14	0
Collectively evaluated for impairment	14	0	14	0
Residential real estate
Changes in the allowance for loan losses
Beginning balance, excluding PCI loans acquired	1,363	1,846	1,378	1,272
Recoveries	0	0	0	0
Provision (release)	(42)	(218)	(57)	356
Charge-offs	(2)	0	(2)	0
Allowance contributed with mortgage combination transaction		(354)		(354)
Ending balance, excluding PCI loans acquired	1,319	1,274	1,319	1,274
Individually evaluated for impairment	0	0	0	0
Collectively evaluated for impairment	1,319	1,274	1,319	1,274
Residential real estate | Purchased credit impaired loans
Changes in the allowance for loan losses
Balance at beginning of period	0	52	84	0
Provision (release)	365	56	281	108
Charge-offs		(11)		(11)
Balance at end of period	365	97	365	97
Collectively evaluated for impairment	365	97	365	97
Home Equity
Changes in the allowance for loan losses
Beginning balance, excluding PCI loans acquired	284	264	298	327
Recoveries	13	2	21	6
Provision (release)	(37)	82	(59)	38
Charge-offs	0	0	0	(23)
Allowance contributed with mortgage combination transaction		0		0
Ending balance, excluding PCI loans acquired	260	348	260	348
Individually evaluated for impairment	69	0	69	0
Collectively evaluated for impairment	191	348	191	348
Consumer
Changes in the allowance for loan losses
Beginning balance, excluding PCI loans acquired	576	58	51	78
Recoveries	0	0	3	2
Provision (release)	609	(8)	1,131	(30)
Charge-offs	0	0	0	0
Allowance contributed with mortgage combination transaction		0		0
Ending balance, excluding PCI loans acquired	1,185	50	1,185	50
Individually evaluated for impairment	0	0	0	0
Collectively evaluated for impairment	$ 1,185	$ 50	$ 1,185	$ 50

Loans and Allowance for Loan _9

Loans and Allowance for Loan Losses - Primary Segments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Components of loans
Individually evaluated for impairment	$ 19,217		$ 17,502
Collectively evaluated for impairment	1,726,961		1,373,352
Total loans, excluding acquired	1,746,178	$ 1,415,362	1,390,854
Total Loans	1,766,288	1,454,801
Commercial and non-residential real estate
Components of loans
Individually evaluated for impairment	12,148		14,350
Collectively evaluated for impairment	1,418,142		1,102,976
Total loans, excluding acquired	1,430,290	1,141,114	1,117,326
Residential real estate
Components of loans
Individually evaluated for impairment	6,971		3,051
Collectively evaluated for impairment	262,996		231,707
Total loans, excluding acquired	269,967	240,264	234,758
Home Equity
Components of loans
Individually evaluated for impairment	95		95
Collectively evaluated for impairment	23,682		34,689
Total loans, excluding acquired	23,777	30,828	34,784
Consumer
Components of loans
Individually evaluated for impairment	3		6
Collectively evaluated for impairment	22,141		3,980
Total loans, excluding acquired	$ 22,144	$ 3,156	$ 3,986

Loans and Allowance for Loan_10

Loans and Allowance for Loan Losses - Troubled Debt Restructurings (Details) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2021USD ($)borrowerloan	Sep. 30, 2020USD ($)contract	Dec. 31, 2020USD ($)
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Specific reserve allocations for TDR's	$ 500		$ 600
Troubled debt restructuring loans	7,700		10,200
Number of Contracts | contract		8
Pre-Modification Outstanding Recorded Investment		$ 6,483
Post-Modification Outstanding Recorded Investment		$ 5,665
Acquisition and development
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Loans defaulted under the restructured terms	$ 2,600
Number of loans to defaulted borrowers | loan	4
Number of borrower defaulted | borrower	2
Commercial and non-residential real estate
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Number of loans to defaulted borrowers | loan	0
Number of Contracts | contract		7
Pre-Modification Outstanding Recorded Investment		$ 6,396
Post-Modification Outstanding Recorded Investment		$ 5,579
Commercial and non-residential real estate | Commercial business
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Number of Contracts | contract		5
Pre-Modification Outstanding Recorded Investment		$ 6,237
Post-Modification Outstanding Recorded Investment		$ 5,427
Commercial and non-residential real estate | Commercial real estate
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Number of Contracts | contract		2
Pre-Modification Outstanding Recorded Investment		$ 159
Post-Modification Outstanding Recorded Investment		$ 152
Residential real estate
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Number of Contracts | contract		1
Pre-Modification Outstanding Recorded Investment		$ 87
Post-Modification Outstanding Recorded Investment		$ 86
Commercial Borrower Two | Acquisition and development
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Loans defaulted under the restructured terms	$ 2,100
Commercial Borrower One | Acquisition and development
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Loans defaulted under the restructured terms	500
Accruing
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Troubled debt restructuring loans	$ 1,400		$ 1,600
Accruing | Portfolio Risk | Troubled Debt Restructured Loans
Details related to loans identified as Troubled Debt Restructurings (TDRs):
Percentage of total impaired loans	8.00%		10.00%

Loans and Allowance for Loan_11

Loans and Allowance for Loan Losses - Carrying Amount of PCI Loans (Details) - Purchased credit impaired loans - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financing Receivable, Impaired [Line Items]
Outstanding balance	$ 20,110	$ 39,439
Carrying amount, net of allowance	$ 20,110	39,355
Commercial and non-residential real estate
Financing Receivable, Impaired [Line Items]
Outstanding balance		21,008
Residential real estate
Financing Receivable, Impaired [Line Items]
Outstanding balance		16,943
Consumer
Financing Receivable, Impaired [Line Items]
Outstanding balance		$ 1,488

Loans and Allowance for Loan_12

Loans and Allowance for Loan Losses - Accretiable Yield (Details) - Purchased credit impaired loans - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]
Beginning balance	$ 8,313	$ 0
New loans purchased	0	11,746
Accretion of income	(3,080)	(2,945)
Other changes in expected cash flows	1,234	(488)
Ending balance	$ 6,467	$ 8,313

Loans and Allowance for Loan_13

Loans and Allowance for Loan Losses - PPP Loans and CARES Act Deferrals (Details) $ in Thousands	Sep. 30, 2021USD ($)loan	Dec. 31, 2020USD ($)
Financing Receivable, Impaired [Line Items]
Total Loans	$ 1,766,288	$ 1,454,801
Commercial and non-residential real estate
Financing Receivable, Impaired [Line Items]
Loans approved for modification	6,600
Consumer
Financing Receivable, Impaired [Line Items]
Loans approved for modification	$ 2,700
SBA PPP
Financing Receivable, Impaired [Line Items]
Number of loans | loan	733
Original balance of loans	$ 27,900
Total Loans	$ 119,400

Premises and Equipment - Premis

Premises and Equipment - Premises and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Premises and equipment
Gross premises and equipment	$ 40,429	$ 40,392
Accumulated depreciation	(15,386)	(14,189)
Premises and equipment, net	25,043	26,203
Land
Premises and equipment
Gross premises and equipment	3,465	3,936
Buildings and improvements
Premises and equipment
Gross premises and equipment	13,393	14,350
Furniture, fixtures and equipment
Premises and equipment
Gross premises and equipment	16,615	17,451
Software
Premises and equipment
Gross premises and equipment	3,978	1,527
Construction in progress
Premises and equipment
Gross premises and equipment	113	49
Leasehold improvements
Premises and equipment
Gross premises and equipment	$ 2,865	$ 3,079

Premises and Equipment - Narrat

Premises and Equipment - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Lease liability	$ 17,100	$ 18,400
Operating lease liability	16,987	18,300
Finance lease liability	70	200
Right-of-use asset	18,200	17,700
Operating lease, right of use asset	17,800	17,500
Finance lease, right of use asset	$ 400	$ 200
Finance lease, weighted average remaining lease term (in years)	1 year 10 months 24 days	2 years 3 months 18 days
Finance lease, weighted average discount rate, (as a percentage)	2.10%	2.40%
Operating lease, weighted average remaining lease term (in years)	12 years 2 months 12 days	12 years 10 months 24 days
Operating lease, weighted average discount rate, (as a percentage)	2.80%	2.90%

Premises and Equipment - Lease

Premises and Equipment - Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating lease cost	$ 504	$ 473	$ 1,458	$ 1,594
Short-term lease cost	2	0	4	26
Variable lease cost	9	10	29	30
Amortization of right-of-use assets, finance leases	16	13	44	49
Interest on lease liabilities, finance leases	0	1	2	3
Total lease cost	$ 531	$ 497	$ 1,537	$ 1,702

Premises and Equipment - Summar

Premises and Equipment - Summary of Lease Liability (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Finance Leases
2021	$ 15
2022	42
2023	5
2024	5
2025	4
2026 and thereafter	0
Total future minimum lease payments	71
Less: Amounts representing interest	(1)
Present value of net future minimum lease payments	70	$ 200
Operating Leases
2021	468
2022	1,946
2023	1,897
2024	1,827
2025	1,826
2026 and thereafter	12,901
Total future minimum lease payments	20,865
Less: Amounts representing interest	(3,878)
Present value of net future minimum lease payments	$ 16,987	$ 18,300

Equity Method Investments (Deta

Equity Method Investments (Details) loan in Thousands, $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2021USD ($)loan	Sep. 30, 2020USD ($)loan	Sep. 30, 2021USD ($)loan	Sep. 30, 2020USD ($)loan	Dec. 31, 2020USD ($)
Schedule of Equity Method Investments [Line Items]
Equity method investment income		$ 3,573	$ 13,620	$ 14,570	$ 13,620
Net income		11,828	6,491	29,160	25,573
Locked mortgage pipeline	$ 1,150,000	1,150,000		1,150,000		$ 1,540,000
Equity method investment	38,935	38,935		38,935		$ 46,494
Intercoastal
Schedule of Equity Method Investments [Line Items]
Equity method investment income		3,600		14,600
Interchecks
Schedule of Equity Method Investments [Line Items]
Increase in equity method investment	4,500
Equity method investment	$ 7,700	$ 7,700		$ 7,700
Ownership percentage	16.90%	16.90%		16.90%
Equity Method Investment, Nonconsolidated Investee or Group of Investees | Intercoastal
Schedule of Equity Method Investments [Line Items]
Total revenues		$ 35,229	62,915	$ 126,106	62,915
Net income		9,962	28,979	36,747	28,979
Gain on sale of loans		$ 30,720	$ 39,518	$ 122,621	$ 39,518
Volume of loans sold | loan		1,098,475	1,215,512	4,368,875	1,215,512

Deposits - Schedule of Deposits

Deposits - Schedule of Deposits (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Deposits [Abstract]
Noninterest-bearing demand	$ 999,328	$ 715,791
Interest-bearing demand	767,268	496,502
Savings and money markets	530,538	545,501
Time deposits, including CDs and IRAs	101,806	224,595
Total deposits	2,398,940	1,982,389
Time deposits that meet or exceed the FDIC insurance limit	$ 9,563	$ 16,955

Deposits - Maturities (Details)

Deposits - Maturities (Details) $ in Thousands	Sep. 30, 2021USD ($)
Deposits [Abstract]
2022	$ 64,757
2023	21,466
2024	10,794
2025	3,726
2026	1,063
Total	101,806
Overdrawn deposits	$ 54

Borrowed Funds - Short-term Bor

Borrowed Funds - Short-term Borrowings, Long-term borrowings and Repurchase Agreements (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Borrowed funds
FHLB maximum borrowing capacity	$ 454,400
FHLB, remaining borrowing capacity	443,000
Short-term Borrowings from FHLB
Short-term Borrowings and Repurchase Agreements
Balance at end of period	0	$ 0
Average balance during the period	33,914	68,407
Maximum month-end balance	$ 130,047	$ 154,248
Weighted-average rate during the period	0.36%	0.58%
Weighted-average rate at end of period	0.00%	0.00%
Investment Securities
Short-term Borrowings and Repurchase Agreements
Investment securities held as collateral	$ 11,500	$ 10,700
Repurchase Agreements
Short-term Borrowings and Repurchase Agreements
Balance at end of period	11,139	10,266
Average balance during the period	10,677	9,856
Maximum month-end balance	$ 11,361	$ 10,505
Weighted-average rate during the period	0.14%	0.23%
Weighted-average rate at end of period	0.12%	0.14%

Borrowed Funds - Subordinated D

Borrowed Funds - Subordinated Debt (Details) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
	Nov. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Mar. 31, 2007
Subordinated Debt
Balance at end of period		$ 72,966,000	$ 43,407,000
Subordinated Debt
Subordinated Debt
Balance at end of period		72,966,000	43,407,000
Average balance during the period		43,786,000	7,568,000
Maximum month-end balance		$ 72,966,000	$ 43,524,000
Weighted-average rate during the period		0.17%	3.45%
Weighted-average rate at end of period		4.03%	4.02%
Face amount of debt issued	$ 40,000,000	$ 30,000,000
Term of debt instrument	10 years	10 years
Interest rate on debt security	4.25%	3.25%
Subordinated Debt | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Subordinated Debt
Variable rate basis spread	4.01%
Subordinated Debt | Subordinated Debentures
Subordinated Debt
Face amount of debt issued				$ 4,000,000
Subordinated Debt | Subordinated Debentures | LIBOR
Subordinated Debt
Variable rate basis spread		1.62%

Pension and Supplemental Exec_3

Pension and Supplemental Executive Retirement Plans - Narrative (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)installment	Dec. 31, 2020USD ($)	May 31, 2014
Defined Benefit Plan Disclosure [Line Items]
Discount rate used to re-measure pension obligation			4.50%
Supplemental Employee Retirement Plan
Defined Benefit Plan Disclosure [Line Items]
Employment period	3 years
Benefit obligation	$ 1,800
Number of equal consecutive installments | installment	180
Consecutive installments, amount	$ 10
Discount rate used to re-measure pension obligation	4.00%
Accrued liability	$ 1,300	$ 1,200

Pension and Supplemental Exec_4

Pension and Supplemental Executive Retirement Plans - Defined Benefit Plan Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Components of net periodic pension cost
Service cost	$ 0	$ 0	$ 0	$ 0
Interest cost	78	91	234	273
Expected return on plan assets	(118)	(109)	(354)	(327)
Amortization of net actuarial loss	127	105	381	315
Amortization of prior service cost	0	0	0	0
Net periodic benefit cost	87	87	261	261
Contributions paid	$ 0	$ 119	$ 3,835	$ 587

Stock Offerings (Details)

Stock Offerings (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended				3 Months Ended
	Sep. 30, 2021	Aug. 31, 2021	Apr. 30, 2021	Dec. 31, 2020	Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value (in dollars per share)	$ 1,000			$ 1,000	$ 1,000
Common stock issued related to stock-based compensation					$ 1,000
Interchecks
Subsidiary, Sale of Stock [Line Items]
Common stock issued related to equity method investment (in shares)		107,928
Trabian
Subsidiary, Sale of Stock [Line Items]
Common stock issued related to acquisition (in shares)			17,597
Chartwell
Subsidiary, Sale of Stock [Line Items]
Common stock issued related to stock-based compensation (in shares)	24,408
Sale of stock, price per share (in dollars per share)	$ 40.97				$ 40.97
Common stock issued related to stock-based compensation	$ 1,000
Series B Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value (in dollars per share)				1
Liquidation preference (in dollars per share)				1,000
Dividends declared (in dollars per share)				46.03
Series C Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value (in dollars per share)				1
Liquidation preference (in dollars per share)				1,000
Dividends declared (in dollars per share)				49.86
Series B And Series C preferred Stock
Subsidiary, Sale of Stock [Line Items]
Liquidation amount per share (in dollars per share)				$ 10,000

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Carrying Values and Estimated Fair Values (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Financial Assets:
Cash and cash equivalents	$ 390,081	$ 263,893
Certificates of deposit with banks	9,582	11,803
Investment securities available-for-sale	439,023	410,624
Equity securities	29,809	27,585
Bank-owned life insurance	42,011	41,262
Carrying Value
Financial Assets:
Cash and cash equivalents	390,081	263,893
Certificates of deposit with banks	9,582	11,803
Investment securities available-for-sale	439,023	410,624
Equity securities	29,809	27,585
Loans held-for-sale		1,062
Loans receivable, net	1,738,999	1,427,900
Servicing Assets	2,667	2,942
Accrued interest receivable	8,513	7,793
Bank-owned life insurance	42,011	41,262
Financial Liabilities:
Deposits	2,398,940	1,982,389
Repurchase agreements	11,139	10,266
FHLB and other borrowings	0
Accrued interest payable	802	572
Subordinated debt	72,966	43,407
Estimated Fair Value
Financial Assets:
Cash and cash equivalents	390,081	263,893
Certificates of deposit with banks	9,657	11,986
Investment securities available-for-sale	439,023	410,624
Equity securities	29,809	27,585
Loans held-for-sale		1,062
Loans receivable, net	1,748,759	1,434,275
Servicing Assets	2,667	2,942
Accrued interest receivable	8,513	7,793
Bank-owned life insurance	42,011	41,262
Financial Liabilities:
Deposits	2,375,650	1,964,860
Repurchase agreements	11,139	10,266
FHLB and other borrowings	0
Accrued interest payable	802	572
Subordinated debt	73,825	45,536
Interest rate swap | Carrying Value
Financial Assets:
Derivative asset	8,444	13,822
Financial Liabilities:
Derivative liability	8,444	13,822
Interest rate swap | Estimated Fair Value
Financial Assets:
Derivative asset	8,444	13,822
Financial Liabilities:
Derivative liability	8,444	13,822
Fair value hedge | Carrying Value
Financial Assets:
Derivative asset	1,699	2,215
Financial Liabilities:
Derivative liability	1,129	2,141
Fair value hedge | Estimated Fair Value
Financial Assets:
Derivative asset	1,699	2,215
Financial Liabilities:
Derivative liability	1,129	2,141
Quoted Prices in Active Markets for Identical Assets (Level I) | Estimated Fair Value
Financial Assets:
Cash and cash equivalents	390,081	263,893
Certificates of deposit with banks	0	0
Investment securities available-for-sale	0	0
Equity securities	729	472
Loans held-for-sale		0
Loans receivable, net	0	0
Servicing Assets	0	0
Accrued interest receivable	0	0
Bank-owned life insurance	0	0
Financial Liabilities:
Deposits	0	0
Repurchase agreements	0	0
FHLB and other borrowings	0
Accrued interest payable	0	0
Subordinated debt	0	0
Quoted Prices in Active Markets for Identical Assets (Level I) | Interest rate swap | Estimated Fair Value
Financial Assets:
Derivative asset	0	0
Financial Liabilities:
Derivative liability	0	0
Quoted Prices in Active Markets for Identical Assets (Level I) | Fair value hedge | Estimated Fair Value
Financial Assets:
Derivative asset	0	0
Financial Liabilities:
Derivative liability	0	0
Significant Other Observable Inputs (Level II) | Estimated Fair Value
Financial Assets:
Cash and cash equivalents	0	0
Certificates of deposit with banks	9,657	11,986
Investment securities available-for-sale	397,609	366,945
Equity securities	0	0
Loans held-for-sale		1,062
Loans receivable, net	0	0
Servicing Assets	0	0
Accrued interest receivable	2,621	2,770
Bank-owned life insurance	42,011	41,262
Financial Liabilities:
Deposits	2,375,650	1,964,860
Repurchase agreements	11,139	10,266
FHLB and other borrowings	0
Accrued interest payable	802	572
Subordinated debt	73,825	45,536
Significant Other Observable Inputs (Level II) | Interest rate swap | Estimated Fair Value
Financial Assets:
Derivative asset	8,444	13,822
Financial Liabilities:
Derivative liability	8,444	13,822
Significant Other Observable Inputs (Level II) | Fair value hedge | Estimated Fair Value
Financial Assets:
Derivative asset	1,699	2,215
Financial Liabilities:
Derivative liability	1,129	2,141
Significant Unobservable Inputs (Level III) | Estimated Fair Value
Financial Assets:
Cash and cash equivalents	0	0
Certificates of deposit with banks	0	0
Investment securities available-for-sale	41,414	43,679
Equity securities	29,080	27,113
Loans held-for-sale		0
Loans receivable, net	1,748,759	1,434,275
Servicing Assets	2,667	2,942
Accrued interest receivable	5,892	5,023
Bank-owned life insurance	0	0
Financial Liabilities:
Deposits	0	0
Repurchase agreements	0	0
FHLB and other borrowings	0
Accrued interest payable	0	0
Subordinated debt	0	0
Significant Unobservable Inputs (Level III) | Interest rate swap | Estimated Fair Value
Financial Assets:
Derivative asset	0	0
Financial Liabilities:
Derivative liability	0	0
Significant Unobservable Inputs (Level III) | Fair value hedge | Estimated Fair Value
Financial Assets:
Derivative asset	0
Financial Liabilities:
Derivative liability	$ 0	$ 0

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair value of assets and liabilities
Investment securities available-for-sale	$ 439,023	$ 410,624
Equity securities	29,809	27,585
Recurring
Fair value of assets and liabilities
Equity securities	729	472
Loans held-for-sale		1,062
Recurring | Level I
Fair value of assets and liabilities
Equity securities	729	472
Loans held-for-sale		0
Recurring | Level II
Fair value of assets and liabilities
Equity securities	0	0
Loans held-for-sale		1,062
Recurring | Level III
Fair value of assets and liabilities
Equity securities	0	0
Loans held-for-sale		0
United States government agency securities
Fair value of assets and liabilities
Investment securities available-for-sale	41,971	53,869
United States government agency securities | Recurring
Fair value of assets and liabilities
Investment securities available-for-sale	41,971	56,992
United States government agency securities | Recurring | Level I
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
United States government agency securities | Recurring | Level II
Fair value of assets and liabilities
Investment securities available-for-sale	41,971	56,992
United States government agency securities | Recurring | Level III
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
United States sponsored mortgage-backed securities
Fair value of assets and liabilities
Investment securities available-for-sale	85,271	95,769
United States sponsored mortgage-backed securities | Recurring
Fair value of assets and liabilities
Investment securities available-for-sale	85,271	95,769
United States sponsored mortgage-backed securities | Recurring | Level I
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
United States sponsored mortgage-backed securities | Recurring | Level II
Fair value of assets and liabilities
Investment securities available-for-sale	85,271	95,769
United States sponsored mortgage-backed securities | Recurring | Level III
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
United States treasury securities
Fair value of assets and liabilities
Investment securities available-for-sale	82,422	3,123
United States treasury securities | Recurring
Fair value of assets and liabilities
Investment securities available-for-sale	82,422
United States treasury securities | Recurring | Level I
Fair value of assets and liabilities
Investment securities available-for-sale	82,422
United States treasury securities | Recurring | Level II
Fair value of assets and liabilities
Investment securities available-for-sale	0
United States treasury securities | Recurring | Level III
Fair value of assets and liabilities
Investment securities available-for-sale	0
Municipal securities | Recurring
Fair value of assets and liabilities
Investment securities available-for-sale	207,423	231,887
Municipal securities | Recurring | Level I
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
Municipal securities | Recurring | Level II
Fair value of assets and liabilities
Investment securities available-for-sale	166,009	188,208
Municipal securities | Recurring | Level III
Fair value of assets and liabilities
Investment securities available-for-sale	41,414	43,679
Other securities
Fair value of assets and liabilities
Investment securities available-for-sale	14,436	18,476
Other securities | Recurring
Fair value of assets and liabilities
Investment securities available-for-sale	14,436	18,476
Other securities | Recurring | Level I
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
Other securities | Recurring | Level II
Fair value of assets and liabilities
Investment securities available-for-sale	14,436	18,476
Other securities | Recurring | Level III
Fair value of assets and liabilities
Investment securities available-for-sale	0	0
Interest rate swap | Recurring
Fair value of assets and liabilities
Derivative asset	8,444	13,822
Derivative liability	8,444	13,822
Interest rate swap | Recurring | Level I
Fair value of assets and liabilities
Derivative asset	0	0
Derivative liability	0	0
Interest rate swap | Recurring | Level II
Fair value of assets and liabilities
Derivative asset	8,444	13,822
Derivative liability	8,444	13,822
Interest rate swap | Recurring | Level III
Fair value of assets and liabilities
Derivative asset	0	0
Derivative liability	0	0
Fair value hedge | Recurring
Fair value of assets and liabilities
Derivative asset	1,699	2,215
Derivative liability	1,129	2,141
Fair value hedge | Recurring | Level I
Fair value of assets and liabilities
Derivative asset	0	0
Derivative liability	0	0
Fair value hedge | Recurring | Level II
Fair value of assets and liabilities
Derivative asset	1,699	2,215
Derivative liability	1,129	2,141
Fair value hedge | Recurring | Level III
Fair value of assets and liabilities
Derivative asset	0	0
Derivative liability	$ 0	$ 0

Fair Value Measurements - Recur

Fair Value Measurements - Recurring Level III Assets (Details) - Level III - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 39,770	$ 47,795	$ 43,679	$ 38,919
Realized and unrealized gains (losses) included in earnings	5	(7,338)	25	(1,657)
Purchase of securities	1,757	368	3,575	21,147
Maturities/calls	(74)	(61)	(5,248)	(15,574)
Unrealized gain included in other comprehensive income (loss)	3,300	1,810	7,720	5,872
Unrealized loss included in other comprehensive income (loss)	(3,344)	(466)	(8,337)	(6,599)
Ending balance	41,414	42,108	41,414	42,108
Interest Rate Lock Commitments | Interest Rate Lock Commitments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	7,338	0	1,660
Realized and unrealized gains (losses) included in earnings	0	(7,338)	0	(1,660)
Purchase of securities	0	0	0	0
Maturities/calls	0	0	0	0
Unrealized gain included in other comprehensive income (loss)	0	0	0	0
Unrealized loss included in other comprehensive income (loss)	0	0	0	0
Ending balance	0	0	0	0
Municipal Securities | Total debt securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	39,770	40,457	43,679	37,259
Realized and unrealized gains (losses) included in earnings	5	0	25	3
Purchase of securities	1,757	368	3,575	21,147
Maturities/calls	(74)	(61)	(5,248)	(15,574)
Unrealized gain included in other comprehensive income (loss)	3,300	1,810	7,720	5,872
Unrealized loss included in other comprehensive income (loss)	(3,344)	(466)	(8,337)	(6,599)
Ending balance	$ 41,414	$ 42,108	$ 41,414	$ 42,108

Fair Value Measurements - Ass_2

Fair Value Measurements - Assets Measured at Fair Value on Nonrecurring Basis (Details) - Non-recurring - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Impaired loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	$ 15,114	$ 14,098
Impaired loans | Level I
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Impaired loans | Level II
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Impaired loans | Level III
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	15,114	14,098
Other real estate owned
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	3,442	5,730
Other real estate owned | Level I
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Other real estate owned | Level II
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Other real estate owned | Level III
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	$ 3,442	$ 5,730

Fair Value Measurements - Quant

Fair Value Measurements - Quantitative Information About Level III Significant Unobservable Inputs (Details) $ in Thousands	Sep. 30, 2021USD ($)	Dec. 31, 2020USD ($)
Non-recurring | Impaired loans
Quantitative Information about Level III Fair Value Measurements
Assets, fair value	$ 15,114	$ 14,098
Non-recurring | Impaired loans | Level III
Quantitative Information about Level III Fair Value Measurements
Assets, fair value	15,114	14,098
Non-recurring | Other real estate owned
Quantitative Information about Level III Fair Value Measurements
Assets, fair value	3,442	5,730
Non-recurring | Other real estate owned | Level III
Quantitative Information about Level III Fair Value Measurements
Assets, fair value	3,442	5,730
Recurring | Municipal Securities | Level III
Quantitative Information about Level III Fair Value Measurements
Assets, fair value	$ 41,414	$ 43,679
Appraisal adjustments | Non-recurring | Impaired loans | Appraisal of collateral | Level III | Minimum
Quantitative Information about Level III Fair Value Measurements
Impaired loans	0.20	0.20
Appraisal adjustments | Non-recurring | Impaired loans | Appraisal of collateral | Level III | Maximum
Quantitative Information about Level III Fair Value Measurements
Impaired loans	0.62	0.62
Appraisal adjustments | Non-recurring | Other real estate owned | Appraisal of collateral | Level III | Minimum
Quantitative Information about Level III Fair Value Measurements
Other real estate owned	0.20	0.20
Appraisal adjustments | Non-recurring | Other real estate owned | Appraisal of collateral | Level III | Maximum
Quantitative Information about Level III Fair Value Measurements
Other real estate owned	0.30	0.30
Appraisal adjustments | Recurring | Municipal Securities | Appraisal of bond | Level III | Minimum
Quantitative Information about Level III Fair Value Measurements
Municipal Securities	0.05	0.05
Appraisal adjustments | Recurring | Municipal Securities | Appraisal of bond | Level III | Maximum
Quantitative Information about Level III Fair Value Measurements
Municipal Securities	0.15	0.15
Liquidation expense | Non-recurring | Impaired loans | Appraisal of collateral | Level III | Minimum
Quantitative Information about Level III Fair Value Measurements
Impaired loans	0.05	0.05
Liquidation expense | Non-recurring | Impaired loans | Appraisal of collateral | Level III | Maximum
Quantitative Information about Level III Fair Value Measurements
Impaired loans	0.10	0.10
Liquidation expense | Non-recurring | Other real estate owned | Appraisal of collateral | Level III | Minimum
Quantitative Information about Level III Fair Value Measurements
Other real estate owned	0.05	0.05
Liquidation expense | Non-recurring | Other real estate owned | Appraisal of collateral | Level III | Maximum
Quantitative Information about Level III Fair Value Measurements
Other real estate owned	0.10	0.10

Earnings per Share (Details)

Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator for basic earnings per share:
Net income before noncontrolling interest	$ 11,828	$ 6,491	$ 29,160	$ 25,573
Less: Dividends on preferred stock	0	116	35	345
Net income available to common shareholders	11,828	6,375	29,125	25,228
Numerator for diluted earnings per share:
Net income available to common shareholders - diluted	$ 11,828	$ 6,375	$ 29,125	$ 25,228
Denominator:
Total weighted-average shares outstanding (in shares)	11,880,348	11,948,989	11,684,570	11,948,857
Effect of dilutive stock options and restricted stock units (in shares)	943,961	167,429	881,239	236,280
Total diluted weighted-average shares outstanding (in shares)	12,824,309	12,116,418	12,565,809	12,185,137
Earnings per share - basic (in dollars per share)	$ 1	$ 0.53	$ 2.49	$ 2.11
Earnings per share - diluted (in dollars per share)	$ 0.92	$ 0.53	$ 2.32	$ 2.07
Stock option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded form computation of earnings per share (in shares)	179,694	849,589	185,944	815,089

Comprehensive Income - Reclassi

Comprehensive Income - Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Comprehensive Income
Gain on sale of available-for-sale securities	$ 529	$ 35	$ 3,380	$ 865
Income tax expense	(3,164)	(2,021)	(7,006)	(8,208)
Net income before noncontrolling interest	11,828	6,491	29,160	25,573
Salaries and employee benefits	(16,528)	(10,519)	(42,100)	(49,360)
Interest on investment securities	575	411	1,831	1,554
Amount reclassified from AOCI
Comprehensive Income
Net income before noncontrolling interest	297	(120)	1,807	940
Available-for-sale securities | Amount reclassified from AOCI
Comprehensive Income
Gain on sale of available-for-sale securities	529	35	3,380	865
Income tax expense	(124)	(9)	(793)	(234)
Net income before noncontrolling interest	405	26	2,587	631
Defined benefit pension plan items | Amount reclassified from AOCI
Comprehensive Income
Income tax expense	30	28	89	85
Net income before noncontrolling interest	(97)	(77)	(292)	(230)
Salaries and employee benefits	(127)	(105)	(381)	(315)
Investment hedge | Amount reclassified from AOCI
Comprehensive Income
Income tax expense	3	26	149	(199)
Net income before noncontrolling interest	(11)	(69)	(488)	539
Interest on investment securities	$ (14)	$ (95)	$ (637)	$ 738

Comprehensive Income - Componen

Comprehensive Income - Components of AOCI (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accumulated Other Comprehensive Income (AOCI)
Beginning balance			$ 239,483
Other comprehensive income (loss) before reclassification	$ (517)	$ 821	(1,234)	$ 1,009
Amounts reclassified from AOCI	(297)	120	(1,807)	(940)
Total other comprehensive (loss) income	(814)	941	(3,041)	69
Ending balance	265,565		265,565
Unrealized gains (losses) on available for-sale securities
Accumulated Other Comprehensive Income (AOCI)
Beginning balance	3,136	3,771	7,586	2,942
Other comprehensive income (loss) before reclassification	183	895	(2,085)	2,329
Amounts reclassified from AOCI	(405)	(26)	(2,587)	(631)
Total other comprehensive (loss) income	(222)	869	(4,672)	1,698
Ending balance	2,914	4,640	2,914	4,640
Defined benefit pension plan items
Accumulated Other Comprehensive Income (AOCI)
Beginning balance	(3,301)	(5,388)	(5,047)	(4,295)
Other comprehensive income (loss) before reclassification	(700)	(74)	851	(1,320)
Amounts reclassified from AOCI	97	77	292	230
Total other comprehensive (loss) income	(603)	3	1,143	(1,090)
Ending balance	(3,904)	(5,385)	(3,904)	(5,385)
Investment hedge
Accumulated Other Comprehensive Income (AOCI)
Beginning balance	164	(576)	(313)	32
Other comprehensive income (loss) before reclassification	0	0	0	0
Amounts reclassified from AOCI	11	69	488	(539)
Total other comprehensive (loss) income	11	69	488	(539)
Ending balance	175	(507)	175	(507)
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (AOCI)
Beginning balance	(1)	(2,193)	2,226	(1,321)
Ending balance	$ (815)	$ (1,252)	$ (815)	$ (1,252)

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021USD ($)	Jun. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Sep. 30, 2021USD ($)segment	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment							3
Interest income	$ 20,484			$ 18,627			$ 60,380	$ 61,100
Interest expense	1,388			2,617			4,724	10,461
NET INTEREST INCOME	19,096			16,010			55,656	50,639
Provision for loan losses	380			8,631			(542)	16,365
Net interest income (loss) after provision for loan losses	18,716			7,379			56,198	34,274
Noninterest Income:
Total noninterest income	21,951			19,398			48,053	75,761
Noninterest Expenses:
Salaries and employee benefits	16,528			10,519			42,100	49,360
Other expense	9,301			7,746			26,250	26,894
Total noninterest expense	25,829			18,265			68,350	76,254
Income before income taxes	14,838			8,512			35,901	33,781
Income tax expense (benefit)	3,164			2,021			7,006	8,208
Net income before noncontrolling interest	11,674	$ 9,163	$ 8,058	6,491	$ 18,034	$ 1,048	28,895	25,573
Net loss attributable to noncontrolling interest	154			0			265	0
Net income attributable to parent	11,828			6,491			29,160	25,573
Preferred dividends	0			116			35	345
Net income available to common shareholders	11,828			6,375			29,125	25,228
Capital expenditures	1,975			1,652			4,127	4,211
Assets	2,788,824						2,788,824		$ 2,331,476
Goodwill	3,988						3,988		2,350
Operating Segments | CoRe Banking
Segment Reporting Information [Line Items]
Interest income	20,383			18,737			60,078	56,693
Interest expense	912			2,553			3,294	9,418
NET INTEREST INCOME	19,471			16,184			56,784	47,275
Provision for loan losses	379			8,631			(541)	16,361
Net interest income (loss) after provision for loan losses	19,092			7,553			57,325	30,914
Noninterest Income:
Total noninterest income	20,211			3,106			36,634	24,394
Noninterest Expenses:
Salaries and employee benefits	13,097			7,526			32,323	19,562
Other expense	11,654			8,389			31,261	24,172
Total noninterest expense	24,751			15,915			63,584	43,734
Income before income taxes	14,552			(5,256)			30,375	11,574
Income tax expense (benefit)	2,973			(1,556)			5,290	2,336
Net income before noncontrolling interest	11,579			(3,700)			25,085	9,238
Net loss attributable to noncontrolling interest	154						265
Net income attributable to parent	11,733						25,350
Preferred dividends	0			0			0	0
Net income available to common shareholders	11,733			(3,700)			25,350	9,238
Capital expenditures	1,975			1,652			4,127	4,092
Assets	2,827,019						2,827,019		2,343,556
Goodwill	3,988						3,988		2,350
Operating Segments | Mortgage Banking
Segment Reporting Information [Line Items]
Interest income	105			78			307	6,034
Interest expense	0			232			0	3,136
NET INTEREST INCOME	105			(154)			307	2,898
Provision for loan losses	1			0			(1)	4
Net interest income (loss) after provision for loan losses	104			(154)			308	2,894
Noninterest Income:
Total noninterest income	3,546			16,793			14,499	53,140
Noninterest Expenses:
Salaries and employee benefits	47			82			47	21,550
Other expense	(198)			68			(112)	4,780
Total noninterest expense	(151)			150			(65)	26,330
Income before income taxes	3,801			16,489			14,872	29,704
Income tax expense (benefit)	922			4,245			3,606	7,696
Net income before noncontrolling interest	2,879			12,244			11,266	22,008
Net loss attributable to noncontrolling interest	0						0
Net income attributable to parent	2,879						11,266
Preferred dividends	0			0			0	0
Net income available to common shareholders	2,879			12,244			11,266	22,008
Capital expenditures	0			0			0	99
Assets	53,261						53,261		58,140
Goodwill	0						0		0
Operating Segments | Financial Holding Company
Segment Reporting Information [Line Items]
Interest income	1			0			2	2
Interest expense	481			20			1,437	78
NET INTEREST INCOME	(480)			(20)			(1,435)	(76)
Provision for loan losses	0			0			0	0
Net interest income (loss) after provision for loan losses	(480)			(20)			(1,435)	(76)
Noninterest Income:
Total noninterest income	2,002			1,481			5,892	4,664
Noninterest Expenses:
Salaries and employee benefits	3,384			2,911			9,730	8,248
Other expense	1,653			1,271			4,073	3,837
Total noninterest expense	5,037			4,182			13,803	12,085
Income before income taxes	(3,515)			(2,721)			(9,346)	(7,497)
Income tax expense (benefit)	(731)			(668)			(1,890)	(1,824)
Net income before noncontrolling interest	(2,784)			(2,053)			(7,456)	(5,673)
Net loss attributable to noncontrolling interest	0						0
Net income attributable to parent	(2,784)						(7,456)
Preferred dividends	0			116			35	345
Net income available to common shareholders	(2,784)			(2,169)			(7,491)	(6,018)
Capital expenditures	0			0			0	20
Assets	342,677						342,677		284,943
Goodwill	0						0		0
Intercompany Eliminations
Segment Reporting Information [Line Items]
Interest income	(5)			(188)			(7)	(1,629)
Interest expense	(5)			(188)			(7)	(2,171)
NET INTEREST INCOME	0			0			0	542
Provision for loan losses	0			0			0	0
Net interest income (loss) after provision for loan losses	0			0			0	542
Noninterest Income:
Total noninterest income	(3,808)			(1,982)			(8,972)	(6,437)
Noninterest Expenses:
Salaries and employee benefits	0			0			0	0
Other expense	(3,808)			(1,982)			(8,972)	(5,895)
Total noninterest expense	(3,808)			(1,982)			(8,972)	(5,895)
Income before income taxes	0			0			0	0
Income tax expense (benefit)	0			0			0	0
Net income before noncontrolling interest	0			0			0	0
Net loss attributable to noncontrolling interest	0						0
Net income attributable to parent	0						0
Preferred dividends	0			0			0	0
Net income available to common shareholders	0			0			0	0
Capital expenditures	0			$ 0			0	$ 0
Assets	(434,133)						(434,133)		(355,163)
Goodwill	$ 0						$ 0		$ 0

Acquisitions and Divestitures -

Acquisitions and Divestitures - Narrative (Details)	1 Months Ended		3 Months Ended
	Apr. 30, 2021USD ($)	Feb. 28, 2021USD ($)	Sep. 30, 2021USD ($)	Jul. 31, 2021USD ($)bankingCenter	Dec. 31, 2020USD ($)
Business Acquisition [Line Items]
Goodwill			$ 3,988,000		$ 2,350,000
Noncontrolling interest			1,135,000		$ 0
Disposal Group, Disposed of by Sale, Not Discontinued Operations
Business Acquisition [Line Items]
Branch locations held for sale, number | bankingCenter				4
Deposit liabilities related to disposal group				$ 163,300,000
Loans of branches held for sale				$ 57,800,000
Gain on sale of other real estate owned			$ 10,800,000
Flexia
Business Acquisition [Line Items]
Payments for software		$ 1,000,000
Flexia
Business Acquisition [Line Items]
Ownership percentage by noncontrolling owners		20.00%	20.00%
Trabian
Business Acquisition [Line Items]
Ownership percentage by noncontrolling owners	20.00%		20.00%
Flexia
Business Acquisition [Line Items]
Ownership percentage		80.00%	80.00%
Consideration transferred		$ 2,500,000
Assets acquired		0
Liabilities assumed		0
Noncontrolling interest		$ 500,000
Trabian
Business Acquisition [Line Items]
Ownership percentage	80.00%		80.00%
Consideration transferred	$ 1,600,000
Assets acquired	800,000
Liabilities assumed	700,000
Goodwill	1,600,000
Intangible assets assumed	600,000
Noncontrolling interest	$ 400,000